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ABSTRACT 
Translational control is crucial to balancing the cell's protein output and genetic 
expression. The substrate of the translational machinery - messenger RNA (mRNA) - is 
itself subject to regulation. The lifetime of an mRNA is limited and therefore mRNA 
decay is a critical step in the regulation of gene expression. Translation and mRNA 
decay are intimately related processes as they both handle the cell economy. mRNAs are 
generally in a balancing act between the translational and the repression/decay 
machinery, which ultimately decides the fate of an mRNA and its protein expression rate. 
In fact, translation affects the rate of mRNA decay. For instance, aberrant messages 
which contain a premature-termination codon (PTC) require ribosome scanning in order 
to read the message, discover the mistake, and essentially prompt its destruction. Here, a 
relationship between the nuclear translation-like factor - eIF4AIII, the nuclear import 
factor of eIF4E - 4E-T, and mRNA decay was discovered. eIF4AIII is a nuclear protein 
that interacts physically or functionally with translation initiation factors eIF4G and 
eIF4B, respectively, and shares strikingly high identity with the initiation factors 
eIF4AI1II. This work demonstrates that eIF4AIII but not eIF4AI is required for 
nonsense-mediated decay (NMD). NMD is a surveillance mechanism in eukaryotes 
which degrades the mRNA when a PTC is present. NMD is a splicing and translation-
dependent event in mammalians. We show eIF4AIII is deposited at the exon-exon 
junction during splicing, is a shuttling protein, and is necessary for NMD. At steady 
state, 4E-T is predominantly cytoplasmic and is concentrated in bodies that 
conspicuously resemble the recently described Processing bodies (P-bodies), which are 
sites of mRNA decay. We demonstrate that 4E-T colocalizes with mRNA decapping 
III 
factors in bonafide P-bodies and that its binding partner, eIF4E, is tethered to P-bodies in 
a 4E-T dependent manner. Moreover, 4E-T controls mRNA half life. We demonstrate 
that 4E-T interaction with eIF4E represses translation, which is thought to be a 
prerequisite for targeting of mRNAs to P-bodies. Rence, analysis of prospective 
translation factors has led to elucidation of mRNA decay pathways. 
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RÉSUMÉ 
Le contrôle de la traduction est important pour équilibrer la synthèse protéique et 
l'expression génétique. Le substrat de la machine traditionnelle, l'ARN messager 
(ARNm), est lui-même sujet à régulation. La durée de vie d'un ARNm est limitée, c'est 
pourquoi la dégradation de l'ARNm est une étape critique dans la régulation de 
l'expression des gènes. La traduction et la dégradation des ARNm sont des processus 
intimement lies car ils gèrent tous deux l'économie cellulaire. Les ARNm sont 
généralement dans un état d'équilibre entre la traduction et la répression ou dégradation, 
ce qui décidera ultimement de leur destin et du niveau d'expression de la protéine 
encodée par ces ARNm. En outre, la traduction d'un ARNm affecte son niveau de 
dégradation. Par exemple, des messages aberrants (contenant un codon primature (PTC» 
nécessitent une lecture afin d'interpréter le message, de découvrir l'erreur, et 
éventuellement d'engendrer la dégradation. Nous avons découvert ici une relation entre 
le simili facteur de traduction nucléaire (eIF4AIII), le facteur d'import nucléaire de eIF4E 
(4E-T) et la dégradation des ARNm. eIF4AIII est une protéine nucléaire qui interagit 
physiquement et functionellement avec les facteurs d'initiation de la traduction eIF4G et 
eIF4B, respectivement, et est très similaire aux facteurs d'initiation eIF4AI et eIF4AII. 
Nous démontrons ici qu'eIF4AIII mais pas eIF4AI est impliqué dans la dégradation des 
ARNm non-sens (NMD). Le NMD est un mécanisme de surveillance eucaryote qui 
dégrade les ARNm contenant un PTC. Il s'agit d'un mécanisme dépendant de l'épiçage 
et de la traduction. Nous avons démontré qu'eIF4AIII est déposé au niveau de lajunction 
interrois lors de l' épiçage, transite entre noyau et cytoplasme, et est nécessaire pour le 
NMD. A l'état stationnaire, 4E-T est majoritairement cytoplasmique et se concentre dans 
v 
des foci qui ressemblent aux «processing bodies» (P-bodies) décris récemment et qui 
seraientt des sites de dégradation des ARNm. Nous avons démontré d'une part que 4E-T 
colocalise avec les facteurs responsables de la perte de la coiffe des ARNm dans ces P-
bodies, et d'autre part que son ligand eIF4E se retrouve dans ces P-bodies de façon 4E-T 
dépendante. De plus, 4E-T régule la demi-vie des ARNm. Nous avons aussi démontré 
que l'interaction entre 4E-T et eIF4E réprime la traduction, ce qui est supposé être 
nécessaire à l'adressage des ARNm aux P-bodies. Ainsi, l'analyse de facteurs de 
traduction putatifs a conduit à l'élucidation des voies de dégradation des ARNm. 
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CHAPTERI 
GENERAL INTRODUCTION 
1 
1.0 Overview 
The life of a messenger RNA (mRNA) begins with its transcription in the nucleus by 
RNA Polymerase II. Following its birth in the nucleus, it will venture through nuclear 
processing events that result in its maturation. It will then journey across the nuclear 
envelope to a safe destination or will be immediately engaged in translation, during 
which the message contained in the RNA will be decoded into protein that will, in turn, 
effect the function encrypted by such a message. Along its journey, the mRNA will 
make many associations (with proteins and RNA) which modify its appearance, affect its 
function and its fate, and ultimately determine when it is terminated by decay enzymes. 
Because of its role as a key link in the chain from DNA to prote in, mRNA metabolism 
profoundly influences gene expression. Thus, the stability of mRNA exerts a great 
impact upon cell growth, differentiation and responses to stress, to only name a few. 
Characterization of the mechanisms and regulation of mRNA turnover has revealed an 
affiliation to translation and, in recent years, increasing evidence has uncovered an 
intimate link between these two processes. The work presented here has shed sorne light 
on the relationship between translation and mRNA turnover. 
At first, the general features of an mRNA, which play a crucial role in both 
mRNA stability and translation, will be described. Then, translation initiation, with 
emphasis on cap-dependent translation, will be summarized. Subsequently, the three 
main pathways of mRNA degradation will be addressed, giving particular prominence to 
general deadenylation-dependent decay and nonsense-mediated decay. This chapter will 
conclude with the description of the localization of mRNA degradation within the cell, 
the recently reported processing bodies (P-bodies). Altogether, the work presented in this 
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thesis has contributed to the elucidation of the nonsense-rnediated decay pathway as well 
as the deadenylation-dependent general rnRNA decay in P-bodies. 
3 
1.1 Features of the mRNA 
mRNA is composed of four general features: the cap structure at the 5'end, the open 
reading frame (ORF) which encodes for the effector protein, the poly(A) tail at the 3' 
terminus, and the untranslated regions upstream (5'UTR) and downstream (3'UTR) of 
the open reading frame (Fig. 1.1). 
1.1.1 Cap structure 
The cap (5'm70pppN) is added cotranscriptionally to aH nuc1ear encoded mRNAs at the 
5' terminus and consists of a methylated guanine (m70) at the 7' position bridged by a 5'-
5' triphosphate to the penultimate base (when the 7-methylguanine is counted as the first 
base), which can be any nuc1eotide (N) (Shatkin, 1976). The cap influences rnRNA 
metabolism on multiple levels. It affects RNA splicing, polyadenylation, mRNA export, 
mRNA stability and translation. The cap structure of most messages is affixed 
independently by two main cap-binding proteins, 1) the nuc1ear cap-binding complex 
composed of cap binding protein 20 and 80 (CBP 20/80), which participates in mRNA 
splicing (Izaurralde et al., 1994), polyadenylation (Cooke and Alwine, 1996), export 
(Izaurralde et al., 1992; Visa et al., 1996) and stability (Ishigaki et al., 2001; Lejeune et 
al., 2002), and 2) eukaryotic initiation factor 4E (eIF4E), whose main function is to 
recruit the translation initiation complex to the 5' end of the mRNA and promote protein 
synthesis (Shatkin, 1985). Notably, eIF4E has also been shown to influence mRNA 
transport (Cohen et al., 2001; Lai and Borden, 2000; Rosenwald et al., 1995; Rousseau et 
al., 1996; Topisirovic et al., 2003) and stability (von der Haar et al., 2004) (see section 
1.2.3.1 and 1.2.4). 
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Figure 1.1. Features of the mRNA 
The m7GpppN cap structure at the 5' end of the mRNA, and the poly(A) tail ((A)n in the 
figure) at the 3' end, are canonical motifs that strongly promote translation initiation. 
Secondary structures, such as hairpins, block translation. InternaI ribosome entry 
sequences (IRESs) mediate cap-independent translation. Upstream open reading frames 
(uORFs) normally function as negative regulators by reducing translation from the main 
ORF. Green ovals symbolize binding sites for proteins and/or RNA regulators, which 
usually inhibit, but occasionally promote, translation. (Adapted from (Gebauer and 
Hentze, 2004) 
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1.1.25' and 3' UTRS 
These are noncoding, regulatory elements at the extremities of the rnRNA (Gebauer and 
Hentze, 2004). In the 5' UTR, these may include: hairpin structures, which are 
secondary or tertiary RNA structures which impede translation initiation (Koromilas et 
al., 1992); internaI ribosome entry sites (IRES), which direct translation in a cap-
independent fashion (Pelletier and Sonenberg, 1988); upstream open reading frames 
(ORF) which may decrease translation from the major reading frame (Morris and 
Geballe, 2000); and consensus sequence elements surrounding the initiator AUG which 
facilitate translation initiation (Kozak, 1991). Both the 5' and 3' UTRs may also contain 
sequence specific elements which recruit proteins and/or RNA which regulate translation 
efficiency and/or rnRNA half life. For example, adenine/uridine rich elements (ARE) in 
the 3 'UTR of messages influence rnRNA stability and translation by ARE-binding 
12roteins (ARE-BPs). They may either positively or negatively regulate these processes 
depending on which proteins are bound to these elements (Barreau et al., 2005). 
1.1.3 Poly(A) tait 
The poly(A) tail varies in length from 50 to 200 adenosine monophosphates at the 3' end 
of most eukaryotic mRNAs (Jacobson and Peltz, 1996). The poly(A) tail is a crucial 
determinant ofboth translation and mRNA stability (Kahvejian et al., 2001; Munroe and 
Jacobson, 1990; Wilusz et al., 2001b). It may also play a role in mRNA export (Huang 
and Carmichael, 1996). It is bound primarily by 12oly(A} binding 12rotein (PABP). PABP 
interaction with the translation initiation factor eIF4G, bound at the 5'end ofthe message, 
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results in the circularization of the mRNA, which is believed to be a strong promoter of 
translation initiation (reviewed in (Kahvejian et al., 2001)). 
1.2 Translation Initiation 
Recruitment of the small ribosomal subunit to the 5'end of the mRNA, recognition of the 
initiator AUG, and assembly of the 80S ribosome on the mRNA is referred to as the 
initiation step of translation. Translation initiation is the rate-limiting step of protein 
synthesis. The manner in which the ribosomal subunit encounters an AUG can occur 
through either a cap-dependent manner, which involves either scanning or shunting of the 
ribosome, or in a cap-independent fashion (Gingras et al., 1999; Holcik and Sonenberg, 
2005). 
1.2.1 Cap-dependent translation 
Initiation begins with loading of the 43S pre-initiation complex onto the 5'end of the 
mRNA, and is achieved by the eIF4F complex (Fig. 1.2). The 43S preinitiation complex 
consists of a 40S small ribosomal subunit, which is maintained in its dissociated state by 
eIF 1 A and eIF3, and is also composed of eIF 1, which is crucial for initiation codon 
selection and fidelity, and the methionine temary complex. The temary complex is 
composed of eIF2, which interacts with methionine tRNA and GTP; it is regulated by 
eIF2B, a guanine nucleotide exchange factor which replaces GDP with GTP. eIF4F is 
composed ofthree subunits: i) eIF4E, which interacts directly with the cap; ii) eIF4A, an 
ATP-binding RNA helicase, which is facilitated by eIF4B and eIF4H in unwinding 
secondary structure present in the 5'UTR; and iii) eIF4G, a scaffold protein which binds 
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Figure 1.2. Eukaryotic translation initiation 
See text for details. Adapted from (Holcik and Sonenberg, 2005). 
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to eIF4E, eIF4A, and the ribosome associated factor eIF3, therefore bridging the 
ribosome and the 5'end of the mRNA (Holcik and Sonenberg, 2005). 
Once the pre-initiation complex is assembled onto the mRNA, the ribosome scans 
the mRNA in a 5'to 3'direction until it encounters the initiator AUG in a propitious 
context, a process that requires energy expenditure in the form of ATP hydrolysis. This 
is referred to as the scanning model of cap-dependent translation. Once an initiation 
codon is encountered by methionine tRNA in the form of the 48S preinitiation complex, 
eIF5 catalyses the dissociation of translation initiation factors by promoting eIF2 
hydrolysis of GTP. The 60S large ribosomal subunit joins the small subunit to form the 
80S initiation complex, which requires GTP hydrolysis by eIF5B. Subsequently, 
polypeptide synthesis ensues (reviewed in (Holcik and Sonenberg, 2005)). 
An alternative mode of AUG recognition, to the scanning model just described, is 
referred to as ribosome shunting. In this case, ribosome binding to the mRNA also 
occurs in a cap-dependent fashion; however, the ribosome engages in discontinuous 
scanning by skipping or jumping a segment of mRNA, and therefore bypasses the need 
for melting secondary structures. This mechanism of translation initiation has mainly 
been documented for virus es and will not be described in detail here (reviewed in 
(Gingras et al., 1999)). 
1.2.2 IRES mediated translation 
Recruitment of the ribosome to the mRNA can occur through a mechanism which does 
not involve recognition of the cap. This mode of translation initiation entails the direct 
recruitment of the 40S ribosomal subunit to an internaI structure of the mRNA within the 
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vicinity of the initiator AUG. It was first described for poliovirus and 
encephalomyocarditis virus (EMCV), picornavirus family members which lack a 5'cap 
structure (Jang et al., 1990; Pelletier and Sonenberg, 1988). These structures were coined 
ribosome landing pads (RLP), but are more commonly addressed as, IRES, for internaI 
ribosome entry site. 
However, IRES-mediated translation is not limited to uncapped RNAs since 
IRESes are present in capped viral mRNAs, such as those of hepatitis and cricket 
paralysis virus, and cellular mRNAs, which include ornithine decarboxylase (ODC) and 
vascular endothelial growth factor (VEGF). IRESes are generally characterized as being 
considerably long and containing a significant degree of secondary and tertiary structure; 
however, there is no communal sequence feature among all IRESes (reviewed in (Holcik 
and Sonenberg, 2005)). There is also a discrepancy in the requirement of canonical 
initiation factors amongst several viral IRES es, and it is thought that the tertiary structure 
of an IRES may impart specificity on the translation machinery (Holcik and Sonenberg, 
2005). 
Cellular IRES-containing mRNAs encode for proteins which function in cell 
growth, proliferation and differentiation. Cellular IRES-driven translation is particularly 
relevant to the cellular stress response during which global translation is shut off but 
translation of a subset of messages containing an IRES element, necessary for cell 
survival, takes place (Holcik and Sonenberg, 2005). 
1.2.3 eIF4 F Components 
1.2.3.1. eIF4E 
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eIF4E was identified as a 24 KDa prote in that specifically crosslinks to the cap 
(Sonenberg et al., 1978). The specificity of its interaction was affirmed by the failure to 
crosslink in the presence of cap analogs, m7GMP and m7GDP (Sonenberg et al., 1978). It 
was later purified on an agarose affinity column coupled to m7GDP (Sonenberg et al., 
1979) which heralded subsequent functional analysis of the protein. eIF4E is 
indispensable for cap-dependent translation and is the limiting factor in translation 
initiation in sorne systems (Gingras et al., 1999; Mamane et al., 2004). Its depletion from 
rabbit reticulocyte lysate resulted in the inhibition of translation initiation of capped 
messages, with no effect on lRES-mediated translation initiation (Svitkin et al., 1996). It 
was previously demonstrated that a reduction in eIF4E expression in vivo, via antisense 
RNA, leads to a decrease in general translation rates in HeLa cells and eventually to cell 
death (De Benedetti et al., 1991). Furthermore, its role as a crucial factor in translation 
initiation is underscored by the fact that disruption of the yeast eIF4E gene is lethal 
(Altmann et al., 1989). More recently, in vivo depletion of eIF4E by RNA interference 
(RNAi) in HeLa cells was also shown to negatively affect the rate of translation initiation 
by studying the polyribosome distribution. A larger 80S monosome peak and a shift to 
the lighter polysomes were observed in cells depleted of eIF4E versus control siRNA-
treated cells (Svitkin et al., 2005). 
Conversely, overexpression of eIF4E selectively elevates the synthesis of potent 
stimulatory proteins such as ODC, cyclin Dl, c-myc and VEGF, and is associated with 
increased cellular proliferation (Mamane et al., 2004; Rousseau et al., 1996). The 
profound affect of eIF4E on cellular growth is emphasized by the fact that its 
overexpression induces oncogeneic transformation in NIH 3T3 and CHO (Lazaris-
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Karatzas et al., 1990; Mamane et al., 2004) and promotes malignant growth in mice 
(Ruggero et al., 2004; Wendel et al., 2004). Moreover, serum starved fibroblasts 
overexpressing eIF4E are resistant to apoptosis (Mamane et al., 2004). In line with this 
experimental evidence, increased levels of eIF4E have been found to be associated with 
several human cancers including breast, colon, liver, head and neck, lung, and bladder 
(Mamane et al., 2004; Zimmer et al., 2000). 
eIF4E is highly conserved across phylogeny (Fig. 1.3A). eIF4E is present in 
yeast, Drosophila, and vertebrates (reviewed in (Gingras et al., 1999). The yeast eIF4E 
protein bears 32% identity to human eIF4E (Altmann et al., 1989). Disruption of the 
yeast eIF4E gene causes lethality, which can be rescued by mammalian eIF4E (Altmann 
et al., 1989). Structural analysis of yeast eIF4E by NMR (Matsuo et al., 1997) and X-
Ray crystalIography analysis of murine eIF4E (Marcotrigiano et al., 1997) revealed that 
they share similar structures, which consist of one a/p domain that resembles a cupped 
hand (Fig. 1.3B). The co-crystal structure of murine eIF4E bound to 7-methyl GDP 
analog demonstrated that 7 -methyl recognition takes place on the concave surface of 
eIF4E and is facilitated by three types of interactions: a) sandwiching of guanine between 
two tryptophan residues (W56 and WI02) resulting in 1t-1t stacking interactions between 
the base and the indole groups of the tryptophan residues; b) hydrogen bonds between 
eIF4E and the guanine base which include a hydrogen bond between 0-6 of the guanine 
ring and WI02 and hydrogen bonding between N-l and N-2 of the guanine ring with 
E103 carboxyl group; c) a Van der Waals contact between N7 methyl group and residue 
W166 of eIF4E. AlI of the afore-mentioned residues of eIF4E responsible for cap 
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Figure 1.3 eIF4E alignment and structure 
a) eIF4E Sequence Alignment Across Species. Black and grey boxes indicate similar 
residues conserved in 100%, or greater than 85%, of the sequences, respectively. Blue 
boxes indicate conservation of residues directly involved in recognition of the cap-
structure by human and mouse eIF4E-l and S. cerevisiae eIF4E. Yellow boxes indicate 
conservation ofresidues involved in recognition of eIF4Gs and 4E-BPs by mouse eIF4E-
1. Green or red boxes indicate the presence of a Tyr or a Cys residue at a position 
equivalent to human eIF4E-1 Trp56. Positions of selected Trp residues and residues 
involved in the interaction of eIF4E-1 with eIF4G·4E-BP are indicated above the amino 
acid sequences, as is the location of the conserved consensus sequence (S/T)VXXFW. 
Adapted from (Jo shi et al., 2004). 
h) Crystal Structure of eIF4E. Three-dimensional structure of eIF4E (blue) bound to 
the m7GDP cap analog (yellow). (A) Ribbon diagram of the mouse eIF4E structure 
determined by X-ray crystallography; (B) ribbon diagram of the yeast eIF4E structure as 
determined by NMR; (C) magnified view of the cap-binding area of mouse eIF4E. The 
amino acid si de chains involved in the interaction are highlighted. Adapted from 
(Gingras et al., 1999). 
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recognition are conserved from yeast to mammals (Marcotrigiano et al., 1997) (Fig. 
I.3B). 
eIF4E isoforms exist in nearly all species from C. elegans, Drosophila, and S. 
cerevisiae to mammals (reviewed in (Gingras et al., 1999)) (Fig. 1.3A). In mammalian 
cells, an isoform of eIF4E exists named eIF4E2 or 4E-HP (eIF4E Homologous Prote in) 
(Rom et al., 1998). 4E-HP is also a cap-binding protein (Rom et al., 1998). eIF4E and 
4E-HP are both ubiquitously expressed but have different requirements for interaction 
with eIF4G and 4E-BP. eIF4E interacts with eIF4G and 4E-BP whereas 4E-HP can 
interact with 4E-BP but does not interact with eIF4G (Jo shi et al., 2004). The Drosophila 
homolog of 4E-HP has been characterized as a novel cap-binding repressor oftranslation. 
Drosophila 4E-HP represses translation of caudal mRNA, an anterior/posterior 
determinant in flies, through its interaction with Bicoid which binds a specific element in 
the 3 'UTR (Cho et al., 2005). 
Other cap-binding complexes: CBP20/80 and Dcp 
A similar mode of cap recognition is mediated by the nuclear cap binding complex 
(CBC) which consists of CBP20/80 (Mazza et al., 2001; Mazza et al., 2002a; Mazza et 
al., 2002b). The CBP20 subunit makes direct contact with the cap structure; however, 
CBP20 cannot bind to the cap unaided, and requires CBP80 to facilitate the interaction 
presumably by evoking a conformational change in CBP20 (Izaurralde et al., 1995). 
Furthermore, CBP80 provides a platform for interaction with other proteins which are 
involved in the maturation of the RNA. Although this complex does not bear any 
structural similarities with eIF4E, cap recognition by CBP20 is mediated by base 
sandwiching via two tyrosine residues, in contrast to the two tryptophans in eIF4E 
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(Mazza et al., 2002b). CBP20 exhibits little homology (26% similarity at the amino acid 
level) to human eIF4E and is highly conserved across species (Mazza et al., 2001). 
CBP80 contains three domains similar to those found in the middle fragment of eIF4G 
(MIF4G), which is present in other proteins involved in RNA maturation (Marintchev 
and Wagner, 2005; Mazza et al., 2001). CBP80 interacts directly with eIF4G in yeast 
(Fortes et al., 1999) and mammals (Lejeune et al., 2004; McKendrick et al., 2001). It is 
therefore believed that the displacement of CBC for eIF4E occurs via simultaneous and 
transit interaction of eIF 4G with CBP80 and eIF 4 E (Mazza et al., 2002b). 
CBC plays a crucial role in rnRNA maturation. It binds strongly to the cap and 
has been demonstrated to stimulate splicing (Izaurralde et al., 1994; Lewis et al., 1996a; 
Lewis et al., 1996b) and polyadenylation (Cooke and Alwine, 1996). Furthermore, it is 
exported with mRNA to the cytoplasm (Izaurralde et al., 1992; Shen et al., 2000; Visa et 
al., 1996). It is proposed that messages bound by CBC participate during the pioneer 
round of translation when the message is read for the tirst time by the ribosome (Ishigaki 
et al., 2001; Lejeune et al., 2002) (section 1.3.4). The pioneer round of translation is 
synonymous with a process called nonsense-mediated decay (NMD), an mRNA decay 
pathway which relies on translation to eliminate faulty messages containing a premature 
termination codon (PTC) (section 1.3.4). CBP bound messages have been shown to 
stimulate translation in yeast extracts, wherein eIF4G has been mutated and exhibits 
diminished interaction with eIF4E (Fortes et al., 2000). 
It is expected that the decapping enzyme which hydrolyzes the cap structure when 
no longer bound by eIF4E, accesses the cap through a similar interaction as that of cap 
recognition by eIF4E and CBP80. Although the crystal structure of Dcplp and Dcp2p 
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has been obtained, neither a model nor the residues mediating cap binding have been 
elucidated (She et al., 2006; She et al., 2004). 
1.2.3.2. eIF4G 
eIF4G is the scaffolding prote in of the eIF4F complex. There are two isoforms of eIF4G 
in yeast (Goyer et al., 1993) and in humans termed, eIF4GI and eIF4GII (Gradi et al., 
1998; Yan and Rhoads, 1995). The two isoforms are functionally interchangeable and 
differ in their level of expression among various tissues (Gradi et al., 1998). 
eIF 4G domains 
eIF4G is a large protein which binds to many translation initiation factors inc1uding 
eIF4E, eIF4A, eIF3, PABP, and to the eIF4E kinase, Mnk1l2 (reviewed in (Gingras et al., 
1999)). It is therefore organized into many domains to mediate these interactions (Fig. 
1.4) (Marintchev and Wagner, 2005; Ponting, 2000). eIF4G binds eIF4E at its N-
terminus (Mader et al., 1995). Poliovirus infection causes the c1eavage of eIF4G at its N-
terminus and expulsion of the eIF4E binding site, which resuIts in shutdown of host cell 
protein synthesis (Etchison et al., 1982; Lamphear et al., 1995). The binding site for 
eIF4E is mapped to an YXXXXL<I> motif (where X is any amino acid and <I> symbolizes 
a hydrophobic residue) which is shared among other eIF4E binding proteins (Mader et 
al., 1995) (see section 1.2.4.3). A peptide ofeIF4GII containing this motifhas been co-
crystallized with eIF4E, and shown to contact the convex dorsal surface of eIF4E 
(Marcotrigiano et al., 1999). eIF4G also binds to PABP via its N-terminal region 
(Imataka et al., 1998; Tarun and Sachs, 1996). This region is upstream of the eIF4E 
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Figure 1.4. eIF4G domains 
Comparison between eIF4G and p97/DAP5 domain/motif organization in different 
species. Colored blocks identify homologous regions with % sequence identity to human 
eIF4GI (4GIM, blue; phosphoregion, orange; 4G/C1, green; 4G/C2, red). The small 
purple box denotes the eIF 4 E binding site and the yellow boxes refer to the three HEA T 
domains, MIF4G, MA3 and AA-boxes. Cleavage sites and interaction regions identified 
for human eIF4GI and p97/DAP5 are also shown. The bars above them indicate the 
segments required for interaction with eIF4A and Mnkl, respectively. 
Adapted from (Bellsolell et al., 2006) with modification. 
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binding site and is situated at the 5' proximal end. Interaction of eIF4G with PABP gives 
rise to the closed loop model of translation whereby the 5' and 3' ends of the rnRNA are 
juxtaposed and thought to enhance translation efficiency by recycling ribosomes (Gallie, 
1998; Kahvejian et al., 2001). Depletion of PABP from mammalian cell extracts 
hindered 40S and 80S ribosome formation and inhibited translation; accordingly, addition 
ofPABP to depleted extracts stimulated translation in an eIF4G-dependent manner. Most 
importantly, PABP depletion reduced the efficiency with which eIF4E interacts with the 
cap of poly-adenylated mRNA, whereas its addition to extracts stimulated binding of 
eIF4F components to the cap (Kahvejian et al., 2005). This heralded the view ofPABP 
as a canonical initiation factor. 
The middle portion of eIF4G acts as a multi-adaptor region. The formally 
referred to as middle portion of eIF4G (MIF4G) is predicted to have secondary structure 
rich in a-helices and contains one binding site for eIF4A, eIF3, and a RNA recognition 
motif(RRM) (Gingras et al., 1999; Imataka and Sonenberg, 1997; Lamphear et al., 1995; 
Marintchev and Wagner, 2005; Ponting, 2000). Interestingly, homologs of the MIF4G 
domain are present in proteins which function in mRNA metabolism, i.e. CBP80 and 
Upf2 (Marintchev and Wagner, 2005; Ponting, 2000). 
The C-terminal portion of eIF4G contains another binding site for eIF4A (Imataka 
and Sonenberg, 1997). This region of eIF4G harbours the MA3 domain, which is also 
abundantly a-helical, and is implicated in the binding to eIF4A (Ponting, 2000; Yang et 
al., 2004). The C-terminal end also contains the binding site for Mnk1l2 kinases, and 
brings the kinase within close proximity to its physiological target, eIF4E (Pyronnet et 
al., 1999). The Mnk -binding site is also composed of a a-helical domain which is named 
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AA (acidic/aromatic) box (Bellsolell et al., 2006; Marintchev and Wagner, 2005). The 
MIF4G, MA3 domains and the AA box are also referred to as HEAT domains (Bellsolell 
et al., 2006; Marintchev and Wagner, 2005). The C-terminal portion of elF4G is not 
conserved in lower eukaryotes; it is not essential for cap-dependent translation but 
functions as a modulatory region (Morino et al., 2000). 
Proteins which resemble elF 4G but are not functional homologs include p97 
(Imataka et al., 1997) and poly(A) binding protein interacting protein 1 (Paip1) (Craig et 
al., 1998), Paip1 has homology to the middle portion of elF4G and contains aC-terminal 
P ABP binding domain (Craig et al., 1998); p97 resembles the C-terminal, two thirds of 
elF4G (Imataka et al., 1997). These two proteins both lack a binding site for elF4E and 
have antagonistic effects on translation rates (Craig et al., 1998; Imataka et al., 1997). 
p97 does not contain an elF4E binding site, but does bind to e1F3, elF4A and Mnk1, and 
therefore presumably inhibits translation by sequestering elF4A and elF3 in inactive 
complexes (Imataka et al., 1997). Incidentally, the C-terminal portion of p97, which 
contains an MA3 domain, does not bind to elF4A (Imataka and Sonenberg, 1997). 
However, p97 promotes lRES-mediated translation of selective mRNAs during stress 
(Holcik and Sonenberg, 2005). 
1.2.3.3. eIF4A 
elF4A is an ATP-binding, RNA-dependent helicase which is thought to unwind 
structured mRNAs at their 5' end and facilitate ribosome binding (Grifo et al., 1984; Ray 
et al., 1985; Rozen et al., 1990). It is the prototypic DEAD box prote in. DEAD box 
proteins are a large family of proteins which exhibit ATPase activity and share nine 
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conserved sequence motifs that are required for helicase activity (Fig. 1.5A). Members 
of this family participate at all steps of RNA metabolism including splicing, ribosome 
biogenesis, rnRNA export, rnRNA decay, and translation (Cordin et al., 2006; Rocak and 
Linder, 2004). 
The biochemical functions carried out by DEAD- box proteins are attributed to 
their conserved motifs. Mutational analysis of these motifs has contributed to knowledge 
of their function. To enumerate a few, Motif!, also known as Walker A motif, is needed 
for ATP binding. Motif II, otherwise known as the DEAD motif, is necessary for ATP 
hydrolysis. The Q motif, situated upstream of Motif l, is believed to regulate A TP 
binding and hydrolysis. The SAT motif (Motif III) is essential for unwinding activity. 
Motif VI is critical for RNA binding and ATP hydrolysis (Cordin et al., 2006; Pause et 
al., 1993; Pause and Sonenberg, 1992; Rocak and Linder, 2004)}(Fig. 1.5B). 
The crystal structure ofyeast elF4A has been solved (Benz et al., 1999; Caruthers 
et al., 2000; Cordin et al., 2006; Johnson and McKay, 1999). elF4A is composed oftwo 
domains joined by a linker region and is shaped as a "dumbbell." The two domains form 
a crevice for ATP positioning. The function of the other motifs (motifs la, lb, IV, and V) 
have been deduced by analysis of the crystal structure of eIF4A, and are presumably 
involved in RNA binding by interactions with the sugar phosphate backbone (Cordin et 
al., 2006; Rocak and Linder, 2004) (Fig. 1.5B). elF4A does not contain a canonical RNA 
binding motif; as most other helicases, it does not discriminate in the sequence that it 
binds to so that most rnRNAs are substrates of the unwinding activity ofthis helicase. 
Several mutants were tested for their effect on translation in vitro (Pause et al., 
1994b; Svitkin et al., 2001). Mutations within motifIa (PTRELA to PRRV AA), the 
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Figure 1.5. eIF4A DEAD-box motifs 
(A) Conserved motifs in the DEAD-box and reIated DExDIH-box families. Sequences 
of the conserved motifs from the yeast S. cerevisiae eIF4A (DEAD-box protein), Prp2 
(DEAH-box protein), NS3 (DECH helicase from the hepatitis C virus) and Ski2 (DExH, 
Ski2 family). Symbols used are as follow: 0: S,T; 1: l, L, V; x: any residue; a: F, W, Y; c: 
D, E, H, K, R; h: A, F, G, l, L, M, P, V, W, Y; +: H, K, R; u: A, G. Adapted from 
(Cordin et al., 2006). 
(B) The conserved motifs of DEAD-box proteins and their interaction with ATP. 
Mutational analysis of these motifs has led to identification of their functions which are 
schematically represented here. For more details see text. Adapted from (Rocak and 
Linder, 2004). 
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DEAD motif (DEAD to DQAD) and Motif VI (HRIGRXXR; single mutants of all three 
R to QIK) posed a potent dominant negative effect on both cap-dependent and cap-
independent translation. eIF4A exerts its function in translation as a component of the 
eIF4F complex as well as unaccompanied as a single polypeptide (Pause et al., 1994b; 
Svitkin et al., 2001; Yoder-Hill et al., 1993). eIF4A recycles through the eIF4F complex 
which explains the abundance of eIF4A over eIF4F in cells. Evidence in support of 
recycling include the facts that: a) dominant negative mutants are impaired in their ability 
to recycle through eIF4F in kinetic experiments (Pause et al., 1994b), b) the helicase 
activity of eIF4F but not eIF4A is inhibited in the presence of dominant negative mutants 
(Pause et al., 1994b), c) a dominant negative mutant of eIF4A is more stably associated 
with the eIF4F complex but abolishes cap-binding activity of eIF4F and causes an 
inhibition in 48S ribosomal complex formation (Svitkin et al., 2001). 
eIF4A helicase activity is increased twenty fold when it is part of the eIF4F 
complex (Rayet al., 1985; Rozen et al., 1990). NMR studies have defined the C-terminal 
fragment of eIF4A to be the main interaction face with the middle fragment of eIF4G 
(Oberer et al., 2005). This interaction occurs within the vicinity of the ATP and RNA 
binding regions. It is postulated that eIF4G acts as a clamp on eIF4A and causes the 
cooperative interaction of eIF4A with RNA and ATP, thus resulting in the enhancement 
of eIF4A helicase activity when it is part of the eIF4F complex (Oberer et al., 2005). 
Isoforms ofeIF4A 
There are three isoforms of eIF4A in mammals, eIF4AI, eIF4AII, and eIF4AIII. Murine 
eIF4AI and eIF4AII are ~90% identical at the amino acid level (as are human eIF4AI and 
eIF4AII); they are functionally interchangeable and differ in their expression levels 
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among various tissues (Niel sen et al., 1985; Nielsen and Trachsel, 1988; Yoder-Hill et al., 
1993). Genetic disruption of both yeast isoforrns, TIFI and TIF2, results in lethality 
(Linder and Slonimski, 1989). eIF4AIII is more distantly related to eIF4AI (Li et al., 
1999). Human eIF4AIII bears ~65% identity to human eIF4AI and is ubiquitously 
expressed. It contains all the conserved DEAD box motifs and differs from eIF4AI and 
eIF4AII primarily in its N-terrninal region (Fig. 1.6). eIF4AIII contains, in addition to 
the conserved DEAD-box motifs, eight highly conserved regions (A-H) which are not 
preserved in eIF4AI and eIF4AII (Fig. 1.6). In contrast to eIF4AI and eIF4AII, human 
eIF4AIII cannot forrn a 48S pre-initiation complex in a ribosome binding assay. 
Furtherrnore, eIF4AIII binds only to the middle fragment of eIF4G, unlike eIF4AI which 
possesses two binding sites for eIF4GI (Li et al., 1999). 
eIF4AIII is phylogenetically conserved; its closest homolog is from Xenopus 
which shares ~93% identity to human eIF4AIII (Li et al., 1999; Weinstein et al., 1997). 
In contrast, there does not appear to be an ortholog of eIF4AIII in yeast. In Xenopus, 
eIF4AIII was found to stimulate translation of specifie messages involved in epiderrnal 
formation in embryos (Weinstein et al., 1997). 
Interestingly, human eIF4AIII exhibits a nuclear staining, in contrast to eIF4AI 
and eIF4AII, which are cytoplasmic (Bohnsack et al., 2002; Holzmann et al., 2000; 
Lejbkowicz et al., 1992)). In the nucleus, it colocalizes with splicing factors in speckles. 
Recently, eIF4AIII was identified by mass spectrometry analysis as a component of the 
human splicesomal C complex (Jurica et al., 2002; Rappsilber et al., 2002; Zhou et al., 
2002). 
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Figure 1.6. eIF4AIII sequence alignment 
ClustalW amino acid sequence alignments ofhuman eIF4AI, eIF4AII, and eIF4AIII (Hs-
eIF4AIII, ENSGOOOOOI41543, accession #P38919) and elF4AIII homologs from 
Xenopus laevis (XI-eIF4AIII, #042226), Drosophila melanogaster (Dm-eIF4AIII, 
#CG7483), Caenorhabditis elegans (Ce-eIF4AIII, #044781), Nicotiana plumbaginifolia 
(Np-eIF4AIII, #P41380), and Schizosaccharomyces pombe (Sp-eIF4AIII, #QI0055). 
Identical amino acids are highlighted in black. Positions of eIF4A family consensus 
motifs (Q-VI) and eIF4AlII-specific motifs (A-H) are indicated by black and white bars, 
respectively. Adapted from (Shibuya et al., 2006). 
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eIF4A Cofactors: eIF4B and eIF4H 
The helicase activity of eIF4A is appreciably stimulated by two factors, eIF4B and eIF4H 
(Lawson et al., 1989; Richter-Cook et al., 1998). eIF4B is a dimer and is an RNA 
binding prote in (Methot et al., 1994; Methot et al., 1996a; Methot et al., 1996b). It is 
required for formation of the 48S pre-initiation complex in an in vitro ribosome binding 
assay (Dmitriev et al., 2003). eIF4B increases the affinity of eIF4A for its binding 
partners, RNA and ATP. On its own it has no catalytic activity (Grifo et al., 1984) 
although it stimulates the RNA binding, ATPase and helicase activity of eIF4A (Rogers 
et al., 2001; Rogers et al., 1999). eIF4B is regulated by its phosphorylation, which is 
directly coupled to increased translation rates (Duncan and Hershey, 1985; Manzella et 
al., 1991; Raught et al., 2004; Shahbazian et al., 2006). 
eIF4H is another cofactor of eIF4A (Richter-Cook et al., 1998). It possesses an 
RNA binding domain similar to that found in eIF4B (Richter-Cook et al., 1998) and also 
stimulates the processivity and helicase activity of eIF4A (Richter et al., 1999; Richter-
Cook et al., 1998; Rogers et al., 1999). It is proposed that eIF4H buffers the structural 
remodelling of eIF4A while performing its enzymatic functions in RNA binding, ATP 
catalysis and duplex unwinding (Richter et al., 1999). 
1.2.4 eIF4E Regulation 
eIF4E is the rate-limiting factor in translation initiation in sorne systems. Accordingly, it 
is a target of extensive regulation (see also section 1.2.3.1.). Deleterious consequences of 
its deregulation have been extensively documented (Gingras et al., 1999; Mamane et al., 
2004). eIF4E is controlled at the level of transcription, which directly correlates to its 
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expreSSIOn levels within the cell. It is also regulated post-translationally by 
phosphorylation, and by a group ofproteins which bind to it directly. 
1.2.4.1. Transeriptional regulation of eIF 4 E 
eIF4E mRNA levels are regulated at the transcriptional level by myc, which has two 
binding sites in the eIF4E promoter (Gingras et al., 1999; Jones et al., 1996). In view of 
that, mye levels are correlated with increased eIF4E mRNA levels after growth factor 
stimulation in fibroblasts, which both peak late in G 1 phase (Rosenwald et al., 1993). In 
line with these data, increased eIF4E rnRNA levels are paralleled with increased myc 
function in transformed cells (Rosenwald, 1996; Rosenwald et al., 1993) and cells 
expressing the estrogen receptor-myc fusion protein (Rosenwald et al., 1993). 
1.2.4.2. eIF4E Phosphorylation 
eIF4E is phosphorylated in vivo by Mnk1l2 on serine 209 (S209) (Flynn and Proud, 
1995; Joshi et al., 1995; Waskiewicz et al., 1997; Waskiewicz et al., 1999). However, 
treatment of cells with okadaic acid has revealed another phosphorylated residue, 
threonine 210 (T21O) (Bu et al., 1993). Phosphorylation on T210 was also detected when 
eIF4E is mutated at its major site ofphosphorylation S209 (Whalen et al., 1996). Mnk1l2 
does not interact with eIF4E directly but mediates eIF4E phosphorylation through eIF4G 
(Pyronnet et al., 1999). 
Phosphorylation of eIF4E is generally linked with increased translation rates 
(reviewed in (Gingras et al., 1999; Mamane et al., 2004)). For instance, stimulation of 
cells with growth factors and mitogens increases translation rates, and this is matched by 
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enhanced eIF4E phosphorylation. For the most part, the two are synonymous; however, 
in sorne cases translation rates are inversely correlated with eIF4E phopshorylation, as it 
occurs during arsenite-induced stress (Wang et al., 1998). Flies expressing a 
phosphorylation mutant of eIF4E are smaller in size and are slower in their development 
than their wild type counterparts, therefore accenting the biological relevance of eIF4E 
phosphorylation (Lachance et al., 2002). 
The co-crystal structure of unphosphorylated eIF4E bound to a cap analog, 
predicted that phosphorylation of eIF4E at residue S209 would form a salt bridge with 
lysine 159 (K159) of eIF4E, and that this interaction would stabilize eIF4E interaction 
with the cap (Marcotrigiano et al., 1997). However, there is a discrepancy in the 
correlation between eIF4E phosphorylation and its affinity for the cap. Whereas previous 
data demonstrated that phosphorylated eIF4E has greater affinity for the cap over the 
unphosphorylated form (Jo shi et al., 1995), recent reports have indicated the opposite 
effect (Scheper et al., 2002; Zuberek et al., 2004). New crystal structure studies of eIF4E 
demonstrate that the distance between S209 and K159 is too far to form a salt bridge to 
explain increased binding affinity for the cap, and too far to accommodate the opposing 
view that phosphorylation of eIF4E decreases cap affinity by electrostatic repulsion 
between the phosphorylated S209 and the phosphate of the adenosine present in the cap 
structure (m7GpppA). Therefore, the issue remains divisive (reviewed in (Sonenberg and 
Dever, 2003). Nevertheless, an explanation put forth to connect increased translation 
rates with reduced cap affinity, is that the rate of dissociation of eIF4E is increased in 
these cases and ribosomal initiation complexes are free to scan for the initiation codon 
(Scheper and Proud, 2002). 
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1.2.4.3. Regulation by 4E Binding Proteins (4E-BPs) 
eIF4E is also regulated through interaction with a family of repressor proteins called 4E-
BPs (Richter and Sonenberg, 2005). These members include 4E-BP1, 4E-BP2, 4E-BP3 
and 4E-Transporter (4E-T). 4E-BPs share a conserved eIF4E binding sequence motif 
YXXXXL<I> (where X is any amino acid and <1> represents a hydrophobic residue) that is 
also found in eIF4G, and whose binding is mutually exclusive with eIF4G (Dostie et al., 
2000a; Gingras et al., 1999; Mader et al., 1995; Poulin et al., 1998) (Fig. 1.7A). 4E-BPs 
and eIF4G make contacts with residues on the convex dorsal surface of eIF4E 
(Marcotrigiano et al., 1997; Marcotrigiano et al., 1999). Most notably is the tryptophan 
73 (W73) residue of eIF4E, which is phylogenetically conserved; mutation ofthis residue 
to an alanine (W73A) abrogates interaction ofeIF4E with eIF4G, 4EBP1, 2, 3 and 4E-T 
(Dostie et al., 2000a; Marcotrigiano et al., 1999; Pyronnet et al., 1999). Other notable 
residues on the convex dorsal surface of eIF4E are His37 and V69 which make contact 
with the the tyrosine and the leucine of the eIF4E-binding motif, and L131 and L135 of 
eIF4E, which make contact with the hydrophobic residue (Marcotrigiano et al., 1997; 
Marcotrigiano et al., 1999). 
In the accompanying sections, the regulation of eIF 4 E via its binding partners will be 
elaborated; particular emphasis will be placed on the regulation of eIF4E by 4E-T. 
4E-BPl, 2, 3 
Human cDNAs encoding for 4E-BP1, 2, and 3 were cloned by Far Western screening 
using a 32P-Iabelled eIF4E probe (Pause et al., 1994a). 4E-BPI is present in most tissues, 
but is highly expressed in adipose tissue (Tsukiyama-Kohara et al., 2001). Accordingly, 
4E-BPI knockout mice display differences in metabolic rate and adipose tissue content 
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from the wild type mice (Tsukiyama-Kohara et al., 2001). 4E-BP2 is primarily expressed 
in the brain, and 4E-BP2 knockout mice have impaired long-term memory formation 
(Banko et al., 2005; Tsukiyama-Kohara et al., 2001). 4E-BP3 is mainly expressed in the 
colon, kidney and liver relative to the other 4E-BPs (Poulin et al., 1998; Tsukiyama-
Kohara et al., 2001). 4E-BPI-3 are phosphoproteins (Gingras et al., 1999). Studies 
characterizing the phosphorylation have been mainly performed on 4E-BPl. 4E-BPI is 
phosphorylated on residues Thr 37 and Thr 46 by FRAP/mTOR, even under basal 
conditions (Gingras et al., 2001). Phosphorylation at these sites are a precedent for 
subsequent phosphorylation at serum-sensitive residues S65, Thr70 and S83 by the 
PI3K1Akt pathway (Gingras et al., 2001). Phosphorylation of 4E-BPI regulates its 
binding to eIF4E. Hyperphosphorylated 4E-BPI has reduced affinity for eIF4E whereas 
hypophosphorylated 4E-BP exhibits the opposite effect (Gingras et al., 1999; Pause et al., 
1994a). Treatment with the inhibitor of FRAP/mTOR, rapamycin, results in 
hypophosphorylated 4E-BP1, increased binding to eIF4E, and decreased translation rates 
(Beretta et al., 1996). Hence, rapamycin is being explored as a chemotherapeutic agent 
(Petroulakis et al., 2006). 
4E-Transporter C4E-T) 
4E-Transporter (4E-T) was also discovered by Far-Western screening with a 32P-Iabelled 
eIF4E probe (Dostie et al., 2000a). It binds eIF4E through the same conserved sequence 
motif as that found in 4E-BPs and eIF4G (Dostie et al., 2000a) (Fig. 1.7A). Mutation of 
the tyrosine residue, within the eIF4E-binding motif of 4E-T obstructed its interaction 
with eIF4E, as was reported for other eIF4E-binding proteins (Mader et al., 1995; Poulin 
et al., 1998). 4E-T is a ubiquitously expressed protein with nucleocytoplasmic shuttling 
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Figure 1.7. 4E-T sequence alignment across species 
(A) Amino acid sequence alignment of the eIF4E-binding site of 4E-T with other eIF4E-
binding proteins. Adapted from (Dostie et al., 2000a). 
(B) MAP BCM Search Launcher sequence alignment of human 4E-T (Accession no. 
Q9NRA8) and homologs from mouse (BAB 11963), rat (XP _223589) and X laevis 
(AAH77338). Position of the eIF4E binding site (4EBS) is indicated (brown), arginine 
rich region (blue), nuclear localization signal (NLS, green), serine rich regions (orange), 
and nuclear export signaIs (NES, violet). 
(C) Comparison of human 4E-T with Drosophila Cup (AAB64427) and Cup-like 
(AAN71228) proteins. 
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activity (Dostie et al., 2000a). It contains one classical bipartite nuclear localization 
signal (NLS) and two nuclear export signaIs (NES), which fit the consensus of leucine-
rich nuclear prote in export signaIs. At steady state, 4E-T is cytoplasmic and concentrated 
in foci (Dostie et al., 2000a). Upon treatment with Leptomycin B (LMB), an inhibitor of 
the CRM-I protein export pathway, 4E-T accumulates in the nucleus (Dostie et al., 
2000a). 4E-T imports eIF4E into the nucleus by the importin a/~ pathway, hence the 
name 4E-Transporter (Dostie et al., 2000a). Importin a is an adaptor molecule of 
importin ~, which is the actual receptor molecule. Importin a interacts with basic rich 
NLSs, such as that present in 4E-T. The role of 4E-T as the transporter of eIF4E was 
deciphered using a GST-pull down assay with purified components, in which eIF4E was 
pulled down by GST-tagged importin ~ receptor (in the company of importin a) only in 
the presence of 4E-T (Dostie et al., 2000a). Furthermore, the requirement of the 
interaction of eIF4E with 4E-T for its nuclear import was demonstrated in vivo, using 
overexpressed eIF4E and 4E-T in HeLa cells, and examining their cellular localization in 
the presence of LMB. Whereas wild type 4E-T caused nuclear accumulation of eIF4E 
upon LMB treatment, a mutant of 4E-T which abrogates binding to eIF4E, caused 
nuclear accumulation of 4E-T but not of eIF4E in LMB-treated cells (Dostie et al., 
2000a). 4E-T is a phosphoprotein (Pyronnet et al., 2001). The phosphorylated form of 
4E-T has a reduced affinity for eIF4E in nocodazole-treated cells (i.e. when cells are 
arrested in mitosis) (Pyronnet et al., 2001). More recently, the hypophosphorylated form 
of 4E-T was shown to correlate with decreased translation rates during prolonged 
hypoxia (Koritzinsky et al., 2006). 
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A database search identified 4E-T homologs in mouse, rat, and Xenopus, which 
possess considerable homology to human 4E-T and contain an eIF4E binding site 
(4EBS), NLS, and NES1/2 which are conserved (Fig. 1.7B) (Dostie et al., 2000a). 
Furthermore, the mouse homolog, Clast4, is also a phosphoprotein (Ballif et al., 2004; 
Villaescusa et al., 2006). The Drosophila Cup prote in and the Cup-like prote in (gene 
product CG32016) share limited homology with human 4E-T (h4E-T) in the region 
encompassing amino acids 150-349 (Dostie et al., 2000a) (Fig. 1.7C). The Drosophila 
Cup protein is required for repression of oskar mRNA translation and localization of 
oskar to the posterior pole (Wilhelm and Smibert, 2005). The interaction of Cup with 
eIF4E is necessary for repressing oskar mRNA translation (Wilhelm and Smibert, 2005). 
The C. elegans clone F26F3 (GenBank accession No. S43585) also shows limited 
homology with h4E-T in this region (Dostie et al., 2000a). Even though a yeast homolog 
of 4E-T was not identified by database search, the eIF4E-binding prote in with an 
inhibitory effect on cap-dependent translation in S. cerevisiae, p20, shares homology with 
the eIF4E-binding motif ofh4E-T (Altmann et al., 1997; de la Cruz et al., 1997). 
Approximately 12-33% of eIF4E was localized to the nucleus by 
immunofluorescence analysis and cellular fractionation studies (Dostie et al., 2000b; 
Lejbkowicz et al., 1992). In the nucleus, it colocalizes with splicing factors in speckles, 
an event that is sensitive to treatment with a cap analog (Dostie et al., 2000b). Coversely, 
inhibition of transcription with 5,6-dichloro-1-beta-D-ribobenzimidazole (DRB) leads to 
a more pronounced speckled staining (Dostie et al., 2000b). The localization of eIF4E in 
speckles is regulated by the ClklSty kinase. Overexpression of the wild type ClklSty 
kinase causes a release of eIF4E from splicing factor speckles, whereas a kinase-
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impaired mutant causes rounding up speckles (Dostie et al., 2000b). Because eIF4E does 
not contain an arginine/serine rich phosphorylation domain (RS domain), characteristic of 
SR (serine/arginine rich) proteins which are substrates of the Clk/Sty kinase, it may be 
regulated through another protein which is a direct substrate of this kinase (Dostie et al., 
2000b). Since eIF4E is localized with splicing factors in speckle domains, it may be 
involved in splicing-related events, such as mRNA export and NMD (Dostie et al., 
2000b). 
There is substantial evidence which indicates that the nuclear CBC is essential for 
mRNA splicing (Izaurralde et al., 1994; Lewis et al., 1996a; Lewis et al., 1996b), and 
there is sorne evidence in favour of its role in mRNA export (Ishigaki et al., 2001; 
Izaurralde et al., 1992; Lejeune et al., 2002; Shen et al., 2000; Visa et al., 1996)(section 
1.2.3.1). However, eIF4E may take part in the processing of a subset of mRNA. Stable 
overexpression of eIF4E in NIH3T3 caused a shift in the nucleocytoplasmic distribution 
of certain mRNAs, namely growth stimulatory proteins such as cyclin Dl (Rousseau et 
al., 1996). It was demonstrated that increased cyclin Dl protein levels was the result of 
improved export of cyclin Dl mRNA and not due to increased association with 
ribosomes (Rousseau et al., 1996). This is the first evidence which suggested that eIF4E 
is involved in the export of a subset of mRNAs. It has since been shown that the cap-
binding activity of eIF4E is necessary for the export of cyclin Dl mRNA (Cohen et al., 
2001). 
Evidently, the regulation of eIF4E activity by 4E-T has important consequences 
on translation homeostasis; 4E-T sequesters the limiting factor of translation into the 
nucleus. Once in the nucleus eIF4E associates with splicing factors and regulates the 
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expression of certain mRNAs. The order of events and further biochemical 
characterization of eIF4E activity and regulation in the nucleus has yet to be elucidated. 
eIF4G Regulation: impact on eIF4E activity 
eIF4E activity and availability is also regulated by eIF4G binding. eIF4G is a 
phosphoprotein (Raught et al., 2000). eIF4G is phosphorylated at its C-terminal region 
through the PI3K1 Akt and FRAP/mTOR pathways (Raught et al., 2000). 
Phosphorylation at the C-terminus site seems to be regulated by the N-terminal region 
(Raught et al., 2000). It is not clear how phosphorylation of eIF4G affects its function in 
translation (Gingras et al., 1999; Raught et al., 2000). Since P ABP appears to govem 
eIF4F crosslinking ability through eIF4G, one can imagine that the availability ofPABP 
will impact on eIF4G/eIF4E affinity for the cap (Kahvejian et al., 2005). 
1.3 Eukaryotic mRNA Decay 
The lifetime of an rnRNA is limited so that gene expression is normalized and kept under 
control. mRNA turnover is crucial for three main reasons (Coller and Parker, 2004; 
Moore, 2005; Parker and Song, 2004): The most obvious reason is that it regulates 
protein levels and therefore maintains basal levels of gene expression. An example of 
problems which arise as a consequence of impaired mRNA destruction include an 
increase in c-fos mRNA levels within the cell, which have been correlated with the onset 
of cancer (Wilusz et al., 2001 b). Secondly, mRNA decay is necessary when it cornes to 
eliminating messages which are faulty, for instance messages which contain a premature 
termination codon or messages which lack a termination codon. The best illustrated 
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example of the harmful consequences of this process going astray, is the case of ~­
Thalassemia. ~-Thalassemia arises when ~-globin mRNA containing a PTC within the 
3 'part of the gene is not eliminated, and leads to a truncated protein product with a 
dominant negative function (Holbrook et al., 2004). Thirdly, mRNA turnover is a 
defence mechanism in response to viral infection. This was first demonstrated in plants 
but host cell defence against viral infection by RNA interference (RNAi) has been more 
recently reported in mammals (Schutz and Samow, 2006). 
Eukaryotic mRNA decay pathways can be grouped into three categories (Fig. 
1.8): 1) general mRNA decay which implies the most frequent pathway of mRNA 
turnover and consists ofremoval of the polyA tail (deadenylation) followed by either 5'-
3'digestion of the mRNA body or 3'-5'digestion (Coller and Parker, 2004; Parker and 
Song, 2004; Tourriere et al., 2002; Wilusz et al., 2001b); 2) specialized mRNA decay 
pathways, which eliminate aberrant messages such as NMD, a process involved in 
eliminating mRNAs containing a PTC (Amrani et al., 2006; Behm-Ansmant and 
Izaurralde, 2006; Conti and Izaurralde, 2005; Maquat, 2004), and non-stop decay (NSD) 
which destroys mRNAs which are devoid of a stop codon (Maquat, 2002); 3) RNA 
interference (RNAi) which involves the destruction of mRNAs by short (21-23 
nucleotides) double stranded RNA with perfect complementarity to its target, and induce 
endonucleolytic cleavage of the target mRNA. Degradation of the mRNA may be 
elicited by exogenous short interfering RNA (siRNA) or endogenous microRNA 
(miRNA) (Valencia-Sanchez et al., 2006). mRNA decay relies on signaIs inherent in cis-
acting elements within the 5'UTR and 3'UTR of the message and depends on trans-
acting factors which bind to these regions. mRNA decay is also influenced by translation 
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Figure 1.8. Pathways of eukaryotic mRNA decay 
Adapted from (Coller and Parker, 2004). 
Eukaryotic mRNA decay pathways can be grouped into three categories: (A) general 
rnRNA decay which is prompted by removal of the polyA tail (deadenylation) followed 
by either 5'-3'digestion or 3'-5'digestion of the mRNA body; (B) specialized mRNA 
decay pathways, which eliminate aberrant messages such as the nonsense-mediated decay 
(NMD) and non-stop decay (NSD) pathways; (C) RNA interference (RNAi) which 
involves the destruction of mRNAs by short (21-23 nudeotides) double stranded RNA 
and induce endonudeolytic deavage of the target mRNA. 
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and is contingent upon the translation machinery (Dreyfuss et al., 2002; Moore, 2005). 
The following sections will focus on deadenylation-dependent general mRNA 
decay with particular emphasis on the 5'-3'exonucleolytic decay pathway, followed by a 
description of the NMD pathway which makes part of the specialized pathways of decay 
mentioned above. Reference to RNAi will be made briefly, and an explanation of the 
location of mRNA decay in cytoplasmic P-bodies will conclude this chapter. 
1.3.1 Deadenylation-Dependent Decay 
The S'-3'and 3'-5'exonucleolytic pathways both rely on removal of the polyA tail as the 
primary event in the digestion process (Muhlrad and Parker, 1992; Shyu et al., 1991). 
This is achieved by a group of enzymes called deadenylases. Three different enzyme 
complexes exist as deadenylases in eukaryotes. They include Ccr4/Pop2/Notl complex, 
Pan2/Pan3 complex, and poly(A) ribonuclease (P ARN) (reviewed in (Parker and Song, 
2004». 
1.3.1.1 Deadenylase Complexes 
Ccr4/Pop2/Notl complex is the enzyme complex with major deadenylase activity in 
yeast. This complex is conserved in higher eukaryotes. In yeast, Ccr4p and Pop2p both 
have deadenylase activity while Notl-NotSp and Caf4, Caf16, Caf40 and Caf130p are 
auxiliary proteins which aid its function (Denis and Chen, 2003; Parker and Song, 2004; 
Tucker et al., 2001). Studies performed in yeast demonstrated that Ccr4p constitutes the 
major catalytic component of this complex (Chen et al., 2002; Tucker et al., 2002). 
Pop2p exhibits nuclease activity in vitro, and is needed for mRNA de gradation in vivo 
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(Daugeron et al., 2001; Thore et al., 2003). Therefore, the Ccr4/Pop2/Notl complex may 
have two nucleases, Ccr4 and Pop2 that are regulated under different conditions and have 
different substrate specificities. Alternatively, Pop2 may just improve the nuclease 
activity of Ccr4 by stabilizing its conformation and interactions with the rnRNA (Parker 
and Song, 2004). 
Pan2plPan3p nuclease activity was discovered in yeast Ccr4p-deleted strains 
(Tucker et al., 2001). This complex is conserved from yeast to mammals. Pan2lPan3 
complex is involved in trimming the polyA tail oflong messages to ~55-75 nucleotides in 
yeast (Brown and Sachs, 1998) and less than 110 nucleotides in mammals (Yamashita et 
al., 2005). It was recently demonstrated by in vivo studies that cytoplasmic mRNA 
degradation in mammalians occurs by the dual action of Pan2lPan3 and Ccr4/Cafl 
complexes. Pan2lPan3 clips the poly(A) tail to less than 110 nucleotides, and in the 
second phase of deadenylation, Pan2/Pan3 surrenders to the Ccr4/Cafl complex for 
complete nuclease digestion of the poly(A) tail (Yamashita et al., 2005). The reasons for 
this collaborative effort will become apparent below. Pan2 is the catalytic subunit while 
Pan3 is an accessory protein in this complex. 
The enzyme complex with major deadenylase activity in mammalian cells was 
thought to be PARN, otherwise known as DAN (deadenylating nuclease), based on in 
vitro decay assays (Gao et al., 2000; Korner and Wahle, 1997). PARN was also shown to 
be responsible for poly(A) removal during Xenopus oocyte maturation (Dehlin et al., 
2000). While present in most eukaryotes, a homolog of P ARN in yeast S. cerevisiae and 
Drosophila does not exist (Parker and Song, 2004). P ARN mediates the rapid 
degradation of various ARE-containing messages (Gherzi et al., 2004; Lai et al., 2003; 
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Tran et al., 2004). Its action is stimulated by several message specific AU-binding 
proteins such as TTP (tristetraprolin), KSRP (K homology Splicing Regulatory Protein) 
and RHAU (RNA helicase associated with AU-rich element), which recruit it to the 
message and enable rapid deadenylation of the rnRNA. Furthermore, P ARN is 
implicated in rapid deadenylation during NMD in mammalian cells (Lejeune et al., 
2003). 
What govems the specificity of the deadenylase enzyme complexes for their 
substrates? The Ccr41P0p2/Notl complex is inhibited by P ABP and thus, it cannot 
access its substrate if it is covered by P ABP (Tucker et al., 2002; Viswanathan et al., 
2003). Similarly to Ccr4p, PARN is inhibited by PABP, but unlike Ccr4p, its activity is 
dependent on cap recognition (Dehlin et al., 2000; Gao et al., 2000; Komer and Wahle, 
1997; Martinez et al., 2001). Contrary to Ccr4 and PARN, PAN (Pan2lPan3) is 
stimulated by P ABP, consistent with its physiological role as the poly(A) tail trimmer 
(Sachs and Deardorff, 1992). It seems logical that the reported "biphasic" deadenylation· 
in mammalian cells occurs through PAN first and then Ccr4. Because PAN is stimulated 
by P ABP, it will bind the 3' end of the mRNA and digest it down to less than 100 
nucleotides; the resulting loss of P ABP molecules will alleviate the inhibition of Ccr4 
activity and promote eIF4F disassembly by loss of eIF4G-PABP interaction, and 
therefore stimulate Dcp2 activity (Yamashita et al., 2005). Altematively, the loss of 
P ABP molecules bound to the poly(A) after PAN digestion could promote P ARN 
activity, which is stimulated by the cap structure. 
1.3.2 3'-5'Decay and the Enzymes lnvolved 
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It is proposed that the major decay pathway in mammalian cells occurs via J'-5'digestion 
by the exosome following deadenylation, based on in vitro studies performed in 
mammalian cell extracts (Chen et al., 2001; Mukherjee et al., 2002; Wang and Kiledjian, 
2001). Most of the data cornes from studies done on AU-rich mRNAs (Chen et al., 2001; 
Mukherjee et al., 2002). It has been demonstrated by several groups that the exosome is 
recruited to these messages via interaction with AU binding proteins (Chen et al., 2001; 
Gherzi et al., 2004; Lykke-Andersen and Wagner, 2005; Tran et al., 2004). Altematively, 
the exosome may be targeted directly to an RNA sequence with specifie affinity for any 
ofthe exosomal components; for instance, PmSc175, an exosomal subunit, can recruit the 
exosome to ARE-containing mRNAs (Mukherjee et al., 2002). However, it should be 
noted that ARE-mediated decay does not exclusively necessitate 3'-5' digestion but may 
also undergo 5'-3'decay given that AU-binding proteins, TTP and BRF-1, can interact 
with enzymes of this pathway as well (Fenger-Gron et al., 2005; Lykke-Andersen and 
Wagner, 2005). In addition, more recently, in vivo experiments demonstrated that ARE-
mRNAs undergo predominantly 5'-3'decay when enzyme components ofeither pathway 
are depleted by RNAi (Stoecklin et al., 2006). 
1.3.2.1. The Exosome (3 '-5 'exonuclease) 
In yeast, the majority of mRNAs are degraded by deadenylation-dependent 5'-3'decay 
(Decker and Parker, 1993; Muhlrad et al., 1994; Muhlrad et al., 1995; Schwartz and 
Parker, 1999; Tourriere et al., 2002). Mutations which impaired 5'-3'degradation in 
yeast revealed a separate pathway which effects 3' -5' exonucleolytic digestion by a 
complex called the exosome (Anderson and Parker, 1998; Mitchell et al., 1997; Muhlrad 
40 
et al., 1995). The exosome collectively refers to a complex with an estimated 10 proteins 
in yeast, which have exonuclease activity (Parker and Song, 2004; Raijmakers et al., 
2004). Originally, the exosome was characterized on the basis of its nuclear function in 
RNA processing and degradation of ribosomal RNA (rRNA) , small nuclear RNA 
(snRNA) and small nucleolar RNA (snoRNA), as well as degradation of nuclear pre-
mRNA and mRNA (Parker and Song, 2004; Raijmakers et al., 2004). However, the 
exosome is not confined to the nucleolus and nucleoplasm, it is also localized to the 
cytoplasm and is required for cytoplasmic 3' -5' decay (Allmang et al., 1999; Lejeune et 
al., 2003; Raijmakers et al., 2004). The nuclear specificity of the exosome is conferred 
by the Rrp6p subunit in yeast, which is absent in the cytoplasmic exosome (Allmang et 
al., 1999; Raijmakers et al., 2004). 
The exosome is proposed to be the equivalent of the proteasome for RNA (van 
Hoofand Parker, 1999). The exosome contains enzymes which bear similarity to RNase 
PH exonucleases which are phosphorylases that digest RNAs at their 3' end by employing 
phosphate as a nucleophile (Parker and Song, 2004; Symmons et al., 2002; van Hoof and 
Parker, 1999). Based on structural studies performed on polynucleotide phosphorylase 
(PNPase) from bacteria, it was proposed that the exosome forms a ring-like structure with 
active sites centred toward the cavity of the exosome (Aloy et al., 2002; Parker and Song, 
2004; Raijmakers et al., 2004; Symmons et al., 2002; van Hoof and Parker, 1999). The 
reasons for sequestering the active sites to the center may be to avoid non-specific 
random c1eavage of substrates. Furthermore, separating the recognition of the substrate 
from the degradation reaction, would allow for an additional level of regulation of this 
multiprotein complex (van Hoof and Parker, 1999). The rationale for multiple 
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exonueleases within the complex is that the various enzymes may be differentially 
regulated under certain growth conditions, may have different substrate specificities, or 
may perform different functions on a single substrate (van Hoof and Parker, 1999). 
The exosome is conserved in eukaryotes. Human homologs of exosomal subunits 
with exonuelease activity have been identified (Allmang et al., 1999; Mitchell and 
Tollervey, 2000; Raijmakers et al., 2004). Components of the human exosome consist of 
core proteins Rrp4, Cs14, Rrp40, Rrp41, Rrp46, Mtr3, Rrp42, OIP2, Pm/Sc-175, as well 
as Pm/Sel-IOO (hRrp6p) and Dis3 (Raijmakers et al., 2004). As mentioned above, the 
human exosome is recruited to its substrate by AU binding proteins or through direct 
interaction with RNA. 
1.3.2.2. The Scavenger Decapping Enzyme 
The scavenger decapping enzyme, DcpS, is a pyrophosphatase belonging to the 
histidine triad (HIT) family (Liu et al., 2002). The HIT motif consists of His-X-His-X-
His-X, where X is a hydrophobic residue, and is necessary for hydrolyzing the cap. The 
substrate of DcpS is free cap (m7GpppX), 7-methyl GDP (m7Gpp) or short RNA with 
less than 10 nuc1eotides linked to the cap (Liu et al., 2002) (Fig. 1.9 and Table 1.1). In 
contrast, this enzyme is not able to decap long RNA substrates in mammals (Liu et al., 
2002). The eleavage product of DcpS is m7GMP. DcpS catalyses hydrolysis of the 
capped dinueleotide generated by 3'-5'exosome-mediated decay (Wang and Kiledjian, 
2001). In accordance with this, DcpS was found to coimmunoprecipitate with exosomal 
subunits in mammalian cells (Wang and Kiledjian, 2001). Furthermore, DcpS hydrolyzes 
the m7GDP byproduct of Dcpll2 (see below), to m7GMP (van Dijk et al., 2003). The 
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Figure 1.9. Cap structure and metabolism 
(A) Chemical structure of the mRNA cap. 
(B) Enzymatic synthesis and degradation of the mRNA cap. 
(A) and (B) adapted from (Gu and Lima, 2005). 
(C) Schematic of eukaryotic decapping proteins. Dcp2 contains the NUDIX domain 
that is essential for enzymatic activity. The active site of DcpS contains a HIT (histidine 
triad) domain. Blue shaded regions show are as of evolutionary conservation, and black 
shaded regions show known functional motifs. Known substrates for the decapping 
enzymes are indicated on the right. Adapted from (Fillman and Lykke-Andersen, 2005) 
with modification. 
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seavenger deeapping enzyme is a eritieal effeetor in both 5'-3' and 3'-5' deeay beeause it 
prevents the unwanted sequestering of residual unhydrolyzed cap by eIF4E and from 
interfering with mRNAs to be translated, sinee DepS ean eompete with eIF4E for binding 
to a free cap but not cap attaehed to an RNA moiety (Liu et al., 2004). 
There are two homologs of DepS in S. cerevisiae, Deslp and Des2p (Liu et al., 
2002). Deslp and Des2p bear equal level of identity to DepS and eontain the 
eharaeteristie HIT motif. However, Deslp has deeapping aetivity similar to DepS, 
whereas Des2p does not have eatalytie aetivity (Liu et al., 2002). Des2p is known to bind 
to Deslp and, therefore, it is proposed that it may regulate its aetivity. 
1.3.3 5'-3'Decay Pathway and the Enzymes Involved 
1.3.3.1. Decapping Enzymes Dcp1 and Dcp2 
In eukaryotes, deadenylation-dependent 5'-3' deeay is proeeeded by deeapping of the 
mRNA by a holoenzyme eomplex eonsisting of Dep 1 and Dep2 (Beelman et al., 1996; 
Dunekley and Parker, 1999; Lykke-Andersen, 2002; van Dijk et al., 2002; Wang et al., 
2002b). The Depl: Dep2 eomplex eatalyzes hydrolysis of the cap bound to an RNA 
moiety eonsisting of at least 25 nucleotides (Piecirillo et al., 2003; van Dijk et al., 2002). 
The produet of hydrolysis is a 5'monophosphate mRNA and m70DP, whieh is then a 
substrate for the seavenger deeapping enzyme (Fig. 1.9 and Table 1.1). 5'-3'mRNA 
deeay is the most eommon pathway of degradation utilized by yeast (Deeker and Parker, 
1993; Muhlrad et al., 1994; Muhlrad et al., 1995; Schwartz and Parker, 1999). 
Depl and Dep2 were originally identified in S. cerevisiae. Deplp was the first 
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Table 1.1 Enzymes involved in mRNA decay 
Adapted from (Coller and Parker, 2004) with modification. 
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TABLE 1.1 Enzymes involved in mRNA decay * 
Protein Function Features 
Deadenylation 
Catalytic subunit of the Homology to Mg2+ dependent 
Ccr4p deadenylase endonucleases 
Regulator of deadenylation, may 
Pop2p also have deadenylase activity Homology to RNaseD 
Minor deadenylases, required for 
Pan2p/Pan3p poly(A) length control Pan2p has homology to RNaseD 
Homology to RNaseD. Can bind to 5' 
cap, which stimulates deadenylase 
PARN Mammalian deadenylase activity 
Decapping 
Major component of decapping 
Dcp1p holoenzyme EVH1/WH1 domain 
Catalytic subunit of decapping NUDIX motif, conserved Box A and Box 
Dcp2p holoenzyme B motif 
Exonucleases 
Major cytoplasmic 5'-3' 
Xrn1p exonuclease 
Rat1p Nuclear 5'-3' exonuclease 
Rrp4, Rrp40p, 
Rrp41 p,Rrp42p, 
Rrp43p,Rrp44p, 
Rrp45p, Rrp46p, A complex of 3'-5' exonucleases Domain organization similar to that of 
Mtr3p, Cs14p termed the exosome bacterial PNPase 
* Note that mammalian orthologs have been identified for ail these enzymes; PARN is 
not present in S. cerevisiae. 
subunit identified with decapping activity (LaGrandeur and Parker, 1998) and Dcp2p was 
later identified in a yeast strain containing mutated Dcp 1 p (Dunckley and Parker, 1999). 
Homologs of Dcplp and Dcp2p were later identified in humans (Lykke-Andersen, 2002; 
van Dijk et al., 2002; Wang et al., 2002b). There are two homologs of Dcpl in humans, 
Dcpla and Dcplb (Lykke-Andersen, 2002) (Fig. 1.9 and Table 1.1). They are both 
distantly related to the yeast ortholog and bear similarity to Dcplp primarily in their N-
terminal region, which incidentally contains residues important for decapping activity in 
yeast Dcplp. The two human Dcpl homologs bear very little similarity over their entire 
length but contain 68% identity in their N-terminal region. Human Dcp2 contains 36% 
identity to the yeast homolog and possesses a mutT or Nudix motif which is conserved 
from yeast to humans (Lykke-Andersen, 2002; van Dijk et al., 2002; Wang et al., 2002b). 
The Nudix motif is present among members of a large family of pyrophosphatases called 
NUDIX (nudeoside diphosphate linked to an X moiety) hydrolases. The Nudix motif is 
composed of a 23 amino acid consensus sequence which contains several conserved 
glutamate residues that coordinate the action of a divalent metal ion (Mildvan et al., 
2005; Parker and Song, 2004) and is critical for the decapping activity of Dcp2 (Lykke-
Andersen, 2002; van Dijk et al., 2002; Wang et al., 2002b). Mutations within this region 
lead to a loss of decapping activity in both yeast and mammals (Lykke-Andersen, 2002; 
van Dijk et al., 2002; Wang et al., 2002b). In addition to cap recognition and hydrolysis 
by the Nudix motif, a conserved region flanking the Nudix motif, called Box B, is 
important for the RNA binding ability of Dcp2, which is also necessary for its decapping 
activity (Piccirillo et al., 2003). The RNA binding ability of Dcp2 likely ensures that it 
functions only on capped RNA on which initiation complexes have been disrupted 
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(Fillman and Lykke-Andersen, 2005). 
Dcp2 is the subunit with intrinsic decapping activity, whereas Dcp1 has no 
catalytic activity on its own, but binds to Dcp2 in vitro and in vivo (Bee1man et al., 1996; 
Dunckley and Parker, 1999; Lykke-Andersen, 2002; Steiger et al., 2003) and modulates 
its activity (Lykke-Andersen, 2002; She et al., 2004). The crystal structure of Dcp1 from 
S. cerevisiae has revealed two structurally conserved regions important for decapping 
(She et al., 2004). The N-terminal domain of Dcp1 contains a proline-rich site (PRS) 
through which it may bind proteins that regulate the Dcp 1 :Dcp2 complex. The other site 
is present on the concave surface of Dcp1, opposite of the PRS site, and is essential for 
decapping activity. This site does not seem to be necessary for binding to Dcp2 and 
therefore may be vital to coordinating the metal ion or inducing conformational changes 
in Dcp2 that are pertinent to its enzymatic activity. Another region critical for decapping, 
is a conserved hydrophobic patch situated in the vicinity of the former described region 
(She et al., 2004). 
The crystal structure of Dcp2 from S. pombe has been recently described (She et 
al., 2006). A C-terminally truncated Dcp2 was used in these studies. The Nudix motif, 
which is vital for decapping activity in vitro and in vivo is found in the C-terminal 
portion. A conserved region on the surface of the N -terminal domain mediates the 
interaction with Dcp 1. The flexibility of this region compared to the C-terminal domain 
affirms the fact that interaction with Dcp 1 enhances the intrinsic catalytic activity of the 
C-terminus (She et al., 2006). 
1.3.3.2 Regulation ofDecapping by Dcpl:Dcp2 
Inhibitors ofdecapping 
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Decapping is regulated by a slew of factors which either positively or negatively 
influence the activity of the decapping enzymes (Coller and Parker, 2004; Fillman and 
Lykke-Andersen, 2005; Parker and Song, 2004) (Table 1.2). Decapping is negatively 
affected by translation initiation factors (Schwartz and Parker, 1999). The cap binding 
protein, eIF4E, is in direct competition with the decapping enzyme and its dissociation 
from the cap is necessary for Dcp 1/2 to gain access to this structure (Schwartz and 
Parker, 2000). Therefore, translation and general mRNA decay are antagonistic. Yeast 
strains containing mutations in all the translation initiation factors tested, decreased the 
halflife of the reporter mRNA in S. cerevisiae (Schwartz and Parker, 1999); an increase 
in the rate of deadenylation and decapping was observed. The poly(A) tail is an entity in 
itself which regulates decapping (Coller and Parker, 2004). It is well known that 
deadenylation occurs prior to decapping: the time it takes for decapping to commence 
coincides with the time it takes for deadenylation to complete (Decker and Parker, 1993). 
Furthermore, decapping intermediates for the most part contain short (A) lengths (Decker 
and Parker, 1993; Muhlrad et al., 1994; Muhlrad et al., 1995). Moreover, mRNAs 
containing poly(A) tails are resistant to decapping in in vitro extracts (Wilusz et al., 
2001a). PABP is the major protein associated with the poly(A) tail and is a key player in 
regulating decapping (Coller and Parker, 2004; Wilusz et al., 2001a). PABP also 
physically associates with eIF4G at the S'end resulting in circularization of the mRNA 
(Kahvejian et al., 2001). Therefore, PABP is inhibitory to decapping, presumably by 
preventing the release of the eIF4F complex from the S'end, since it is believed to have a 
stimulatory effect on eIF4F binding to the cap (Kahvejian et al., 2005), and is therefore 
an impediment for the decapping enzyme to access the cap. Alternative explanations to 
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Table 1.2. Regulators of mRNA decapping in yeast and mammals 
Adapted from (Coller and Parker, 2004) with modification. 
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ITABLE 1.2 Regulators of yeast/mammalian mRNA decapping 
Protein Properties 
Contains four N-
terminal RRM 
domains and a 
proline-rich C 
Pab1p* terminus 
eIF-4E* Cap-binding protein 
Lsm1-
7p* Sm-like proteins 
88kDa protein with 
Pat1 pt 
no recognizable 
sequence motifs 
Member of the ATP-
dependent DExD/H 
Dhh1p* box helicase family 
Small, basic 
proteins with weak 
Edc1p, homology to each 
Edc2p other 
Contains five 
Edc3p* conserved domains 
Pumillo-like protein, 
Puf3pt 
contains eight PUF 
repeats 
Upf1p, Upf1 P is an ATP-
Upf2p, dependent RNA 
Upf3p* helicase 
Hedls or Contains a WD40 
Ge-fI: repeat region 
* mammalian ortholog present 
t no mammalian ortholog 
:t: no yeast homolog 
Function 
Major protein associated with poly(A) tail. 
Blocks mRNA decapping and stimulates 
translation. Primary coupler of 
deadenylation and decapping. 
Component of the eukaryotic translational 
initiation complex, eIF-4F. Blocks mRNA 
decapping by competing with Dcp1/2p for 
access to the cap. 
Required for the efficiency of decapping 
in vivo. Forms a heteroheptameric ring 
complex and interacts with the mRNA 
after deadenylation. May facilitate the 
assembly of the decapping complex. 
Interacts with both polyadenylated and 
deadenylated transcripts. Required for 
efficiencyof both decapping and 
formation of P bodies in vivo. May "seed" 
the decapping complex on the mRNA. 
Required for the efficiency of decapping 
in vivo. Homologs across species are 
required for translational repression 
during mRNA storage events. 
Required for efficient decapping in vitro. 
Directly binds to the mRNA substrate. 
A general and mRNA-specific regulator of 
decapping. Regulates the decapping of 
the RPS28a mRNA. 
Messages specific activator of mRNA 
deadenylation and decapping. Homologs 
facilitate translational repression. 
Regulates the decapping of the COX17 
mRNA. 
Required for non-sense- mediated 
decapping. 
Enhances decapping activity of Dcp2 and 
Promotes the interaction between Dcp1 
and Dcp2 
Significant 
interactions 
eIF-4G, eRF3, 
Pan2/3p 
Lsm7p, eIF-4G, 
elF- 4A, eIF-4B, 
Pab1p 
Dcp1 p, Dcp2p, 
Dhh1 p, Pat1 p, 
Xrn1 p, Upf1 P 
Dcp1 p, Dcp2p, 
Lsm1-7p, Dhh1p, 
Xrn1p, Crm1p 
Dcp1p, Dcp2p, 
Lsm1-7p, Ccr4p, 
Pop2p, Caf17p, 
Pbp1p, Edc3p 
Dcp1 p, Dcp2p 
Dcp1 p, Dcp2p, 
Dhh1 p, Crm1 p, 
Rps28ap, 
Nup157p, Lsm8p 
eRF1, eRF3, 
Dcp2p, Upf2p, 
Lsm1p 
Dcp1, Dcp2 
the inhibitory role of P ABP in the decapping process, independent of the poly(A) tail, 
have been put forth since: a) tethered Pabp1 (yeast PABP) can inhibit decapping 
independent of the poly(A) tail (Coller et al., 1998), b) deletions of the eIF4G binding site 
of Pabp1 can still inhibit decapping (Coller et al., 1998; Schwartz and Parker, 1999), c) 
when translation initiation factors are mutated in yeast they do not bypass deadenylation 
which suggests that P ABP may function independently of its interaction with the 
initiation complex (Schwartz and Parker, 1999). Thus, it has been suggested that PABP 
can either interact directly with a prote in which inhibits the decapping enzyme or it may 
bind the cap directly (Coller and Parker, 2004; Khanna and Kiledjian, 2004). 
Altematively, it may function in inhibiting the localization of translating pools of 
mRNAs away from degradation enzyme factories (see section 1.4) (Coller and Parker, 
2004). 
Positive regulators ofdecapping 
Decapping is also regulated by a host of factors which enhance its activity (see Table 1.2 
for summary). These factors have been mainly characterized in S. cerevisiae and inc1ude 
Dhhl p, Lsml p-7p, Patl p and the enhancers of decapping (Edcp) proteins; they are 
collectively referred to as decapping factors (Coller and Parker, 2004; Parker and Song, 
2004). 
Dhh1 P is a member of the DEAD box family of RNA helicases. It interacts with 
the decapping enzymes in RNAseA-treated extracts (Coller et al., 2001). The interaction 
of Patlp and Lsmlp-7p with the Dcp1p:2p complex, however, is RNA-dependent 
(Bouveret et al., 2000; Tharun and Parker, 2001). When each ofthese factors is deleted 
in S. cerevisiae, there is a rise in deadenylated mRNAs which are capped, which suggests 
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that they are important for decapping (Bouveret et al., 2000; Coller et al., 2001; Tharun et 
al., 2000). Dhhl P is a putative RNA helicase which stimulates the decapping activity of 
Dcp 1 in vitro, and interacts with all the decapping factors and with the deadenylase 
complex; its RNA unwinding activity is thought to be important for conformational 
mRNP changes at the 5' end and for making the cap accessible to decapping enzymes 
(Coller et al., 2001; Fischer and Weis, 2002). The Lsml-7 complex is a group ofproteins 
which have RNA-binding activity, and possess an Sm-like motif (from which they 
derived their name) which mediates protein-protein interactions and binding to RNA (He 
and Parker, 2000). The related complex, Lsm 2-8, is a nuclear RNA-binding heptameric 
complex which is involved in pre-rnRNA splicing (He and Parker, 2000). In contrast, 
Lsml p-7p is involved in cytoplasmic mRNA degradation and stimulates decapping 
(Bouveret et al., 2000; Tharun et al., 2000). Lsmlp-7p proteins assemble on 
deadenylated mRNAs which no longer have translation factors PABP, eIF4E and eIF4G 
bound on the rnRNA (Tharun and Parker, 2001). Therefore, the Lsml-7 complex is a 
critical marker of mRNAs bound for decay, and its binding to the mRNA may promote 
mRNP rearrangements which accelerate removal of translation factors and association of 
decapping factors. Lsmlp-7p interacts directly with Patlp (Tharun and Parker, 2001). 
Patl p, unlike Lsml p-7p, is bound to mRNAs on which translation factors have not been 
displaced and remains bound after they have been removed (Tharun and Parker, 2001). 
Therefore, Patl p is a bridging molecule between a translationally active state of the 
mRNP and one receptive for decay. Patlp may function to recruit proteins which assign 
the mRNA for decapping and decay. The Edcp proteins are a family 3 proteins identified 
in S. cerevisiae which interact with the Dcp 1 p:Dcp2p complex and enhance decapping. 
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They bind mRNA and stimulate decapping directly through the Dcplp:Dcp2p complex in 
vitro (Schwartz et al., 2003). Edclp and Edc2p are not essential for decapping; yeast 
strains in which each of these factors is deleted alone had no significant effect on mRNA 
decay rates. However, deletion of Edc 1 p or Edc2p in yeast strains partially compromised 
for decapping, significantly decreased mRNA decay rates. Accordingly, overexpression 
of either these proteins increased mRNA decay rates in strains defective in mRNA 
decapping (Schwartz et al., 2003). Edc3p is not homologous to Edclp and Edc2p. It 
interacts with the Dcp 1 p: Dcp2p complex itself and enhances decapping (Kshirsagar and 
Parker, 2004). 
Homologs of Lsmlp-7p, Dhhlp, Patlp, and Edc3p are also present in higher 
eukaryotes (Fillman and Lykke-Andersen, 2005). Human homologs of Lsm1 p-7p (Lsm 
1-7) (Achsel et al., 1999), Dhh1p (referred to as rck/p54) (Smillie and Sommerville, 
2002) and hEdc3 (Fenger-Gron et al., 2005) have been identified and linked to mRNA 
decay mainly by colocalization of these factors in P-bodies (Cougot et al., 2004; Fenger-
Gron et al., 2005; Ingelfinger et al., 2002; Sheth and Parker, 2003), discrete cytoplasmic 
foci where mRNA decay takes place (see section 1.4), and by interaction studies with 
decapping enzymes (Fenger-Gron et al., 2005; Fillman and Lykke-Andersen, 2005; 
Lykke-Andersen and Wagner, 2005). Two additional factors that have been identified in 
humans and lack an observable homolog in yeast are GWl82 and Hedls (human enhancer 
of decapping large subunit, otherwise known as Ge-l) (Eystathioy et al., 2002; 
Eystathioy et al., 2003; Fenger-Gron et al., 2005; Yu et al., 2005). Hedls interacts with 
Dcp2 in RNAse treated extracts and mediates the interaction of Dcp2 with Dcpl (Fenger-
Gron et al., 2005). Furthermore, Hedls promotes hydrolysis of the cap by Dcp2 in an in 
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vitro decapping assay (Fenger-Gron et al., 2005). Therefore, Hedls is an enhancer of 
decapping in human cells. hEdc3 appears to be necessary for the interaction of rck/p54 
with Dcp1a (Fenger-Gron et al., 2005). GW182 is a large protein which contains multiple 
glycine/trytophan repeats (GW repeats) (Eystathioy et al., 2002). This protein was 
assoeiated to mRNA decay by its colocalization with the decapping enzyme in discrete 
cytoplasmic foei using serum containing antibodies against the autoantigen GW182, from 
patients with motor and sensory neuropathy (see section 1.4) (Eystathioy et al., 2003). 
GW182 contains an RNA recognition motif(RRM) and is bound to a subset ofrnRNAs 
in HeLa (Eystathioy et al., 2002). GW182 plays a critical role in RNAi (see section 
1.3.5) (Jakymiw et al., 2005; Liu et al., 2005a; Rehwinkel et al., 2005). 
1.3.3.3. Xrn exonucleases 
Once decapping is complete, the 5'monophosphate mRNA becomes a substrate of the 5'-
3'exonuclease, Xml. Xml is present in yeast and is conserved in other eukaryotes 
(Bashkirov et al., 1997; Ingelfinger et al., 2002; Johnson and Kolodner, 1991; Kolodner 
et al., 1987). Deletion of Xml in yeast leads to an accumulation of deadenylated, 
decapped rnRNA intermediates (Hsu and Stevens, 1993; Schwer et al., 1998). Rat! 
(Xrn2) exists in yeast and humans and is localized in the nucleus where it may function in 
5'-3'digestion ofnuclear RNAs (Amberg et al., 1992; Johnson, 1997). 
1.3.4 Nonsense Mediated Decay (NMD) 
Nonsense mediated decay (NMD) is considered a specialized pathway of mRNA decay 
that rids the cell of messages containing a premature termination codon (PTe), which 
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originates from mutated genes as a result of nonsense or frameshift mutations, or that 
arises from transcriptional or splicing errors. It is also implicated in the regulation of 
normal transcripts in about ~ 10% of the yeast, human and Drosophila transcriptome 
(Behm-Ansmant and Izaurralde, 2006; Conti and Izaurralde, 2005; Maquat, 2004). 
NMD is an RNA surveillance pathway which is conserved in yeast, Drosophila, 
C. elegans and mammals (Conti and Izaurralde, 2005). In all eukaryotes, a surveillance 
complex is formed upon recognition of a PTC, however, how a stop codon is considered 
premature and the mechanism involved in the decay of the message differs across 
organisms. In this section, only the mechanism involved in the mammalian NMD 
pathway will be discussed. The importance of this pathway is underscored by the fact 
that approximately 30% of human genetic disorders are the result of a PTC in the mRNA 
(Holbrook et al., 2004). To put this into perspective, a drug that promotes readthrough of 
a PTC, which is a result from an inherited mutation in the gene linked to cystic fibrosis, is 
currently in clinical trials and shows much promise (Ainsworth, 2005). 
1.3.4.1. Splicing dependency ofmammalian NMD 
NMD is a splicing dependent event in mammals. During splicing, a group of proteins are 
deposited 20-24 nucleotides upstream of the exon-exon junction, which is termed the 
exon-junction complex (ElC) (Kataoka et al., 2000; Le Hir et al., 2000a; Le Hir et al., 
2000b) (Fig. 1.10). The ElC forms a stable, position-dependent and sequence-
independent contact with the mRNA and communicates the position of the PTC; it is 
essentially a mark for destruction of the mRNA if found downstream of a termination 
codon (Le Hir et al., 2001 b; Le Hir et al., 2000a; Le Hir et al., 2000b). A stop codon is 
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Figure 1.10. Splicing dependency ofNMD 
Position-dependent effects of the EJC on NMD. Figure rnodelled against (Lejeune and 
Maquat, 2005). When a terrnination codon is located greater than 50-55 nt upstream of 
the last exon-exonjunction, the rnRNA will be subjected to NMD, as indicated by the red 
underlying arrow. 
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considered premature if it is found at least 50-55 nucleotides upstream of a spliced intron 
(Fig. 1. 1O) (Carter et al., 1996; Nagy and Maquat, 1998; Zhang et al., 1998a; Zhang et al., 
1998b). In fact, siRNA against components of the EJC inhibits NMD; on the other hand, 
tethering of the EJC factors to the 3' end of a normal transcript results in decay of that 
message (Gehring et al., 2003; Lykke-Andersen et al., 2000; Lykke-Andersen et al., 
2001; Mendell et al., 2002). 
1.3.4.2 Components of the EJC 
As mentioned above, during splicing the splicesome deposits a complex of proteins at the 
exon-exon junction. Sorne of the proteins at this position remain bound to the mRNA 
once it exits the nucleus and enters the cytoplasm, while other proteins are displaced from 
the EJC along its journey (Dreyfuss et al., 2002; Moore, 2005) (Fig. 1.11). The latter set 
of proteins are considered accessory factors and aid in either splicing (for instance, 
SRm160) or in export of the mRNA through the nucleopore complex (for instance, 
UAP56, REF/Aly and TAP) (Le Hir et al., 2001b). EJC factors which remain bound to 
spliced mRNA, at the position of the EJC, even upon entry of the mRNA into the 
cytoplasm include Y14, Magoh, Barentsz, and RNPSI (Degot et al., 2004; Kataoka et al., 
2001; Kataoka et al., 2000; Kim et al., 2001 b; Le Hir et al., 2001 a; Le Hir et al., 2001 b; 
Lykke-Andersen et al., 2001) (Fig. 1.11). In addition to these proteins, a component of 
the trimeric surveillance complex (see section 1.3.4.4), Upf3, is often considered a 
component of the EJC because it has a nuclear distribution at steady-state, it binds 
specifically to spliced mRNAs at the postion of the EJC, and it shuttles between the 
nucleus and the cytoplasm which suggests that it exits with spliced mRNAs from the 
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Figure 1.11. The EJC core and auxiliary factors 
Three spheres of EJC factors. The minimal EJC core likely consists of a tetrameric 
complex containing eIF4AIII (note: our studies and others have identified eIF4AIII as a 
noveZ compone nt of the EJC, see Chapter 2), MLN51, Magoh, and Y14, with eIF4AIII 
providing direct contact to the mRNA. AlI factors in this core are shuttling proteins and 
most likely foIlow the mRNA to the cytoplasm. Proteins in the outer sheIl were aIl found 
by mass spectrometry of the in vitro-derived EJC. RNPSl, Acinus, and SAP18 can stably 
associate and may bind the EJC core as a trimeric complex. However, RNPS 1 may also 
bind alone, e.g., via interactions with Pinin. SAP18, RNPSl, and AlylREF are shuttling 
proteins, whereas Acinus and Pinin are nuclear restricted. Transiently interacting factors 
are proteins not identified in the in vitro-derived EJC, but which likely interact 
dynamicaIly with either the EJC core or outer sphere proteins. Adapted from (Tange et 
al.,2005). 
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nucleus (Kim et al., 2001a; Lykk:e-Andersen et al., 2000). Binding assays have 
substantiated the formation of such a complex (EJC) and have also delineated the 
specificity and the relevance ofthese interactions with respect to NMD. Y14 and Magoh 
directly interact and form a heterodimer in vitro and in vivo (Kataoka et al., 2001; Le Rir 
et al., 2001a). The association of Y14 and Magoh is necessary for cell viability in 
Drosophila S2 cells (Le Rir et al., 2001a). siRNA against Y14 inhibits NMD while 
tethering ofY14 to a reporter induces NMD (Gehring et al., 2003; Lykk:e-Andersen et al., 
2001). A connection between Y14 and NMD is further supported by the fact that Y14 
also interacts with UpfJ in RNAse treated extracts. The interaction of Y14 with UpfJ is 
necessary for NMD mediated by tethered UpfJ (Gehring et al., 2003). RNPS 1 can 
interact with the Upf complex in RNAse treated extracts and is therefore proposed to be a 
key mediator between the EJC and the surveillance complex (Lykk:e-Andersen et al., 
2001). Tethering of RNPSI to a reporter also induces NMD (Lykk:e-Andersen et al., 
2001). Barentsz has RNA-binding activity and associates with EJC components. 
Furthermore, Barentsz colocalizes with Magoh in nuc1ear speckels, which are sites where 
splicing factors are stored (Degot et al., 2004; Le Rir et al., 2001a). It is not surprising 
that EJC proteins which are deposited by the splicesome onto the mRNA (i.e. Y14, 
Magoh, RNPS 1 and Barentsz), are also found in this location (Degot et al., 2004; 
Kataoka et aL, 2001; Kataoka et al., 2000; Le Rir et al., 2001a; Lykk:e-Andersen et al., 
2001). The localization of Barentsz in nuc1ear speckles and its binding to Magoh and 
RNA, occurs through the same region called SELOR (mJ~ckle localizer and RNA binding 
module) (Degot et al., 2004). 
The EJC is thought to be removed during the first round of translation (Dostie and 
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Dreyfuss, 2002) (see below). Y14 co sediments with rnRNAs at the top of the sucrose 
gradient and with 80S monosome fractions in a ribosome profiling assay of HeLa cell 
extracts. Furthermore, Y14 is retained on rnRNAs in which translation is inhibited by a 
hairpin structure in its 5' UTR, in vitro and in vivo, which indicates that translation is 
required to remove Y14 from rnRNAs (Dostie and Dreyfuss, 2002). The dependency of 
NMD on translation is discussed below. 
1.3.4.3. Translation Dependency ofNMD 
NMD is dependent on ongoing translation (Fig. 1.12). The reliance of NMD on 
translation is supported by several lines of evidence: 1) mutations within the initiator 
AUG, 2) suppressor tRNAs and 3) hairpin structures within the 5'UTR of the mRNA, 
which aH inhibit translation, also inhibit NMD. This is manifested by an accumulation of 
PTC-containing mRNAs (Belgrader et al., 1993; Le Hir et al., 2001a; Wang et al., 
2002a); 4) protein synthesis inhibitors with different modes of action inhibit NMD 
(Carter et al., 1995) and 5) infection with poliovirus, which results in eIF4G cleavage at 
its N-terminus and host cell shutoff of prote in synthesis, also inhibits NMD (Carter et al., 
1995). Altogether, these data point to the involvement of a surveillance mechanism 
which relies on scanning of the ORF by the ribosome for a termination codon in the 
wrong context. 
It is proposed that NMD occurs during a pioneer round of translation, which is 
defined as the first time the reading frame is scanned by the ribosome, and is believed to 
occur in association with a different set of translation factors which function uniquely in 
NMD (Chiu et al., 2004; Ishigaki et al., 2001; Lejeune et al., 2002; Lejeune et al., 2004). 
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Figure 1.12 Translation dependency ofNMD 
Model of the dependency ofNMD on the position of a PTC relative to the EJC and the 
translating ribosome. Adapted from (Dreyfuss et al., 2002) with modification. 
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It has been reported that messages subject to NMD are bound by CBP20/80 at the cap 
instead of eIF4E and that the poly(A) tail is bound by PABP2 not in lieu ofPABPI but 
simultaneously with PABPI on the mRNA (Ishigaki et al., 2001; Lejeune et al., 2002). 
More recently, it was shown that eIF4G is necessary for NMD and that it directly 
interacts with CBP80 (Lejeune et al., 2004; Mc Kendrick et al., 2001). In accordance 
with the role of CBP20/80 in NMD, 4E-BPI inhibited translation of a reporter luciferase 
but did not inhibit NMD (Chiu et al., 2004). In contrast, PAIP2 (Poly(A) Binding Protein 
Interacting Protein 2), an inhibitor of P ABP 1 function (Khaleghpour et al., 2001 a; 
Khaleghpour et al., 2001 b), inhibited both translation of a reporter luciferase mRNA and 
NMD (Chiu et al., 2004). 
It is debatable where the pioneer round of translation takes place, i.e. the nucleus 
or the cytoplasm (Ibo rra et al., 2004; Nathanson et al., 2003; Wilkinson and Shyu, 2002). 
Most of the PTC-containing mRNAs analyzed to date are degraded in the nuclear fraction 
(Wilkinson and Shyu, 2002). Sorne have thus postulated that the first round of translation 
takes place in the nucleus by a ribosome-like particle, and is based mainly on evidence 
that sorne translation factors are localized to the nucleus and that amino acid 
incorporation occurred in permeabilized cells or purified nuclei (Iborra et al., 2001). 
However, the latter has met considerable debate and it is presumably more commonly 
accepted that the mRNA is likely to be read by cytoplasmic ribosomes as it egresses from 
the nucleus, but that its degradation per se co-fractionates with the nucleus (Bohnsack et 
al., 2002; Nathanson et al., 2003). Since rnRNA decay is associated mainly with the 
nuclear fraction and since sorne translation factors are localized in the nucleus, including 
those reported to function in NMD [i.e. CBP80 (Izaurralde et al., 1994), PABP2 (Calado 
61 
and Carmo-Fonseca, 2000), and eIF4G (McKendrick et al., 2001)], it is conceivable that 
nuclear translation initiation factors are assembled on the mRNA in the nucleus and are 
exported to the cytoplasm where they are then engaged by the ribosome. 
1.3.4.4. The Trimeric Surveillance Comp/ex: Upfl.:Upj2: UpfJ 
The "effector" arm of NMD refers to the mechanism involved in the decay of the PTC-
containing mRNA. The signal for decay cornes from the surveillance complex which is 
composed of 3 core proteins: Upfl, Upf2, Upf3. These proteins are conserved in aIl 
eukaryotes and are essential for NMD in aIl organisms (Behm-Ansmant and Izaurralde, 
2006; Conti and Izaurralde, 2005). As mentioned above, Upf3 is a nuclear protein which 
is associated with the EJC and remains associated at the EJC after export from the 
nucleus (Kim et al., 2001a; Lykke-Andersen et al., 2000). Upf2 is localized at the 
perinuclear interface; it is proposed that Upf2 joins Upf3 upon exit from the nucleus 
(Lykke-Andersen et al., 2000). Upfl is a cytoplasmic protein which contains ATP-
dependent RNA helicase activity (Lykke-Andersen et al., 2000). Its helicase activity is 
required for NMD (Sun et al., 1998; Weng et al., 1996). Upfl is also involved in 
translation termination and interacts with translation release factors eRFl and eRF3 
(Czaplinski et al., 1998). If the ribosome encounters a stop codon upstream of an EJC 
during translation, a premature translation termination event bridges Upfl, associated 
with release factors eRFl and eRF3 at the stop site, with downstream bound Upf2 and 
Upf3. The recruitment of Upfl results in the formation of the surveillance complex: 
Upfl :Upf2:Upf3. Formation of the Upfl :Upf2:Upf3 trimeric complex is supported by 
interaction data, genetic studies and even structural data (Behm-Ansmant and Izaurralde, 
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2006). Upfl interacts directly with Upf3 and Upfl (Behm-Ansmant and Izaurralde, 
2006; Kadlec et al., 2004). Upfl contains three MIF4G domains. The last of the three 
MIF4G is involved in the interaction with Upf3 (Kadlec et al., 2004). The binding site of 
Upfl is mapped to the RNA-binding domain of Upf3 (Kadlec et al., 2004). The binding 
sites on both Upfl and Upf3 are conserved among eukaryotes. Upfl makes contact with 
Upfl through both its N and C-terminal regions (Behm-Ansmant and Izaurralde, 2006). 
Formation of the surveillance complex elicits Upfl phosphorylation, which in 
turn prompts decay of the mRNA (reviewed in (Behm-Ansmant and Izaurralde, 2006). 
The phosphorylation of Upfl is required for NMD to occur and is mediated by SMG-l, a 
phosphoidyl-inositol-3 (PI3)-like kinase. Based on recent data from Kashmina et al, a 
model for surveillance complex formation and Upfl phosphorylation has emerged 
(Behm-Ansmant and Izaurralde, 2006; Kashima et al., 2006). When premature 
translation termination occurs, a complex of proteins consisting of at least eRFl, eRF3, 
Upfl, and SMG-l is assembled, and is referred to as the SURF complex (Fig. 1.13). 
Interaction of Upfl with downstream bound Upfj EJC factors instigates Upfl 
phosphorylation by SMG-l and dissociation of eRFl and eRF3. So Upfl 
phosphorylation requires SMG-l, Upfl and Upf3. The bridging ofUpfl between release 
factors and EJC components results in the formation of an intermediate complex termed 
DECID (decay-ingucing fomplex). After Upfl phosphorylation and release factor 
dissociation, SMG7 is recruited to the EJC and promotes dephosphorylation ofUpfl. A 
14-3-3-1ike domain has been mapped as the binding site of Upfl on SMG7. SMG7 
recruits other proteins, SMG5 and SMG6, which presumably aid ln the 
dephosphorylation ofUpfl. SMG7 has been shown to coimmunoprecipitate with 
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Figure 1.13. Trimeric complex assembly and recruitment of SMG7 triggers decay 
See text for details. (Red and blue boxes) Exons; (PTe) premature translation 
termination codon. Adapted from (Behm-Ansmant and Izaurralde, 2006). 
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phosphorylated Upfl, SMG5 and protein phosphatase PP2A. SMG6, in turn, has been 
shown to interact with PP2A and Upfl; however, it is ambiguous whether it is in the 
same complexes containing SMG5 and SMG7. Therefore, it has been suggested that a 
minimal complex ofSMG5 and SMG7 instigates dephosphorylation ofUpfl by PP2A, so 
that Upfl can be recycled into another round ofNMD. 
1.3.4.5. mRNA Decay Enzymes in NMD 
Binding of SMG7 to Upfl is thought to coincide with the recruitment of decay enzymes 
(Unterholzner and Izaurralde, 2004). Tethering SMG7 to a reporter transcript, regardless 
of whether it contains a PTC, promotes its degradation (Unterholzner and Izaurralde, 
2004). The increased turnover of SMG7-bound transcripts is mediated by its C-terminal 
domain. Coincidentally, the C-terminal domain of SMG7 is needed for localization in 
foci where mRNA decay occurs (see section 1.4); the ability oftethered SMG7 to induce 
decay of bound messages relies on Dcp2 and Xml (Unterholzner and Izaurralde, 2004). 
siRNA against Dcp2 or Xml inhibits the mRNA decay function of fulllength SMG7 and 
of a deletion mutant of SMG7 containing only the C-terminal domain (Unterholzner and 
Izaurralde, 2004). Overexpression of SMG7 results in the recruitment of coexpressed 
SMG5 and coexpressed Upfl in mRNA decay foci (Unterholzner and Izaurralde, 2004). 
SMG7 interacts with phosphorylated Upfl and SMG5 via its N-terminal l4-3-3-like 
domain (Unterholzner and Izaurralde, 2004). Upfl in turn has been shown to interact 
with Dcp2 in a yeast two hybrid assay (Dunckley and Parker, 1999). Therefore, SMG7 
appears to be the link between the changes in the phosphorylation state of Upfl with 
mRNA decay, i.e. SMG7 induces decay of mRNAs bound by phosphorylated Upfl by 
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recruiting decay enzymes and targeting their decay in discrete foci in the cytoplasm 
(Unterholzner and Izaurralde, 2004). 
Degradation of PTC-containing mRNAs involves the same enzymes utilized in 
general mRNA decay. In S. cerevisiae, PTC-containing rnRNAs, in general, bypass 
deadenylation of the mRNA and undergo rapid decapping by Dcp1/2 and 5'-3'decay by 
Xml (Muhlrad and Parker, 1994). Sorne PTC-containing mRNAs are also degraded by 
the 3'-5'exonucleolytic pathway, whereby they undergo rapid deadenylation, digestion of 
the mRNA by the exosome and the Ski complex (Cao and Parker, 2003; Mitchell and 
Tollervey, 2003). In mammalian cells, both pathways have been reported to elicit decay 
ofPTC-containing mRNAs (Chen and Shyu, 2003; Lejeune et al., 2003). 
1.3.4.6. Alternative NMD Pathways in Mammalian Cells 
Two alternative complexes with differential requirements for Upt2 have recently been 
reported to elicit NMD (Behm-Ansmant and Izaurralde, 2006; Gehring et al., 2005). 
Both complexes require Upfl, however, they have different sensitivities to depletion of 
the various EJC components, most notably there seems to be a discrepancy in the 
requirement of one of the core proteins of the surveillance complex, Upt2. In one NMD 
pathway, reporter transcripts that are triggered for NMD by tethering known EJC 
components is not inhibited by Upt2 depletion (Gehring et al., 2005). In another 
pathway, Upt2 depletion inhibits NMD triggered by tethering sorne but not all EJC 
factors discussed above (Gehring et al., 2005). Endogenous targets of the alternative 
NMD pathways have been identified by gene expression profiles in cells treated with 
siRNA agaiinst Upfl, Upt2, RNPS 1 or Barentsz (Gehring et al., 2005). These alternative 
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NMD pathways may be minor pathways in mammalian NMD (Behm-Ansmant and 
Izaurralde, 2006). Another possibility is that low levels of Upf2 remaining after si RNA 
mediated knockdown are sufficient to sustain NMD in these assays. Notably, the 
tethering assays may not reflect NMD that is studied by PTC-containing reporter mRNAs 
and may not mirror true NMD (Behm-Ansmant and Izaurralde, 2006) (see General 
Discussion, section 4.2). 
Besides its role in mRNA stability, the EJC stimulates other functions such as 
mRNA export (Le Hir et al., 2001b) and translation (Nort et al., 2004; Wiegand et al., 
2003) (see General Discussion for further detail). 
1.3.5 RNA Interference (RNAi) 
The third group which constitutes one of the mRNA degradation pathways utilized by 
eukaryotes, involves the destruction of target transcripts by short RNAs which are 
complementary to the mRNA (for review and references therein refer to (Murchison and 
Hannon, 2004; Valencia-Sanchez et al., 2006». This mode of RNA silencing is carried 
out by two types of small RNAs, microRNAs (miRNAs) and short interfering RNAs 
(siRNAs). miRNAIsiRNA silence their targets by inducing endonuclease cleavage of the 
mRNA but it is also likely that they, altematively, induce deadenylation and decapping of 
the message (see below). miRNAs also silence specifie targets not by inciting cleavage 
of the rnRNA but by repressing its translation. Interestingly, miRNAs regulate 
approximately 30% of human genes. RNAi by siRNAs and miRNAs will be discussed 
briefly here. 
siRNAs and miRNAs are ~21-25 nucleotides in length. They are processed from 
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different precursors. miRNAs are processed from noncoding reglOns of mRNAs 
produced by RNA Polymerase II, which form a stem loop structure (Fig. 1.14). These 
structures are metabolized in the nucleus by Drosha, an RNAse III enzyme, and its 
interacting partner, DGCR8. After cleavage, the stem loop RNA is reduced to a 65-75 
nucleotide precursor miRNA (pre-miRNA), which is exported from the nucleus by 
exportin 5. In the cytoplasm, the pre-miRNA is processed further by another RNAse III 
endonuclease, DICER, which yields the -21-25 nucleotide double stranded RNA 
(dsRNA). The dsRNA is incorporated into a RNA-induced silencing complex (RISC) 
which is cornposed of several proteins, including a group called Argonaute (Ago) 
proteins. It is this complex which effects RNA silencing of the target mRNA (reviewed 
in (Valencia-Sanchez et al., 2006)). siRNA is produced by processing long dsRNA 
which can either be provided exogenously (for example, by viruses or by transfection of 
cells in culture) or from endogenous precursors (Sontheimer and Carthew, 2005). They 
are also metabolized by DICER and incorporated into a RISC complex. One of the key 
players in the RISC complex is Argonaute 2. This protein has been identified as the 
"slicer"protein, i.e. the prote in which catalyzes the endonuclease cleavage of the mRNA 
target (Meister et al., 2004). 
The specificity of the short RNA to the target govems whether the target will be 
degraded or whether it will be translationally repressed. In general, perfect base pairing 
of the siRNAIrniRNA favours degradation of the mRNA, whereas imperfect base pairing 
by a miRNA results in translational repression (Humphreys et al., 2005; Jing et al., 2005; 
Olsen and Ambros, 1999; Petersen et al., 2006; Pillai et al., 2005; Valencia-Sanchez et 
al., 2006). However, sorne mismatching by miRNA can allow for mRNA cleavage in 
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Figure 1.14. RNA silencing 
Adapted from (Wienholds and Plasterk, 2005). 
Although the miRNA processing pathway is illustrated here, siRNAs are processed from 
long dsRNA (which have been provided exogenously or which are derived 
endogenously) by DICER in the cytoplasm and incorporated into a RISC complex in a 
similar fashion as miRNA, but the protein components which constitute the siRISC may 
differ from miRISC. The mRNA targeted by the siRNA is then degraded in P-bodies like 
the miRNA illustrated in the diagram, which induces cleavage of its target. 
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some cases (Valencia-Sanchez et al., 2006; Wu et al., 2006). Furthermore, while slicer 
activity requires binding to one site of the target mRNA, efficient translation repression 
by miRNA requires binding to many sites on the target. The repression of translation by 
miRNA reportedly occurs by interruption of translation initiation (Humphreys et al., 
2005; Pillai et al., 2005) or a step in translation after initiation (Olsen and Ambros, 1999; 
Petersen et al., 2006). It has been proposed that the two mechanisms of repression are 
not mutually exclusive but that miRNA-mediated repression may influence a 
combination of translation events (Olsen and Ambros, 1999; Valencia-Sanchez et al., 
2006). Furthermore, a relationship of miRNAIsiRNA to rnRNA decapping and 
deadenylation-dependent decay and/or translation repression is suggested by the 
localization of target mRNAs and RISC components in P-bodies with decapping factors 
(see section 1.4) (Jakymiw et al., 2005; Liu et al., 2005a; Liu et al., 2005b; Sen and Blau, 
2005). Therefore, localization of mRNAs in P-bodies may represent an additional level 
ofmiRNA-mediated translational control (Valencia-Sanchez et al., 2006). 
1.4 Processing Bodies (P-bodies) 
1.4.1 Composition ofP-bodies, sites ofmRNA decayenzymes 
Processing bodies (P-bodies) are cytoplasmic foci, visible by light microscopy, where 
mRNA decay takes place (Coller and Parker, 2004; Fillman and Lykke-Andersen, 2005; 
Parker and Song, 2004). These bodies were originally identified as mRNA graveyards in 
yeast, S. cerevisiae, by immunostaining against proteins involved in decapping and 5'-
3'exonuclease digestion (Sheth and Parker, 2003). The DcpllDcp2 decapping complex, 
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Xml, and decapping activators Dhhlp, Patlp, and Lsml-7 as well as rnRNA have all 
been reported to localize in these foci (Sheth and Parker, 2003). Mammalian 
counterparts of the yeast P-body also exist. The mammalian homologs of Dcpll2, Xml, 
Lsml-7 have all been localized to cytoplasmic foci (Cougot et al., 2004; Ingelfinger et 
al., 2002; Liu et al., 2004; van Dijk et al., 2002) which are referred to as mammalian 
processing bodies (P-bodies) but are also known as Dcp bodies (Cougot et al., 2004) or 
GW bodies (Eystathioy et al., 2003), because of the localization of the human GW182 
autoantigen in these foci. The human homolog of dhhlp, p54/Rck, is also concentrated 
in P-bodies (Cougot et al., 2004). In addition, human Edc3 and Hedls, are localized in P-
bodies (Fenger-Gron et al., 2005). Contrary to yeast, the Ccr4 deadenylase is partially 
localized in mammalian P-bodies (Cougot et al., 2004). Components of the exosome, 
however, are excluded from P-bodies, at least in yeast (Coller and Parker, 2005). 
The size and number of P-bodies varies depending on the flow of mRNA going 
through the decapping step (Coller and Parker, 2004). In yeast cells depleted of Dcpl, 
Dcp2, Lsml or Xml there is an increase in the size and number of P-bodies (Sheth and 
Parker, 2003). It is reasoned that mRNAs are trapped at the decapping step and cannot be 
degraded. Accordingly, depletion of Xml from HeLa cells resulted in an accumulation of 
poly(A) RNA in P-bodies (Cougot et al., 2004). In contrast, deletion of decapping factors 
Patl p or Dhhl p results in a loss of yeast P-bodies which suggests that these proteins 
mark the rnRNP for decay in P-bodies (Coller and Parker, 2005; Sheth and Parker, 2003). 
Incidentally, these proteins, in addition to being activators of decapping, are inhibitors of 
translation (Coller and Parker, 2005). Treatment with the translation inhibitor 
cycloheximide results in the disappearance of P-bodies in yeast and mammalian cells 
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(Cougot et al., 2004; Sheth and Parker, 2003). Cycloheximide traps polysomes on the 
mRNA and reflects the state of an rnRNA which is not accessible to decapping enzymes 
and exonucleases, hence the decrease in rnRNAs going through decapping and a decrease 
in P-bodies. Thus, the rnRNA is needed for localization of decapping factors in P-bodies. 
In accordance with the lack of ribosomes in P-bodies, translation factors are absent from 
the foci (Coller and Parker, 2005; Teixeira et al., 2005). Immunoprecipitation of Lsm 
complex components, revealed that Lsmlp-7p coimmunopurifies with rnRNA which is 
not bound by eIF4E, eIF4G and PABP in S. cerevisiae (Tharun and Parker, 2001). This 
led to the hypothesis that there is a rearrangement in the composition of factors bound to 
the rnRNA which coincides with loss of P ABP and with deadenylation (Coller and 
Parker, 2004) (Fig. 1.15). A rearrangement in the rnRNP from a translationally active 
state to an mRNP destined for decay is believed to be necessary for its localization in P-
bodies, where it is either degraded or remains in a translationally repressed state, 
sequestered from the translating pool ofmRNA (Brengues et al., 2005; Coller and Parker, 
2005; Teixeira et al., 2005). 
1.4.2 P-bodies: sites of translationally repressed mRNA 
Bodies with similar morphology exist in Xenopus, Drosophila and C. elegans (Coller and 
Parker, 2004). In these organisms, the bodies represent sites where translationally 
repressed rnRNPs, consisting of maternaI mRNA, are kept for later activation needed in 
development. There is evidence in yeast which also favours that P-bodies are sites 
containing repressed mRNPs which can be released and reactivated. The evidence in 
support ofthis includes: 1) cycloheximide treatment reduces P-bodies even in strains in 
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Figure 1.15. Hypothesis of mRNA decapping and translational repression in yeast 
Adapted from (Coller and Parker, 2004). 
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which decapping is absent (~dcplp), 5'-3'degradation is compromised (~Xrnl), or 3'-5' 
degradation is compromised (~Ski2) (Brengues et al., 2005); furthermore, the number of 
P-bodies is also reduced after cycloheximide treatment in a ~Ski2 strain, which is also 
impaired in decapping by a temperature sensitive mutation (dcpl-2 ski2il) (Brengues et 
al., 2005). This collectively suggests that rnRNPs can exit P-bodies in the absence of 
mRNA degradation. 2) Glucose deprivation induces an increase in the size and number 
of P-bodies; however, GFP-Iabelled rnRNA is restored into the translating pool and away 
from P-bodies when glucose is resupplemented into the media. Moreover, glucose 
resupplementation is accompanied by a disassembly of P-bodies to normal levels (i.e. 
such as seen before glucose deprivation) even in dcpl-2 strains (Brengues et al., 2005). 
3) Yeast strains containing a temperature sensitive mutant of eIF3 (prtl-63) display an 
increased number of P-bodies during glucose deprivation similar to wild type strains, but 
the disassembly of P-bodies does not occur in the prtl-63 after glucose 
resupplementation like in the wild type strains; therefore, the disassembly of P-bodies 
requires translation to be functional (Brengues et al., 2005). 4) Finally, another striking 
example which favours P-bodies as sites where translationally silenced rnRNAs are 
stored, cornes from the co-Iocalization of RISe components (Agol and Ag02) with 
Dcp1l2 and GW182 in mammalian P-bodies (Jakymiwet al., 2005; Liu et al., 2005a; Liu 
et al., 2005b; Rehwinkel et al., 2005; Sen and Blau, 2005). Furthermore, interaction of 
Ag02 with Dcpl/2 and GW182 has been verified (Jakymiw et al., 2005; Liu et al., 2005a; 
Liu et al., 2005b). Moreover, mRNAs which are the target of miRNAs and shown to be 
silenced in a slicer-independent manner (i.e. not cleaved by Ag02 but inhibited at the 
level of translation) also localize to P-bodies (Liu et al., 2005b). Depletion ofGW182 by 
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siRNA not only disrupts P-bodies but impairs RNA silencing of both a miRNA and 
siRNA - targeted reporter (Jakymiw et al., 2005; Liu et al., 2005a; Rehwinkel et al., 
2005). On the other hand, transfection of siRNA into HeLa cells results in an 
accumulation of GW182 to P-bodies (Jakymiw et al., 2005). Whether or not repression 
of translation by miRNA is the effect or the cause of localization of mRNP into P-bodies 
remains to be determined (see General Discussion, Chapter 4). Furthermore, interaction 
of Agol and Ag02 with Dcpl/2 and its colocalization with these factors in P-bodies 
suggests that silencing by miRNA can result in deadenylation and/or decapping of certain 
messages and their degradation; indeed sorne miRNAs are able to elicit mRNA 
degradation (see section 1.3.5). 
1.4.3 P-bodies and NMD 
Given that P-bodies are sites of mRNA decay, it is conceivable that factors involved in 
the "effector arm" ofNMD may also localize in cytoplasmic foci. Overexpressed SMG5 
and SMG7 (see section 1.3.4.5) localize in P-bodies with endogenous P-body factors 
(Unterholzner and Izaurralde, 2004). The localization of SMG5 to P-bodies is dependent 
on its interaction with SMG7. The C-terminal fragment of SMG7 is necessary for its 
localization in P-bodies and for eliciting decay when tethered to an mRNA. Incidentally, 
overexpression of SMG7 also recruits Upfl in P-bodies (Unterholzner and Izaurralde, 
2004). The C-terminal domain of SMG7, however, is not sufficient to accumulate Upfl 
in P-bodies and bypasses the need for Upfl in a tethering assay. Based on these data, a 
model for the role of SMG7 in the NMD pathway has been proposed (Behm-Ansmant 
and Izaurralde, 2006; Conti and Izaurralde, 2005). The N-terminal fragment of SMG7 
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interacts with SMG5 and phosphorylatd Upfl whereas the C-terminal do main is required 
for recruiting mRNA decay enzymes and for concomitant localization in P-bodies where 
the mRNA willlikely be degraded. In this regard, SMG7 is an important link between 
PTC recognition and rnRNA decay. It has yet to be determined whether NMD mRNA 
targets are present in mammalian P-bodies (see General Discussion, Chapter 4). 
1.5 Rationale for the studies performed 
The studies performed here focused on the potential role in rnRNA decay of two 
factors first characterized in this laboratory, termed eIF4AIII and 4E-T (Dostie et al., 
2000a; Li et al., 1999). Both studies were prompted by the unique Iocalization of these 
factors within the cell by immunostaining. eIF4AIII, unlike its other family members 
eIF4AI and eIF4AII, localized predominantly to the nucleus (J. Dostie unpublished data; 
(Bohnsack et al., 2002; Holzmann et al., 2000; Lejbkowicz et al., 1992)). Interestingly, 
eIF4AIII was present in nuclear speckles reminiscent of splicing factor storage sites 
(Holzmann et al., 2000). Furthermore, eIF4AIII peptides were recovered from mass 
spectrometry analysis of the human splicesomal C complex (Jurica et al., 2002; 
Rappsilber et al., 2002; Zhou et al., 2002). Because eIF4AIII localized to the nucleus and 
is recruited to the splicesomal complex, we suspected a function of eIF4AIII in NMD, an 
mRNA decay process that is dependent on splicing and which cofractionates with the 
nucleus. 
We reported that 4E-T is the nuclear import factor of eIF4E (Dostie et al., 2000a). 
In these studies, the localization of 4E-T at steady state revealed a predominantly 
cytoplasmic localization with a prominent punctate staining. At the time, the nature of 
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these foci eluded us. Within recent years, studies performed in mammalian cells and S. 
cerevisiae revealed the localization ofmRNA decay enzymes in discrete cytoplasmic foci 
(Bashkirov et al., 1997; Ingelfinger et al., 2002; Sheth and Parker, 2003; van Dijk et al., 
2002). mRNA decay intermediates were localized to these foci in yeast, which were 
coined P-bodies, providing the first direct evidence that mRNA decay can occur in 
specific sites of the cytoplasm. Thereafter, the function of 4E-T in mRNA decay was 
addressed. Indeed, we report that elF4AIII is a novel component of the EJC and is 
required for NMD in Chapter 2, and that 4E-T is a bonafide component of P-bodies in 
mammalian cells which functions in mRNA decay in Chapter 3. 
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CHAPTER2 
A nuclear translation-like factor eIF4AIII 
is recruited to the mRNA during splicing 
and functions in nonsense-mediated decay 
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2.1 ABSTRACT 
In eukaryotes, a surveillance mechanism known as nonsense-mediated decay (NMD) 
degrades the mRNA when a premature-termination codon (PTC) is present. NMD 
requires translation to read the frame of the mRNA and detect the PTC. During pre-
mRNA splicing, the exon-exon junction complex (EJC) is recruited to a region 20-24 
nucleotides upstream of the exon junction on the mature mRNA. The presence of a PTC 
upstream from the EJC elicits NMD. eIF4AIII is a nuclear protein that interacts 
physically or functionally with translation initiation factors eIF4G and eIF4B, 
respectively, and shares strikingly high identity with the initiation factors eIF4AI/II. 
Here we show that siRNA against eIF4AIII, but not against eIF4AIIII, inhibits NMD. 
Moreover, eIF4AIII, but not eIF4AI, is specifically recruited to the EJC during splicing. 
The observations that eIF4AIII is loaded onto the mRNA during splicing in the nucleus, 
has properties related to a translation initiation factor, and functions in NMD raises the 
possibility that eIF4AIII substitutes for eIF4AIIII during NMD. 
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2.2 Introduction 
Ribosome recruitment to the mRNA in eukaryotes requires the RNA helicase, eukaryotic 
initiation factor 4A (eIF4A), which is thought to unwind 5' secondary structure in the 
mRNA and facilitate binding of the small ribosomal subunit (1). eIF4AI and eIF4AII are 
two similar gene products that are functionally redundant for translation initiation (2); 
eIF4AI accounts for the majority (about 75%) of total eIF4A in a rabbit reticulocyte 
lysate (3). eIF4AIII, which is ~70% identical to eIF4AIIII (4), cannot substitute for these 
proteins in an in vitro rnRNA ribosome binding assay (4). Nevertheless, a relationship of 
eIF4AIII to a translation-like mechanism is suggested by the observation that eIF4AIII 
requires the initiation factor eIF4B for efficient RNA unwinding activity (4). In addition, 
eIF4AIII interacts with another essential initiation factor, eIF4G (4). eIF4AIII can inhibit 
translation in a rabbit reticulocyte lysate when added in large amounts (4), whereas it 
may have a stimulatory effect on selective mRNA translation in Xenopus oocytes (5). 
Importantly, in contrast to eIF4AIIII, which are cytoplasmic, eIF4AIII is nuclear where it 
co-Iocalizes with splicing factors in speckle domains (6). 
Nonsense-mediated decay (NMD) is an RNA surveillance mechanism that rids 
the cells of defective mRNAs bearing a PTC (7-9). About 30% of inherited genetic 
disorders are the consequence of mutations that create a PTC (10). NMD is both a 
splicing and translation-dependent event (11). An exon-exonjunction complex (EJC) is 
assembled 20-24 nucleotides upstream of the exon-exon junction on the mRNA as a 
result of splicing (12, 13). The EJC is composed of rnRNA export factors (such as 
Aly/REF) and factors that are required for NMD (such as RNPS1, Y14, mago and Upf3) 
(11, 14, 15). Many ofthese splicing-dependent mRNA binding proteins are localized in 
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the nucleus but shuttle between the nucleus and the cytoplasm (11, 14). The EJCs are 
positional markers of introns; when a termination codon is present at least 50-55 
nucleotides upstream of a spliced intron, i.e. upstream of an EJC, it is recognized as 
premature (16-19). In mammalian cells, intronless, PTC-bearing mRNAs are not subject 
to NMD, demonstrating the importance of splicing for NMD (20-22). In addition to being 
splicing-dependent, NMD also requires translation. Protein synthesis inhibitors (23), 
mutation of the initiation codon (24), hairpin structures in the 5'UTR (25, 26) and 
suppressor tRNAs aIl inhibit NMD (24). 
NMD is thought to occur during the so-called pioneer round of translation, which 
is defined as the first time the reading frame of the mRNA is read (27). According to a 
CUITent view, the pioneer round of translation occurs when the cap and polyA tail are 
bound by the nuclear proteins CBC and P ABP2, whereas bulk translation occurs when 
the cytoplasmic proteins eIF4E and PABP are bound (27). Because eIF4AIII is localized 
to the nucleus, is a homologue of a translation factor necessary for bulk translation, and 
interacts with translation factors (eIF4B and eIF4G), it is conceivable that it could 
function in the pioneer round of translation and thus in NMD (27). 
Here we report that knockdown of eIF4AIII using RNA interference (RNAi) 
results in inhibition ofNMD, whereas knockdown of eIF4AI and II fails to inhibit NMD. 
We also demonstrate that eIF4AIII, but not eIF4AI, associates with mRNA during 
splicing at a region containing the EJC. FinaIly, we show that eIF4AIII is a 
nucleocytoplasmic shuttling protein. Together, these data indicate that eIF4AIII is loaded 
onto the mRNA during splicing in the nucleus and then functions during NMD. 
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2.3 ResuUs 
RNA interference (RNAi) was carried out in HeLa cens to determine whether eIF4AIII 
plays a role in NMD. To assay for NMD, we analyzed the levels of TCR-~ mRNA, a 
transcript that undergoes NMD in a nuclear-associated manner (24). Wild-type and PTC 
containing TCR-~ transcripts were analyzed (23, 24). Treatment of cens with sman 
interfering RNA (siRNA) against eIF4AIII reduced its level by 80% (Fig.2.1B, lane 4). In 
HeLa cens expressing a PTC-containing TCR-fi gene, the levels of the mutant mRNA 
were very low relative to the levels of the wild type rnRNA, indicating that NMD has 
occurred (Fig. 2.1 A, compare lane 1 to 2). As expected, NMD was strongly inhibited 
upon the addition of the translation inhibitor, cycloheximide (Fig. 2.1A, lane 4)(23). 
NMD was significantly inhibited in cens treated with siRNA against eIF4AIII (Fig. 2.1A, 
lane 5; siRNA against eIF4AIII is accompanied by a decrease in actin, which is 
presumably a consequence of increased cen death), but not in cens treated with a 
negative control siRNA (4E-T inverted; 4E-T inv(28); Fig. 2.1A, lane 9). Furthermore, 
siRNA against eIF4AIII inhibits decay of PTC+ TCR-~ mRNA to a similar extent as 
siRNA against Upfl (29,30). We conclude that eIF4AIII functions in NMD. 
To determine whether siRNA against eIF4AI and eIF4AII affects NMD, we 
treated HeLa cens with siRNAs against these factors (see Table 2.1 for a list of 
sequences). The siRNA treatments resulted in a specific reduction of protein levels of 
75% for eIF4AI and 95% for eIF4AII (Fig. 2.1B). Strikingly, and in sharp contrast to the 
results obtained with RNAi to eIF4AIII, knockdown of eIF4AI and II (Fig. 2.1B, lanes 2 
and 7, respectively) failed to inhibit NMD (Fig. 2.1A, lanes 6 and 7); the PTC-containing 
mRNA was present at levels similar to those seen in untransfected cens or cens treated 
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Figure 2.1. RNAi against eIF4AIII impairs NMD. 
(A) Northern blot analysis of polyadenylated [(poly(A)] RNA hybridized with V~8.1 
probe(23). Lanes 1 and 2 represent stable cell lines expressing wild type TCR-~ mini-
gene and PTC-containing TCR-~ mini-gene, respectively. Cycloheximide treatment in 
both ceIllines was performed for 2h at 37°C (lOOug/ml final) (lanes 3 and 4). siRNAs 
were transfected into stable cell lines expressing a PTC-containing TCR-~ mini-gene 
(PTC+) (lanes 5-9) and wild type TCR-~ mini-gene (PTC-) (lanes 10-14). ~-actin served 
as a loading marker. The 28S and 18S ribosomal RNA serve to demonstrate equal 
loading for eIF4AIII siRNA treated samples because siRNA against eIF4AIII is 
accompanied by decreased levels of actin due to cell death (see Results). CHX, 
cycloheximide. (B and C) Western analysis of the levels of translation initiation factors 
after knockdown. Thirty micrograms of protein extract was resolved by SDS/P AGE. 
Proteins were quantitated against ~-actin (Sigma) as a loading control and the level of 
protein in negative control (4E-T inv) transfected cells was normalized to 100. NT, 
nontransfected . 
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Table 2.1 Summary of the siRNA used for gene expression knockdown 
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Table 1. Summary of the small interfering RNA (siRNA) 
used for gene expression knockdown 
Name 
Synthetic siRNA 
elF4AI 
elF4AII 
elF4AIli 
4E-T Inverted 
Position in the 
open reading frame 
226-244 
122-140 
75-93 
935-953 
siRNA Structure 
5'- GCCCAAUCUGGGACUGGGA dTdT -3' 
3'- dTdT CGGGUUAGACCCUGACCCU -5' 
5'- AGGAGUCUCUCCUUCGUGG dTdT -3' 
3'- dTdT UCCUCAGAGAGGAAGCACC -5' 
5'- AGUGGAAUUCGAGACCAGC dTdT -3' 
3'- dTdT UCACCUUAAGCUCUGGUCG -5' 
5'- CGUACCGUGGAAUAGUUCC dTdT -3' 
3'- dTdT GCAUGGCACCUUAUCAAGG -5' 
with the negative control siRNA (28) (lane 9). To deterrnine whether eIF4AII 
compensates for the loss of eIF4AI function or vice versa, a double knockdown was 
perforrned (Fig. 2.1C). No effect on NMD was observed (Fig. 2.1A, compare lane 8 to 
9). Thus, a large reduction in the levels of the cytoplasmic eIF4A translation initiation 
factors failed to affect NMD, whereas a similar reduction in eIF4AIII exhibited a major 
inhibitory effect on NMD. These data indicate that eIF4AIII, but not eIF4AIIII, functions 
in NMD, although we cannot ru1e out the possibility that the small amounts of remaining 
eIF4AI/II are sufficient for NMD (see Discussion). Notably, the effect of siRNA against 
eIF4AIII is not caused by an increase in transcription of TCR-~ as is evident in the wild 
type cell line (PTC-) (Fig. 2.1A, compare lane 10 to 13 and 14). Furtherrnore, the 
observation that eIF4AI and eIF4AII si RNA fail to inhibit NMD, is not the result of 
inhibition of transcription by these siRNA (compare lanes Il and 12 to lanes 13 and 14). 
To obtain additional evidence that eIF4AI and eIF4AIII have distinct roles in 
NMD, we next asked whether either of these proteins associates with spliced mRNA. 
After splicing, the mature mRNA is packaged into a specific spliced mRNP complex for 
transport to the cytoplasm (31). To deterrnine whether eIF4AIII and/or eIF4AI are 
present in the spliced mRNP we perforrned in vitro splicing of AdML pre-mRNA in 
HeLa nuclear extract followed by immunoprecipitations (Fig. 2.2A, Left). Significantly, 
the spliced mRNA is immunoprecipitated by the eIF4AIII antibody but not by the eIF4AI 
antibody (Fig. 2.2A, compare lanes 2 and 3). As shown in Fig. 2.2A (Right), eIF4AI and 
eIF4AIII are present in both nuclear and cytoplasmic extracts. As eIF4AI is a 
cytoplasmic protein (32-34), this protein, like tubulin (Fig.2.2A, Right), is likely to be a 
contaminant in the nuclear extract. Thus, the failure to immunoprecipitate the rnRNA 
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Figure 2.2. eIF4AIII, but not eIF4AI, associates with the EJC on spliced mRNA. 
(A) eIF4AIII, but not eIF4AI, is associated with spliced mRNA but not with intronless 
mRNA (Left). Western analysis showing the presence of eIF4AIII, eIF4AI, and a-tubulin 
in the nuc1ear (NE) and cytoplasmic (Cyto) extracts (Right). (B) eIF4AIII associates with 
the region of the mRNA that contains the EJC. (Left) Schematic of AdML mRNA 
showing the locations of oligonuc1eotides. The numbers indicate the middle of each 
12mer oligonuc1eotide. (The RNA fragments containing the EJC are designated a, c, and 
e.) (Right) The total reaction after splicing and oligonuc1eotide-directed RNase H 
c1eavage was used for the immunoprecipitations and is shown in lanes designated input. 
Immunoprecipitations were carried out with the indicated antibodies after c1eavage with 
each oligonuc1eotide. The RNA fragments containing the EJC that were 
immunoprecipitated are indicated (a, c, and e). The RNA fragments that do not contain 
the EJC are also indicated (b and d). A darker exposure oflanes 9-12 is inc1uded in order 
to detect fragment d (55nt) generated with the +0 oligonuc1eotide (lane 9). The 13 nt 
RNA fragment generated with the +36 oligonuc1eotide is not detected. 
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with the eIF4AI antibody is not due to the absence of this protein from the nuclear 
extract. The eIF4AI antibody is functional for immunoprecipitation assays as determined 
by immunoprecipitation/Western blot (data not shown). Together, these data indicate 
that eIF4AIII, but not eIF4AI, is specifically associated with the mRNA. 
To determine whether the association of eIF4AIII with the mRNA is splicing 
dependent, we transcribed a construct that is identical to that encoding AdML pre-mRNA 
except that it is lacking the intron. This intronless mRNA (Ai-AdML) was then incubated 
in the nuclear extract and used for immunoprecipitations. Significantly, the Ai-AdML 
mRNA is immunoprecipitated very poorly by the eIF4AIII or eIF4AI antibody (Fig. 
2.2A, lanes 4-6). We conclude that eIF4AIII is specifically associated with mRNA in a 
splicing-dependent manner. This result is consistent with previous studies showing that 
eIF4AIII is specifically associated with highly purified spliceosomal complexes (35-38). 
Proteins that function in NMD as weIl as proteins that function in mRNA export 
are localized on the spliced mRNA to a distinct region located 20-24 nts upstream of the 
exon-exonjunction (12, 13, 15). The proteins that are bound to this region are referred to 
as the exon-exon junction complex (EJC)(11-14). The EJC proteins were originally 
localized on the mRNA using a combination of immunoprecipitation and 
oligonucleotide-directed RNase H cleavage of the mRNA (12). Thus, we next used this 
approach to determine where eIF4AIII is bound on the mRNA. After in vitro splicing, 
three different 12-mer oligos were used for RNase H digestion (see schematic, Fig. 2.2B). 
Immunoprecipitations were carried out with antibodies to eIF4AI and eIF4AIII. In 
addition, we used an antibody to Aly, a known EJC protein (12), as a positive control. In 
lanes 1-4, immunoprecipitations carried out without RNase H digestion demonstrate that 
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eIF4AIII and Aly antibodies, but not eIF4AI antibodies, immunprecipitate spliced mRNA 
but not pre-mRNA in vitro. The mRNA fragments containing the exon-exon junction, 
bands labelled as a, c, and e, were generated by digestion with a -48 oligonucleotide (Fig. 
2.2B, lanes 5-8), +0 oligonucleotide (Fig. 2.2B, lanes 9-12) and +36 oligonucleotide (Fig. 
2.2B, lanes 13-16), respectively. Fragments containing the exon-exonjunction region are 
immunoprecipitated by Aly (Fig. 2.2B, lanes 6, 10, and 14) and eIF4AIII antibodies (Fig. 
2.2B, lanes 8, 12 and 16), but not by eIF4AI antibodies (Fig. 2.2B, lanes 7, 11 and 15). 
The products of the digestion lacking the exon-exon junction (labelled b and d) are 
immunoprecipitated by neither eIF4AIII nor Aly antibodies. We note that the 3' RNase 
H digestion products, which lack the 5'cap (e.g fragments a and d), are more readily 
degraded than the 5' RNase H digestion products, which contain the cap (e.g. fragments 
b, c and e). The 13nt fragment generated with the +36 oligo is not detected at aIl, most 
likely because it is rapidly degraded as it is very small and uncapped. A long exposure of 
the gel shows that fragment d, which does not contain the EJC, is not immunoprecipitated 
by any of the antibodies (Fig. 2.2B, lanes 9-12). Together, these results indicate that 
eIF4AIII, like Aly, is present on the region of the mRNA that contains the EJC. 
To determine whether eIF4AIII associates with spliced rnRNA in vivo, GST-
eIF4AIII or buffer alone (Fig. 2.3A) was pre-injected into Xenopus oocyte cytoplasm. 
After incubation of the oocytes, the eIF4AIII was imported into the nucleus (Fig. 2.3B). 
VAP56, which serves as a marker for the nucleus, is detected in the nuclei of pre-injected 
oocytes (Fig.2.3B). A mixture of 32P_pre_rnRNA, VI and V6 snRNAs (Fig. 2.3C, lane 1) 
was then injected into nuclei ofthe pre-injected oocytes and incubated to allow splicing. 
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Figure 2.3. eIF4AIII is associated with spliced mRNA in vivo. 
(A) Coomassie-stained gel showing GST-eIF4AIII used for microinjection into oocyte 
cytoplasm. (B) Western analysis of Xenopus oocyte nuclei after pre-injection showing 
the presence of UAP56, a known nuclear protein, and recombinant GST-eIF4AIII. (C) 
Inj indicates the total RNA before injection and l indicates the RNA species present in 
the nuclear lysates prior to the addition of glutathione beads. Total RNA unbound (U) 
and bound (B) to the beads is shown. 
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The nuclei were then isolated and the nuclear lysates incubated with glutathione beads. 
The spliced mRNA, but not the pre-rnRNA or snRNAs, is bound to the beads when the 
oocytes contain GST-eIF4AIII (Fig. 2.3C, lane 7). In contrast, no RNAs bind to the 
beads in the buffer control (Fig. 2.3C, lane 4) or when other nuclear GST-fusion proteins 
(GST-Sir2 and GST-~C Aly (39)) are pre-injected (data not shown). We conclude that 
eIF4AIII is specifically associated with spliced mRNA in vivo. The observation that 
eIF4AIII is present in the EJC and is associated with mRNA is consistent with the 
possibility that eIF4AIII plays a direct role in NMD. Moreover, eIF4AIII is recruited to 
the rnRNA during splicing, while the rnRNA is still in the nucleus. 
To determine whether eIF4AIII might accompany the mRNA to the cytoplasm 
together with other EJC components (Y14, magoh, Aly/REF), we used a heterokaryon 
assay (40), that measures the ability of a prote in to shuttle between the nucleus and the 
cytoplasm. A hemagglutinin-tagged eIF4AIII expression plasmid was transfected into 
HeLa cells, followed by fusion to murine NIH 3T3 cells. Three hours after fusion, 
eIF4AIII was detected in most (>95%) of the fused murine nuclei (Fig. 2.4). Incubation 
with leptomycin B (LMB), which inhibits CRM1-dependent protein export, had no effect 
on eIF4AIII shuttling (Fig. 2.4) even after overnight incubation (data not shown). In 
contrast, Leptomycin B aboli shed export of 4E-T, a protein known to be a substrate of the 
CRM1 receptor (28). We conclude that eIF4AIII exits the nucleus in a CRM1-
independent fashion and thus may accompany the mRNA via the T AP-mediated export 
pathway (41-43). The observation that eIF4AIII shuttles, suggests that it can conceivably 
participate in NMD in the cytoplasm and/or nucleus (33, 44, 45). 
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Figure 2.4. eIF4AIII is a shuttling protein. 
eIF4AIII and 4E-T localization was detected by staining with anti-HA antibody (1/1000 
dilution, Covance/Babco,) and Texas red-conjugated anti-mouse IgG (Molecular 
Probes). Human and mouse nuclei are differentiated by staining with Hoechst dye 33258 
(Sigma). The mouse nucleus is indicated by an arrow. Leptomycin B (LMB, Sigma) 
treatments were performed at 5ng/ml final for 5h. Images were processed with a Nikon 
Eclipse E800 microscope at 60X magnification. 
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2.4 Discussion 
Here we have shown that RNAi of eIF4AIII, a protein with striking similarity to the well-
known cytoplasmic initiation factors eIF4AIIII, inhibits NMD. In contrast, RNAi of 
eIF4AIIII had no effect on NMD, suggesting that these proteins do not have a function in 
NMD. Although we cannot rule out the possibility that small amounts of eIF4AI/II are 
sufficient for NMD, we also show that eIF4AIII, but not eIF4AI, is associated with the 
EJC, a complex known to function in NMD. Thus, both the RNAi data and the 
biochemical studies support a role for eIF4AIII and not its close homolog eIF4AI, in 
NMD. We note that eIF4AI knockdown effectively inhibits translation (>80%) of 
poliovirus, which is confined to the cytoplasm and is more dependent on eIF4AI for 
translation than other viral and cellular mRNAs (46, 47) (see Appendix Fig. Al). Thus, 
eIF4AI knockdown affects its function in cytoplasmic translation. 
The early recruitment of eIF4AIII to the spliced mRNA raises the possibility that 
the protein functions in an initial step of NMD. It was previously proposed that NMD 
occurs during the pioneer round of translation (27). Considering (i) the structural and 
functional similarities between eIF4AIII and eIF4AIIII, i.e. its interaction with the middle 
domain of eIF4G 1 and its helicase activity stimulated by eIF4B, (U) the essential role of 
eIF4AIII in NMD, (iii) the presence of eIF4AIII at the EJC (our results; (30, 34, 48)) and 
the recruitment of eIF4AIII to the mRNA while it is still in the nucleus, it is plausible that 
eIF4AIII is required for NMD because it substitutes for eIF4AIIII in the pioneer round of 
translation. Another, but not mutually exclusive possibility, is that eIF4AIII functions as 
a structural component of the EJC and that its helicase activity is required for remodeling 
the components of the EJC. This may be necessary for its positioning, likely through 
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Upf2 and Upf3, in proximity to the ribosome and its associated factors to communicate 
the site of the PTC. In a previous study, Upf2, was shown to interact with eIF4AI (49). 
It is possible that this interaction occurs during a later step of NMD or functions in 
cytoplasmic NMD, as this interaction was shown in yeast, where NMD appears to be a 
purely cytoplasmic process. 
It is still a matter of debate whether the first round of translation takes place in the 
nucleus or the cytoplasm. Given that eIF4AIII is a nucleocytoplasmic shuttling factor, it 
can conceivably function in either compartment. It was reported earlier that the nuclear 
cap binding complex, nCBC, substitutes for the cytoplasmic cap-binding prote in, eIF4E, 
in the pioneer round of translation (27). Other potential translation initiation factors that 
could function uniquely in NMD include PABP2 and an eIF4G-like protein (35, 36). 
Similar to eIF4AIII, these proteins are present in the nucleus and are specifically 
recruited to spliceosomes (35, 36). eIF4G-like contains a region which is similar to the 
domain in eIF4G that interacts with eIF4AIII (4). By analogy to the cytoplasmic 
initiation complex, eIF4G-like may interact with both eIF4AIII and nCBC. The 
cytoplasmic translation initiation factor PABPI interacts with eIF4G and the poly(A) tail, 
and PABP2 is a candidate for this protein in the nuclear initiation complex. Together, 
these observations raise the possibility that NMD involves a set of previously 
uncharacterized translation initiation factors that are loaded onto the rnRNA early in its 
biogenesis in the nucleus. 
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2.5 Materials and Methods 
2.5.1 siRNA Transfections 
siRNA transfections were performed in HeLa cells using Lipofectamine Plus Reagent 
(Invitrogen). One day prior to siRNA transfection cells were trypsinized to achieve 50-
60% confluency. For a 6-well plate, 15~1 ofsiRNA duplex (20~M annealed duplex from 
Dharmacon) was mixed with 100ul OPTI-MEM medium and 1O~1 Plus Reagent and 
incubated for 15 minutes at room temperature. In a separate tube, 20~1 Lipofectamine 
(Invitrogen) was added to 100~1 OPTI-MEM. Lipofectamine mix was added to pre-
complexed RNA mix and incubated for an additional 15 min. RNA and prote in were 
harvested 48 hours post-transfection for use in Northern and Western blots, respectively. 
For double knockdown of eIF4AI and eIF4AII, eIF4AII si RNA was transfected using 
conditions described above, 12 hours later eIF4AI siRNA was transfected in the same 
manner and cells were collected 60 hours post-transfection. 
2.5.2 Western Blot 
Cells were washed twice and scraped in ice-cold PBS and pelleted at maximum speed for 
10 minutes in a microcentrifuge. Cell pellets were frozen on dry ice and thawed in RIP A 
buffer (150mM NaCI/50mM Tris-HCl pH 7.5/1% NP-40/0.5% sodium 
deoxycholate/O.l % SDS and a cocktail of protease inhibitors [Roche Diagnostics D, 
incubated on ice for 10 min and centrifuged for 5 min at maximum speed to recover the 
supernatant. The amount of prote in loaded is indicated in the figure legends. Proteins 
were separated on a SDS/I0% PAGE , transferred to a nitrocellulose membrane 
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(0.22uM), blocked ovemight in 5% non-fat milk, and incubated with antibodies (anti-
eIF4AIII (4), anti-eIF4AI (4), and anti-eIF4AII (50)) prepared in 1 %BSA/PBST (0.5% 
Tween) at a dilution of 1/1000 (except for 4AII which was used at 1/500 dilution) for 1h 
at room temperature, washed four times for 15 minutes with PBST (0.5% Tween), and 
incubated with secondary antibody (1/5000) for lh at room temperature. 
2.5.3 NMD Assay 
Cells stably expressing TCR-~ wt (3C1) and TCR-~ containing a PTC (7C3) were a 
generous gift from Miles Wilkinson and Melissa Moore(51). Total RNA was isolated 
using Qiagen (Valencia, CA) RNAeasy kit according to the manufacturer's instructions. 
For Northem blots, 3ug of total RNA was separated on a 1.3% agarose/formaldehyde gel, 
transferred to a Hybond-N membrane (Amersham Pharmacia) and probed with 32p_ 
labeled, random-primed DNA probes: TCR-p V p8.1 and human actin probes were 
prepared from plasmids pl17 and p290, respectively(23, 52). Cycloheximide treatment 
was performed at a final concentration of 100ugimi for the indicated amount of time. 
2.5.4 Immunoprecipitation of Spliced mRNA and Oocyte Injections 
Oligonucleotide-directed RNase H cleavage and immunoprecipiation was performed 
essentially as described(12). Briefly, endogenous RNase H digestion was accomplished 
by adding each cDNA oligo to a final concentration of O.5/-lM to in vitro splicing 
reactions and incubating the reaction for 10 min at 30°C. For no oligo controls, 
equivalent volumes of TE buffer was added to the splicing reactions. 
Immunoprecipitated RNAs were recovered by phenol/chloroform extraction and ethanol 
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precipitation. RNA species were analyzed on 15% denaturing polyacrylamide gels and 
visualized by Molecular Dynamics PhosphorImager. Oocyte microinjection was carried 
out according to Luo. et al(31). The plasmid encoding GST-eIF4AIII was constructed by 
cloning the cDNA encoding human eIF4AIII protein into protein expression vector 
pGEX5 at BamHI and XhoI sites. GST pull-down of the in vivo complexes was done as 
described (53). 
2.5.6 Heterokaryon Assay 
HeLa and NIH 3T3 fusions were performed as previously described(54). HA-tagged 
eIF4AIII and 4E-T were previously reported(4, 28) and were transfected into HeLa cells 
by the calcium phosphate method. Cells were treated with 5nglml LMB (Sigma) 3h 
before cell fusion. Cells were subsequently washed with PBS 1 X and cell fusions were 
formed by incubation for 2 min in 50% polyethylene glycol (PEG) 8000 in PBS. Cells 
were washed extensively with PBS and returned to fresh media containing 100uglml 
cycloheximide and 5ng/ml leptomycin B. After 2h, cells were fixed and processed for 
immunofluorescence as described previously(28). 
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APPENDIX (TO CHAPTER2) 
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Figure Al. Effect of eIF4A RNAi on cellular translation measured by 35S_ 
methionine incorporation into TCA precipitable mate rial. 
(A) siRNA treatment was performed as described in Materials and Methods (Chapter 2). 
Forty-eight hours later cells were labeled with 35S-methionine for 60 minutes and assayed 
for incorporation of 35S-methionine into acid-insoluble material in 5ul-aliquots of 
translation samples (Schoenberg, D.R., mRNA Processing and Metabolism, Methods and 
Protocols, Svitkin and Sonenberg, Chapter 13, Section 3.8). Radioactivity was 
determined by liquid scintillation counting and normalized to actin levels by NIH Image 
software. The result is an average of three independent experiments. 4E-T inv = 
negative control. (B) Knockdown efficiency by Western of eIF4AI and eIF4AIII in two 
independent experiments. 
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Figure A2. Effect of eIF4A RNAi on poliovirus translation. 
HeLa CCL2 were transfected with si RNA in a 24-well plate with lipofectamine plus 
reagent (see Chapter 2, Materials and Methods). 48h later, cells were infected with the 
Mahoney strain of poliovirus type 1 at a multiplicity of infection (M.O.!) of 5 plaque-
forming units (Pfu) per cell. After virus adsorption at room temperature for 30 min, cells 
were further incubated at 37°C. At the indicated time points after infection, the medium 
was replaced with media containing 101lCi/mL eSS]-methionine. After further incubation 
for 30 minutes at 37°C, the cells were washed once in PBS and lysed in IX laemmli-
sample buffer. Uninfected cells were radiolabelled and collected at 6 hours. Twenty 
microliters of celllysate was resolved by 15% SDS-PAGE, transferred to a nitrocellulose 
membrane and subjected to autoradiography. Viral proteins are indicated by ellipsoids. 
The membrane was subsequently subjected to Western analysis with anti-eIF4AI and 
eIF-4AIII antibodies. p-Actin served as a loading control. 
102 
hours uninfected 
negative control 
6 
elF4AIli 
siRNA 
6 
elF4AI mock 
6 6 
hours post-infection 4 5 6 4 5 6 4 5 6 4 5 6 
35S-methionine 
labelling 
Western 
Blot ae'F4A'III---- ___ --""11 --__ lae'F4A' 
~;;;;;;~;;~;;==~;;~;;~;;~a;;~11 i a actin 
----II" .r - ~ 1 aactin ~----------------------------------~ 
CONNECTING TEXT 
Studies performed in yeast S. cervisiae unequivocally demonstrated that mRNA can be 
degraded in distinct sites within the cytoplasm. mRNA decay enzymes and decapping 
factors involved in the 5' to 3' decay pathway, as well as mRNA decay intermediates, 
were stained in specific sites of the cytoplasm in yeast, which were called processing 
bodies (P-bodies). We previously reported that 4E-T is a nucleocytoplasmic shuttling 
protein which imports eIF4E to the nucleus. At steady state, 4E-T is predominantly 
localized in the cytoplasm with a prominent staining in discrete cytoplasmic foci. The 
nature of these foci, at the time, was unbeknownst to us. The resemblance of 4E-T 
staining to that seen with decapping factors in yeast P-bodies, and the resemblance of P-
bodies to particles in other organisms where repressed mRNAs gather, prompted our 
study of the role of 4E-T in translation repression and mRNA decay. In Chapter 3, we 
show that 4E-T is a component of mammalian P-bodies, as well as is its binding partner, 
eIF 4 E. We demonstrate that a 4 E-TI eIF 4 E interaction results in the inhibition of cap-
dependent translation, that 4E-T is essential to the formation of P-bodies and is required 
for mRNA turnover. In summary, we describe a distinct function of 4E-T from its role in 
the nuclear import of eIF4E, which may contribute to translational homeostasis. 
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CHAPTER3 
A role for the eIF4E-binding protein 4E-T 
in P-body formation and mRNA decay 
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3.1 Abstract 
4E-Transporter (4E-T) is one of several proteins which bind the mRNA 5'cap-binding 
protein, eukaryotic initiation factor 4E (eIF4E), through a conserved binding motif. We 
previously showed that 4E-T is a nucleocytoplasmic shuttling protein, which mediates the 
import of eIF4E into the nucleus. At steady state, 4E-T is predominantly cytoplasmic and 
is concentrated in bodies that conspicuously resemble the recently described Processing 
bodies (P-bodies), which are believed to be sites of rnRNA decay. In this report, we 
demonstrate that 4E-T colocalizes with rnRNA decapping factors in bana fide P-bodies. 
Moreover, 4E-T controls mRNA half life, because its depletion from cells using short 
interfering RNA (siRNA) increases mRNA stability. The 4E-T binding partner, eIF4E, 
also is localized in P- bodies. 4E-T interaction with eIF4E represses translation, which is 
believed to be a prerequisite for targeting of mRNAs to P-bodies. Collectively, these data 
suggest that 4E-T interaction with eIF4E is a priming event in inducing mRNP 
rearrangement and transition from translation to decay. 
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3.2 Introduction 
The regulation of mRNA biogenesis and decay plays an important role in the control of 
gene expression. mRNA decay regulates protein levels, eliminates aberrant mRNAs, and 
is an essential host defense mechanism during viral infection (Coller and Parker, 2004). 
There are 3 major rnRNA decay pathways (Coller and Parker, 2004; Parker and Song, 
2004). The general pathway involves deadenylation followed by decapping of the 
mRNA. In yeast, transcripts are primarily degraded in a 5' to 3'direction by the Xml 
exonuclease (Coller and Parker, 2004; Muhlrad et al., 1995; Parker and Song, 2004; 
Schwartz and Parker, 1999), whereas in higher eukaryotes, mRNAs mostly are eliminated 
in a 3' to 5' fashion by the exosome after deadenylation (Chen et al., 2001; Hilleren et al., 
2001; Mukherjee et al., 2002; Tourriere et al., 2002; Wang and Kiledjian, 2001; Wilusz et 
al., 2001). mRNA degradation also can occur through a second pathway which involves 
endonucleolytic cleavage of mRNAs (Schoenberg and Chemokalskaya, 1997), and in 
addition, through specialized mechanisms, including nonsense-mediated decay and 
nonstop decay (For reviews see (Coller and Parker, 2004; Parker and Song, 2004; 
Tourriere et al., 2002; Wilusz et al., 2001). 
mRNA decapping is a crucial step in general and specialized rnRNA decay 
(Parker and Song, 2004). Decapping is mediated by a heterodimeric complex composed 
of Dcp1 and Dcp2 (Beelman et al., 1996; Dunckley and Parker, 1999; Lykke-Andersen, 
2002; van Dijk et al., 2002; Wang et al., 2002). Numerous factors that regulate 
decapping activity have been identified in yeast and mammals. The Lsm 1-7 complex, 
Pat1p, Dhhlp, Edclp, Edc2 and Edc3 are positive regulators of decapping, characterized 
in yeast (Coller and Parker, 2004; Parker and Song, 2004). 
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Most mammalian mRNAs studied are the target of degradation by the 3'-
5'exosome (Chen et al., 2001; Mukherjee et al., 2002; Wang and Kiledjian, 2001). 
Nonetheless, decapping activity similar in function to the yeast Dcplp has been detected 
in HeLa cells (Gao et al., 2001) and mammalian homologues of Dcp1l2 (Lykke-
Andersen, 2002; Wang et al., 2002), the Lsm proteins (Achsel et al., 1999), and Dhh1p 
(Smillie and Sommerville, 2002) also exist. Furthermore, Xml homologs have been 
identified in mammals (Bashkirov et al., 1997; Ingelfinger et al., 2002). However, it has 
not been demonstrated unequivocally whether deadenylated-decapped mRNAs are 
subject to 5'or 3'exonucleolytic decay in mammalian cells in vivo (discussed m 
(Mukherjee et al., 2002; Wang and Kiledjian, 2001; Wilusz and Wilusz, 2004). 
The mRNA 5' cap structure and the 3' polyA tail play important roles in the 
decapping process (Coller and Parker, 2004; Wilusz et al., 2001). The polyA inhibits 
decapping, likely through the polyA binding protein (PABP) interaction with eIF4G, a 
component of the eIF4F cap-binding complex (Coller and Parker, 2004). eIF4F also 
contains the cap binding prote in, eukaryotic initiation factor 4E (eIF4E), and the RNA 
helicase, eIF4A (Gingras et al., 1999). The interaction ofPABP with eIF4G enhances the 
binding of eIF4F to the mRNA (Kahvejian et al., 2005), and thus, hinders the access of 
the decapping complex to the cap. Consequently, translation and decapping are 
antagonistic. Consistent with this idea, mutations in eIF4E and eIF4G can lead to an 
increase in decapping in yeast (Schwartz and Parker, 1999). Importantly, decapping 
requires the removal of eIF4F from the 5'cap structure, which, in turn, necessitates a 
transition from a translationally active mRNP to one destined for decay. This transition 
entails the replacement of initiation factors on the mRNA with decapping factors (Coller 
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and Parker, 2004; Parker and Song, 2004; Teixeira et al., 2005; Tharun and Parker, 
2001). The switch from translation to decay occurs concomitantly with aggregation of 
mRNPs into distinct cytoplasmic foci, termed processing bodies (P-bodies) in yeast 
(Sheth and Parker, 2003), or GW bodies (Eystathioy et al., 2003) or Dcpla bodies in 
mammals (Cougot et al., 2004); these are referred to as P-bodies throughout this article. 
The decapping enzyme, Dcpl/2, and decapping associated factors, Lsml-7, Dhhlp/p54 
and Xml, are concentrated in these foci (Cougot et al., 2004; Ingelfinger et al., 2002; Liu 
et al., 2004; Sheth and Parker, 2003; van Dijk et al., 2002). However, little is known 
about the recruitment mechanism of mRNAs to P-bodies, or how initiation factors are 
exchanged with decapping enzymes. 
We reported earlier the cloning of 4E-Transporter (4E-T), which interacts with 
eIF4E through a conserved eIF4E recognition motif (YXXXXL<l>, where <l> is a 
hydrophobic amino acid) that is found also in eIF4G and 4E-BP. 4E-T is a 
nucleocytoplasmic shuttling protein that mediates the nuclear import of eIF4E through 
the importin a/p pathway. At steady state, 4E-T is predominantly cytoplasmic and is 
concentrated in bodies that conspicuously resemble the recently described P-bodies 
(Dostie et al., 2000a; Sheth and Parker, 2003). Here, we report that 4E-T colocalizes 
with eIF4E and decapping factors in bona jide P-bodies and controls mRNA turnover. 
Significantly, depletion of 4E-T from cells enhances mRNA stability. 
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3.3 Results 
3.3.1 4E-Tcolocalizes with decappingfactors 
To determine whether 4E-T associates with P-bodies, the localization of 4E-T and P-
body components was analyzed by immunofluorescence in HeLa cens. Cells transfected 
with HA-4E-T were analyzed by double-label immunofluorescence microscopy using 
anti-HA antibody and an affinity-purified anti-Dcp1a antibody that recognizes the 
endogenous protein (see Materials and Methods). Transfected HA-4E-T and endogenous 
Dcp1a colocalized in the cytoplasm in discrete foci that strongly resemble P-bodies (Fig. 
3.1 A). Similar results were obtained with a GFP- tagged 4E-T (Fig. 3.1 B). To show that 
endogenous 4E-T also localizes to P-bodies, its colocalization with Me31B was studied. 
[Me31B is the Drosophila homolog of the human decapping factor Dhh1p/p54, and 
similar to Dcp1a, is an established marker of P-bodies (Sheth and Parker, 2003; Tseng-
Rogenski et al., 2003). Me31B shares 71% identity with Dhh1p/p54 and was shown to 
form cytoplasmic granules in germline cens (Nakamura et al., 2001)]. HeLa cens 
transfected with myc-EYFP-Me31B were stained with an affinity purified anti-4E-T 
antibody, and analyzed by microscopy. Endogenous 4E-T colocalizes with myc-EYFP-
Me31B in discrete cytoplasmic foci (Fig. 3.1 C). Thus, endogenous and transfected 4E-T 
colocalize with bona fide decapping factors in cytoplasmic foci, which fulfil the criteria 
of P-bodies. 
3.3.2 4E-T downregulates cap-dependent translation 
In the yeast Saccharomyces cerevisiae, targeting of rnRNAs to P-bodies is believed to 
occur as a consequence of cessation of translation (Schwartz and Parker, 1999; Teixeira 
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Figure 3.1. 4E-T colocalizes with decapping factors in P-bodies. 
(A and B) Transfected 4E-T colocalizes with endogenous Dcpla. HeLa cells transfected 
with HA-4E-T (A) or GFP-4E-T (B) were stained with anti-Dcpla to visualize 
endogenous Dcp 1 a. The localization of HA -4 E-T was determined by indirect 
immunofluorescence with anti-HA (Covance) and Alexa Fluor 594 anti-mouse IgG. 
Dcpla was revealed with anti-Dcpla and either Alexa Fluor 488 anti-rabbit IgG (A) or 
Alexa Fluor 594 anti-mouse IgG (B). The colocalization of HA-4E-T or GFP-4E-T with 
Dcpla appears yellow (right). (C) Endogenous 4E-T colocalizes with transfected myc-
EYFP-Me31B. HeLa cells were transfected with myc-YFP-Me31B and colocalization 
with endogenous 4E-T was performed with anti-4E-T and Texas-Red conjugated anti-
rabbit IgG. Colocalization appears yellow (right). 
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et al., 2005; Tharun and Parker, 2001). Thus, it is conceivable that changes in mRNP 
composition that lead to translational arrest result in targeting the mRNA to P-bodies in 
mammals. 4E-T interacts with eIF4E through a conserved binding site, which is also 
found in eIF4G (Mader et al., 1995), and thus might promote targeting of mRNAs to P-
bodies by inhibiting translation initiation. To address this possibility, the inhibitory effect 
of 4E-T on translation was examined in vivo. HeLa cells infected with recombinant 
vaccinia virus vTF7-3 (to synthesize the T7 RNA polymerase in the cytoplasm) were co-
transfected transiently with plasmid DNA containing a 4E-T cDNA and a bicistronic 
reporter construct expressed from a T7 promoter. The bicistronic reporter construct 
consists of the luciferase (LUC) and chloramphenicol acetyl transferase (CAT) cistrons, 
separated by the poliovirus internaI ribosome entry site (IRES) (Pause et al., 1994) (Fig. 
3.2 A). Translation of the LUC cistron proceeds in a cap-dependent manner, whereas 
translation of the CAT cistron is cap-independent and serves as a surrogate control for 
mRNA levels. [Note that quantification of the RNA by Northern blotting could not be 
performed because the vaccinia virus T7 system produces heterogenous RNA transcripts, 
generating smeared bands (Fuerst and Moss, 1989). This is attributed to the lack of an 
authentic T7 RNA polymerase termination sequence. However, this has no deleterious 
effect on mRNA turnover or translation (Fuerst and Moss, 1989)]. Only a fraction (5-
10%) of T7 transcribed RNAs are capped by the vaccinia capping enzyme (Fuerst and 
Moss, 1989). However, uncapped RNA is translated inefficiently both in vivo and in 
vitro (Both et al., 1975; Fuerst and Moss, 1989; Peng and Schoenberg, 2005; Shatkin, 
1976; Sonenberg et al., 1980), and unpublished data). Thus, even if on1y a small fraction 
of the T7 transcribed RNAs are capped in the T7 vaccinia virus system, the uncapped 
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Figure 3.2. 4E-T inhibits cap-dependent translation in vivo. 
(A) Schematic presentation of the bicistronic reporter plasmid (pGEM-LUC-POLIRES-
CAT). HeLa cells were infected with the vaccinia virus vTF7-3, and transiently 
transfected with the reporter plasmid and pcDNA3-4E-T constructs. (B, bottom panel) 
Western blot analysis of the transfected cells was performed with anti-4E-T antibody. 
Lane 1, pcDNA3; lane 2, pcDNA3-4E-T; lane 3, pcDNA3-4E-T - Y30A. The interaction 
of the wt and mutant 4E-T prote in with eIF4E was examined by Far-Western analysis 
(top panel) using a e2p]-labeled eIF4E probe. (C) LUC and CAT activity were 
measured 16 h after transfection. The LUC/CAT activity ratio is expressed as a 
percentage of the control (pcDNA3) set at 100%. The experiments were performed four 
times in duplicate. 
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products largely are untranslated (~0.4-1 % of uncapped compared to capped RNA: 
unpublished data). AlI constructs were expressed to similar levels (Fig.3.2 B, bottom 
panel, compare lanes 2 and 3). The binding of 4E-T to eIF4E was demonstrated by Far-
Western blotting with e2p]HMK-eIF4E (Fig. 3.2 B, lane 2, top panel). The 4E-T mutant, 
Y30A, which is mutated in the YXXXXL<I> motif, did not bind to eIF4E, as expected 
(Fig. 3.2 B, lane 3, top panel). LUC expression was decreased significantly by 
overexpression of wild type 4E-T (Fig. 3.2 C, left, top panel), whereas CAT activity 
remained relatively unchanged (Fig. 3.2 C, left, bottom panel). In contrast, the Y30A 
mutant of 4E-T did not affect LUC or CAT expression. Therefore, overexpression of 
wild type 4E-T, but not the mutant Y30A, strongly inhibited (88%) translation (Fig. 3.2 
C). In conclusion, overexpression of 4E-T in HeLa cells results in the repression of 
translation only when bound to eIF4E. 
3.3.3 eIF4E localizes to P-bodies 
Because 4E-T localizes to P-bodies, and because it interacts with eIF4E, it was pertinent 
to ask whether eIF4E also localizes to P-bodies, and whether this localization requires 
4E-T. To this end, we performed immunofluorescence analysis of endogenous eIF4E in 
HeLa cells using a monoclonal antibody, which recognizes eIF4E in the cytoplasm 
(Kimball et al., 2003). Although eIF4E is distributed throughout the cytoplasm, it is 
concentrated in foci reminiscent of P-bodies (Fig. 3.3 A). This staining pattern is 
observed in two different HeLa cell sublines: HeLa CCL2 and HeLa S3 (Carter et al., 
1995), but with qualitative differences (Fig. 3.3 A and B-E, respectively), and in mouse 
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Figure 3.3. eIF4E colocalizes with 4E-T, Dcpla and Dcp2 in P-bodies. 
(A) HeLa cells (CCL2) were fixed and the localization of eIF4E was determined by 
indirect immunofluorescence with mouse anti-eIF4E monoclonal antibody and Alexa 
Fluor 594 anti-mouse IgG. The localization of 4E-T was examined with anti-4E-T and 
that of Dcp2 with anti-Dcp2 and Alexa Fluor 488 anti-rabbit IgG. The colocalization of 
these factors appears yellow in the merged image. (B) The colocalization of endogenous 
eIF4E with 4E-T and Dcpla was examined with anti-4E-T and anti-Dcpla in HeLa S3 as 
above. The left panel demonstrates endogenous eIF4E localization in HeLa S3. Zoomed 
images (right panel) display colocalization of endogenous eIF4E and Dcpla in P-bodies. 
Sorne of the more distinct P-bodies are indicated by arrowheads. (C) HeLa cells were 
transfected with GFP-4E-T and the staining of endogenous eIF4E was performed with 
anti-eIF4E antibody as described above. (D) The intensity of fluorescence of 
endogenous eIF4E in P-bodies from GFP-4E-T-transfected cells (from panel C) was 
compared against the intensity of fluorescence of eIF4E from nontransfected cells along 
the path which is indicated by the arrow. The P-bodies along the path of the arrow are 
circled in the adjacent panel for comparison for better visibility. The signal was allowed 
to bleach before quantification in order to avoid a saturated signal. The graphs plot the 
intensity of fluorescence against the distance (!lm) traversed by the arrow. (E) HeLa cells 
transfected with GFP-4E-T were incubated with Alexa Fluor 594 anti-mouse IgG (M-
AF594) without prior incubation with anti-eIF4E antibody to demonstrate the integrity of 
the green filter. 
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embryo fibroblasts (not depicted). Furthermore, transiently transfected HA-eIF4E also 
displays a similar cytoplasmic distribution pattern (see below, Fig. 3.4 A). 
Double-label immunofluorescence analysis shows that eIF4E colocalized with 
4E-T and Dcp2 in P-bodies (Fig. 3.3 A). eIF4E exhibited a more pronounced association 
with P-bodies in CCL2 (Fig. 3.3 A) as compared to HeLa S3 (Fig. 3.3 B). eIF4E 
colocalized with Dcp1a and 4E-Tin P-bodies, albeit staining of eIF4E in these structures 
is not as apparent as the staining of 4E-T and Dcp1a in HeLa S3 (Fig. 3.3 B). Strikingly, 
overexpression of GFP-4E-T resulted in enhanced staining of eIF4E in P-bodies (Fig. 3.3 
C). Because localization of eIF4E in P-bodies was more prominent, and the foci 
appeared larger and brighter in GFP-4E-T overexpressing cens than in parental cens, 
these data suggest that 4E-T might tether eIF4E to P-body structures. This effect is 
illustrated in a graph plotting the intensity of the eIF4E signal (red channel) in two P-
bodies marked by an arrow in cens overexpressing 4E-T levels (Fig. 3 D, right panel) and 
in cens expressing endogenous 4E-T levels (Fig. 3.3 D, left panel; the respective P-bodies 
traversed by the arrow are circled in the adjacent panel for comparison). The signal 
intensity of eIF4E was approximately two-fold higher in cens overexpressing 4E-T as 
compared with endogenous 4E-T levels, when P-bodies of weaker intensity were selected 
from cens overexpressing 4E-T to avoid signal saturation of the plot. Similar results 
were obtained with a monoclonal antibody against eIF4E from Transduction Laboratories 
(610270), and with a monoclonal antibody (lOC6), which recognizes eIF4E 
predominantly in the nucleus (Dostie et al., 2000b; Lejbkowicz et al., 1992); unpub1ished 
data). The enhanced eIF4E signal is not due to 1eakage of the FITC signal, since no 
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significant signal was detected in the red channel when cells transfected with GFP-4E-T 
were stained with the secondary antibody alone (Fig. 3.3 E). 
To determine whether the association of eIF4E with P-bodies reqmres its 
interaction with 4E-T, we performed immunofluorescence analysis using wild type HA-
eIF4E and a mutant lacking the 4E-T binding site (eIF4E W73A) (Dostie et al., 2000a). 
Low eIF4E cDNA amounts were transfected transiently into HeLa cells to obtain a 
predominantly cytoplasmic (Dostie et al., 2000a) and P-body localization (Fig.3.4 A). 
Cytoplasmic eIF4E levels in HA-eIF4E-expressing cells were similar to endogenous 
levels. However, a more pronounced cytoplasmic foci staining was observed in - 40% of 
the transfected cells, presumably because more eIF4E is expressed in these cells. In 
contrast, HA-eIF4E W73A did not localize to P-bodies, and was distributed uniformly 
between the cytoplasm and the nucleus (Fig. 3.4 A). Therefore, loss of 4E-T interaction 
[and also interaction with eIF4G and 4E-BPs (Mader et al., 1995)] leads to deregulated 
cellular localization, which results in diffuse staining throughout the cell. In addition, 
because the HA-4E-T (Y30A) mutant, which is defective in eIF4E binding (Dostie et al., 
2000a), still localizes to P-bodies, these results suggest that 4E-T is required for the 
association of eIF4E with P-bodies, but not vice versa (see also Fig. 3.5 C). 
Because eIF4E is part of the heterotrimeric eIF4F complex, it was important to 
determine whether eIF4A and eIF4G also localize to P-bodies. Because 4E-T and eIF4G 
are expected to compete for binding to eIF4E, no other eIF4F complex components - with 
the exception of eIF4E - were expected to localize to P- bodies. To investigate this, the 
localization of endogenous eIF4GI and eIF4A was studied in HeLa cells transfected with 
GFP-Dcp1b. Western blot analysis with anti-eIF4A, which recognizes both eIF4AI and 
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Figure 3.4. eIF4E requires interaction with 4E-T for localization to P-bodies while 
the other components of the eIF4F complex are excluded from P-bodies. 
(A) HeLa cells were transfected with HA-eIF4E wt, HA-eIF4E W73A, or HA-4E-T 
Y30A. Localization of proteins was studied by indirect immunofluorescence with anti-
HA (Covance) and Alexa Fluor 594 anti-mouse IgG. (B and C) HeLa cells were 
transfected with GFP-Dcplb and staining of endogenous eIF4GI (B) or eIF4A (C) was 
detected with anti-eIF4GI and Texas Red conjugated anti-rabbit IgG or with anti- eIF4A 
and Alexa Fluor 594 anti-mouse IgG. (D) HeLa extract (50 and 100 /lg) was resolved by 
SDS-8% PAGE and a Western blot was performed with rabbit anti-eIF4GI polyclonal 
antibody. For eIF4A detection, proteins were resolved by SDS-IO% PAGE and Western 
blot was performed with a mouse anti- eIF4A monoclonal antibody. 
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eIF4AII (Edery et al., 1983), and anti-eIF4GI revealed protein bands corresponding to the 
expected size of the proteins (Fig. 3.4 D). Immunofluorescence analysis with these 
antibodies shows that eIF4GI and eIF4A do not localize to P-bodies because neither 
protein colocalizes with the P-body marker, GFP-Dcp1b (Fig. 3.4, B and C). Similar 
results were obtained using two other anti-eIF4GI antibodies (unpublished data). Thus, 
eIF4E, but neither eIF4GI nor eIF4A, localized to P-bodies in vivo. It is highly likely that 
eIF4GII behaves in a similar manner, because it exhibits very similar properties to 
eIF4GI (Gradi et al., 1998). 
3.3.4 siRNA against 4E-T results in decreased localization of decapping 
factors to mammalian P-bodies 
To investigate whether 4E-T plays a role in the formation of P-bodies, cellular 4E-T 
protein levels were reduced by RNA interference (RNAi). Western blotting (Fig. 3.5 A) 
and immunofluorescence analysis (Fig. 3.5 C) demonstrate that 4E-T was reduced 
strongly (85%) after treatment with a short interfering RNA (siRNA) against 4E-T, but 
not by the corresponding inverted sequence (4E-T inverted) (Fig. 3.5 A). Another 
nonspecific siRNA that was used as a control, 4AIII inverted (Ferraiuolo et al., 2004), 
failed to affect 4E-T protein levels (Fig. 3.5, A and C). 4E-T depletion caused Dcp1a and 
eIF4E to disperse throughout the cytoplasm and no longer concentrate in foci (Fig. 3.5 C; 
cells which were unaffected in their staining in P-bodies are those which had not taken up 
the siRNA against 4E-T, as confirmed by immunostaining with anti-4E-T antibody: not 
depicted). The disappearance of P-bodies was not observed in cells that were transfected 
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Figure 3.5. Depletion of 4E-T from HeLa eeUs results in disappearanee of 
deeapping factors from P-bodies. 
(A) HeLa cells were transfected with siRNA against 4E-T or control siRNAs (4AIII 
inverted or 4E-T inverted). 48 h aftertransfection, cells were split into chamber slides for 
immunofluorescence analysis (see (C)) and into a 6 cm dish for Western blot analysis. 60 
h after transfection, prote in cell extracts were prepared and 20 Jlg of extract was resolved 
by SDS-I0% PAGE. Western blotting was performed with rabbit anti-4E-T and anti-
eIF4E antibodies, or mouse anti-~-actin monoclonal antibody (Sigma-Aldrich). 4E-T 
levels were quantified against ~-actin, which served as a loading control, and the level of 
protein in the negative control (4AIII inverted) transfected cells was set as 100. (B) 
HeLa extract (20Jlg) as in (A) was resolved by SDS-lO%PAGE and Western blotting was 
performed with rabbit anti-Dcpla and anti-Xenopus p54 (Xp54) antibodies, or 
monoclonal mouse anti-eIF4E (SK) and anti-~-actin antibodies. (C) HeLa (CCL2) cells 
were transfected with control siRNA (4AIII inverted) or 4E-T siRNA and indirect 
immunoflorescence was performed 60 h after transfection with rabbit anti-4E-T and anti-
Dcpla antibodies, or monoclonal mouse anti-eIF4E antibody. (D) HeLa S3 cells were 
transfected with 4E-T siRNA or control siRNA (4AIII inverted). 24 h after transfection, 
cells were transfected with myc-EYFP-Me31B; 36 h later, extracts were collected for 
either SDS-P AGE analysis or fixed for immunofluorescence. Cell extracts were resolved 
by 10% SDS-PAGE and Western blot analysis with rabbit anti-4E-T, or monoclonal anti-
myc (9EI0) and anti-~-actin was performed. Indirect immunofluorescence was 
performed to assess the localization of 4E-T, and the localization of myc-EYFP-Me31B 
was assessed by direct immunofluorescence. The right most panels show the enlarged 
bordered image. 
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with the nonspecific control siRNA. No changes in Dhh1p/p54, Dcp1a, and eIF4E 
prote in levels occured in 4E-T depleted cells as compared with nonspecific siRNA 
controls (Fig. 3.5, A and B). 
The effect of 4E-T depletion on Me31B localization also was examined (Fig. 3.5 
D). The tagged version of Drosophila Me31B was used because the antibody against 
endogenous p54, used in Fig. 3.5 B for Western analysis, is not suitable for 
immunofluorescence. HeLa cells transfected with 4E-T or control siRNAs were 
transfected with the myc-EYFP-Me31B plasmid, and analyzed by Western blotting and 
double label immunofluorescence (Fig. 3.5 D). 4E-T levels were reduced efficiently in 
4E-T siRNA treated cells, and the myc-EYFP-Me31B protein was expressed in cells 
treated with control or 4 E-T siRNAs (left panel). In control cells, myc-EYFP-Me31 B 
was predominantly cytoplasmic and concentrated in P-bodies (right panel). However, 
when 4E-T levels were reduced, Me31B exhibited a diffuse staining pattern throughout 
the cytoplasm and reduced or no staining in P-bodies (right panel). Thus, reduction of 
4E-T protein levels causes mislocalization of eIF4E and decapping factors away from P-
bodies. 
3.3.5 Cycloheximide inhibits localization of 4E-T to P-bodies whilst LMB 
treatment does not affect its localization 
In yeast and mammalian cells, cycloheximide treatment releases decapping factors from 
P-bodies (Cougot et al., 2004; Sheth and Parker, 2003). Cycloheximide inhibits mRNA 
translation at the elongation step, which prevents mRNA degradation because of its 
protection by ribosomes (Ross, 1995). To study whether 4E-T localization to P-bodies is 
dependent on mRNA availability, the effect of cycloheximide on the localization of 4E-T 
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was examined. HeLa cells were treated with cycloheximide (lOJlg/ml), and analyzed by 
immunofluorescence with anti-Dcp1a and anti-4E-T antibodies. A near complete loss of 
4E-T and Dcp1a from P-bodies was observed after 30 min of cycloheximide treatment 
(Fig. 3.6 A); this suggested that the accumulation of 4E-T in P-bodies is dependent on 
mRNA availability. This effect is not due to a reduction in 4E-T protein levels. Western 
blot analysis demonstrates that the levels of 4E-T and Dcp1a remain unchanged 
throughout the cycloheximide treatment (Fig. 3.6 B). Similar results were obtained in 
HeLa cells transiently transfected with HA-4E-T (Fig. 3.6 C, middle panel). 
Leptomycin B (LMB) is an inhibitor of chromosome region maintenance-1 
(CRM-1)-dependent protein nuclear export. We previously reported that 4E-T is a 
shuttling protein that exits the nucleus through the CRM-1 pathway (Dostie et al., 2000a). 
Because Dhh1p/p54 also shuttles between the nucleus and the cytoplasm (Smillie and 
Sommerville, 2002), it is possible that nuclear eXPOrt is required for the localization of 
4E-T and decapping factors to P-bodies. To test this hypothesis, the effect of LMB on 
the localization of 4E-T and Dcp1a to P- bodies was studied. LMB treatment resulted in 
the accumulation of 4E-T in the nucleus, but did not affect its association with P-bodies 
(Fig. 3.6 C, bottom panel). The distribution of Dcp1a was also unaffected by the drug 
(bottom panel). Thus, the presence of 4E-T in P-bodies is dependent on mRNA, but is 
independent of its nucleo-cytoplasmic shuttling. 
3.3.6 4E-T knockdown increases mRNA half-life 
The results described above suggest that 4E-T might play a role in promoting mRNA 
degradation. To test this hypothesis, we analyzed the turnover of several rnRNAs in 4E-T 
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Figure 3.6. Effect of cycloheximide and LMB 4E-T localization in P-bodies. 
(A) HeLa cells were treated with cycloheximide (CHX; 10J.lg/ml) for 30 min, and 
immunofluorescence staining of 4E-T and Dcpla were examined as described above. (B) 
HeLa cell extract (20J.lg) treated with cycloheximide (CHX; 10J.lg/ml) for 30 and 60 min 
was resolved by 10% SDS-PAGE and Western blot analysis with rabbit anti-4E-T and 
anti-Dcpla, or monoclonal mouse p-actin was performed. (C) HeLa cells were 
transfected with HA-4E-T. 36 h after transfection, the medium was replaced with fresh 
medium (control) or medium containing CHX (100J.lg/ml), and cells were incubated for 3 
h before fixation. Alternatively, media containing LMB (5ng/ml) was added to cells and 
incubated for 5 h before fixation. The colocalization of HA-4E-T was determined by 
indirect immunofluorescence with anti-HA (Covance) and that ofDcpla with anti-Dcpla 
antibody as described above. The colocalization ofHA-4E-T and Dcpla appears yellow. 
122 
o 
<C 
c 
0-
E 
0 
M 
c 
0-
E 
0 
e 
+J 
C 
o 
u 
ta 
or--
0-
u 
Cl 
>< I 
Ü 
+ 
1-
1 
w 
~ 
al 
~ 
..J 
+ 
1-;-
w 
V 
0 
\0 
0 
CV') 
0 
c 
E 
x 
:::I: 
U 
ltI 
..... c a. op 
u u 0 ltI 
, 1 
1 1 1 
depleted and control cens. A p-globin reporter that is under the control of a tetracycline-
responsive promoter was fused at its 3' end to one of two distinct adenine/uridine rich 
elements (AREs) (Stoecklin et al., 2004), that of GMCSF or c-fos. The reporter gene -
either lacking or containing the ARE - was co-transfected with a plasmid encoding the 
activator of transcription (pTet-Off) into HeLa cens which were transfected previously 
with 4E-T or control siRNA. Doxycycline was subsequently added to block transcription 
and RNA was conected at the indicated times and analyzed by Northern blotting. As 
expected, p-globin lacking an ARE remained stable throughout the doxycycline 
treatment, whereas p-globin containing the GMCSF or c-fos AREs were rapidly 
degraded, as was previously reported (Chen et al., 1995) (Fig. 3.7, A and B). However, 
4E-T diminution in HeLa cens resulted in significant stabilization (>2-fold) of both p-
giobinlGMCSF and p-globinlc-fos ARE-containing mRNA, with no effect on P-globin 
reporter rnRNA lacking an ARE (Fig. 3.7, A and B). Western blot analysis demonstrates 
that 4E-T protein levels were diminished efficiently in HeLa cens that were transfected 
with the reporter plasmids and in the presence of doxycyc1ine (Fig. 3.7 C). The effect of 
4E-T depletion on endogenous c-fos mRNA turnover also was analyzed. Similar to 
transfected p-globin containing the destabilizing element of c-fos, endogenous c-fos was 
stabilized in the absence of 4E-T (unpublished data). 
The stability of the labile p21 mRNA, which contains an ARE (LaI et al., 2004), 
also was examined in 4E-T-depleted cens. Western blotting analysis demonstrates that 
4E-T RNAi strongly reduced the amount of 4E-T (> 80%, Fig. 3.7 D). p21 mRNA 
stability was determined by Northern blot analysis after actinomycin D treatment to 
inhibit de nova transcription. p21 mRNA levels were quantified in cens that were treated 
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Figure 3.7. siRNA-mediated depletion of 4E-T affects mRNA turnover. 
HeLa cells were transfected with siRNA against 4E-T or a control (Ctrl) siRNA (4AIII 
inverted). Protein and RNA were harvested for use in Western (C and D) and Northern 
(A, B, and E) analysis, respectively. (A and B) HeLa cells were transfected with siRNA 
against 4E-Tor with control si RNA and later cotransfected with pTet-~-globin or pTet-~­
globin c-fos or GMCSF ARE and pTet Off. Cells were treated with doxycycline 
(1Jlglml) -72 h after transfection to block transcription. Total RNA was isolated at 0.5, 
2, 3, 4 hours for ~-globinlGMCSF ARE assays (A) and 0.5, 1.5, 3, 6 h for ~-globinlc-fos 
ARE (B) and analyzed by Northern blot. GAPDH served as a loading control. rnRNA 
half lives were calculated from Northern blots and normalized against GAPDH levels. 
(C) Protein extracts were collected at 6 h after treatment with doxycycline (1 Jlglml) from 
cells that were transfected with the reporter plasmid and pTetOff and resolved by SDS-
PAGE. Lanes 1 and 4: glo= ~-globin + pTetOff; lanes 2 and 5: fos= ~-globinlc-fos ARE 
+ pTetOff; lanes 3 and 6: GM= ~-globinlGMCSF ARE + pTetOff. (D) Protein extracts 
were collected at the latest time point of actinomycin D treatment and resolved by 10% 
SDS-PAGE. Western blot analysis was done with anti-4E-T and anti-~-actin antibodies. 
NT=nontransfected. (E) At 48h after transfection, the half lives of p21 mRNA were 
assessed by using actinomycin D (5Jlglml) for the indicated amount oftime. Total RNA 
(5Jlg) was resolved on 1.3% formaldehyde gel and analyzed by Northern blotting. 28S 
levels and 18S levels served as a loading marker. rnRNA half-lives were calculated from 
Northern blots and normalized against 32P-Iabeled 18S levels and plotted on a graph with 
the zero time point set at 100. 
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with 4E-T siRNAs and in nondepleted cells, and normalized to 18S rRNA Ievels (Fig. 3.7 
E). 4 E-T depletion resulted in a modest (~1.5 fold) , but significant, increase in the 
mRNA half-life (Fig. 7 E). The difference in p2l mRNA stability achieved with 4E-T 
depletion is related inversely to that obtained when the mRNA stabilizer, HuR, is 
depleted from cells (~ 2-fold decrease) (LaI et al., 2004). Thus, 4E-T promotes 
degradation of mRNAs that contain an ARE in their 3' untranslated region (3' UTR). 
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3.4 Discussion 
Here we report a new role for 4E-T in mammalian mRNA degradation. We demonstrate 
that 4E-T inhibits translation, colocalizes with decapping factors in cytoplasmic P-bodies, 
and decreases rnRNA stability. 4E-T interacts with eIF4E through a shared recognition 
motif (YXXXXL<D) also found in eIF4G (Dostie et al., 2000a). Similar to other cap-
dependent translation inhibitors, 4E-T is likely to inhibit translation by competing with 
eIF4G for binding to eIF4E and preventing formation of the eIF4F complex (Pause et al., 
1994; Poulin et al., 1998). Accordingly, overexpression of 4E-T wt, but not of a mutant 
defective in eIF4E binding, strongly inhibited cap-dependent translation of a reporter 
mRNA in vivo (Fig. 3.2). 
The transition of an mRNA from a translationally active rnRNP to one destined 
for decay is believed to be a consequence of translational inhibition, espeeially in yeast 
(Teixeira et al., 2005; Tharun and Parker, 2001). Remarkably, 4E-T is present in P-
bodies, which are cytoplasmic foei containing factors involved in mRNA decay (Cougot 
et al., 2004; Ingelfinger et al., 2002; Liu et al., 2004; Sheth and Parker, 2003; van Dijk et 
al., 2002) (Fig. 3.1). In this study, we also show that eIF4E is localized to mammalian P-
bodies (Fig. 3.3). Overexpression of 4E-T in HeLa cells caused a marked increase of 
eIF4E in P-bodies (Fig. 3.3). This observation suggests that translation inhibition and 
targeting of eIF4E to P-bodies are causally related. The accumulation of eIF4E in P-
bodies requires interaction with 4E-T, because an eIF4E mutant that fails to bind to 4E-T 
cannot localize to P-bodies (Fig.3.4), and depletion of 4E-T resulted in loss of eIF4E 
from P-bodies (Fig.3.5). However, the localization of 4E-T to P-bodies does not require 
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interaction with eIF4E, because a 4E-T mutant defective ln binding to eIF4E also 
localizes to P-bodies (Fig. 3.4). 
eIF4GI and eIF4A did not localize to mammalian processing bodies (Fig. 3.4), 
which is in agreement with studies that demonstrated that mRNA pools from P-bodies are 
distinct from translating pools (Schwartz and Parker, 1999; Teixeira et al., 2005; Tharun 
and Parker, 2001). These observations favor a model whereby translation inhibition that 
results from disruption of the translation initiation complex occurs outside P-bodies, and 
precedes P-body formation. 
As was shown for Dcpla (Cougot et al., 2004; Sheth and Parker, 2003), 
cycloheximide treatment of HeLa cells reduced the amount of 4E-T associated with P-
bodies (Fig. 3.6). This result indicates that ongoing mRNA translation regulates the 
association of 4E-T with P-bodies, and suggests that 4E-T is not a permanent P-body 
constituent, but rather localizes to these structures in an mRNA-dependent manner. 
Importantly, 4E-T RNAi treatment results in decreased decapping activity in HeLa cells 
as evidenced by diminished localization of Dcpla and p54 to P-bodies. Taken together, 
these data support a model whereby interaction of 4E-T with eIF4E acts as a priming 
event leading to mRNP remodeling and mRNA decay. 
In addition to their role in mRNA decay, P-bodies were suggested to function as 
mRNA storage sites (Coller and Parker, 2004; Sheth and Parker, 2003). For example, the 
Drosophila decapping factor Me31 B, is concentrated in cytoplasmic granules in germline 
cells where bicoid and oskar mRNAs are translationally masked (Nakamura et al., 2001). 
In addition, the Xenopus equivalent, Xp54, is a major constituent of maternaI mRNA 
storage particles where translation is repressed (Ladomery et al., 1997; Minshall and 
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Standart, 2004). Thus, it is possible that under certain conditions, the presence of eIF4E 
within P-bodies might permit the transition of a translationallly repressed/stored mRNA 
to a translationally competent state. 
Homology searches using BIast algorithms failed to identify 4E-T yeast homologs 
(Dostie et al., 2000a), and eIF4E was shown not to localize to P-bodies in yeast (Coller 
and Parker, 2004), unpublished observations). Therefore, 4E-T might represent a more 
evolutionarily complex mRNA decay/storage regulation pathway in higher eukaryotes. 
The Drosophila 4E-T homologue, Cup, was reported to mediate translational repression 
of nanos and oskar by interacting with eIF4E and 3' trans-acting factors (Wilhelm and 
Smibert, 2005). Interestingly, the RNA-binding protein Smaug, which interacts with 
Cup, recently was shown to recruit the CCR4 deadenylase complex in Drosophila 
embryos (Semotok et al., 2005). 
An important finding in this paper is that reduction in 4E-T results in an increase 
in rnRNA stability (Fig. 3.7). AlI the mRNAs tested here are ARE-containing mRNAs, 
which are believed to be subject to 3'-5' degradation by the exosome, based on in vitro 
decay assays (Chen et al., 2001; Mukherjee et al., 2002). The major deadenylase of AU-
containing mRNAs in mammalian cells is believed to be poly (A) ribonuclease (P ARN) 
(Gao et al., 2000; Lai et al., 2003). Therefore, 3'-5'degradation would require 
destabilization of the interaction between PABP and eIF4G to allow entry and 
association ofPARN with the cap (Wilusz et al., 2001). Therefore, 4E-T may instigate 
the dissociation of P ABP from eIF4G by binding to eIF4E and displacing eIF4G. The 
decay machinery which processes mRNA through the 5'-3' exonucleolytic pathway, is 
present in P-bodies. Recent studies have implied that the 5'-3' and 3'-5' pathways 
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converge at these sites. For instance, mRNA decay enzymes involved in 5'-3'and 3'-
5'decay are recruited by the ARE binding proteins, tristetraprolin and butyrate response 
factor (Lykke-Andersen and Wagner, 2005). Moreover, tristetraprolin, which mediates 
ARE degradation by recruiting the exosome (Chen et al., 2001), also is found localized in 
P-bodies (Kedersha et al., 2005). Because the disappearance of P-bodies with 4E-T RNAi 
was not synonymous with complete stabilization of p21 mRNA, it is possible that this 
process occurs outside of P-bodies or that its deadenylationldecay occurs by way of a 
distinct pathway from c-fos and GMCSF rnRNAs. 
In conclusion, the interaction of 4E-T with eIF4E in cells has two consequences: 
import of eIF4E to the nucleus (Dostie et al., 2000a) and the targeting of eIF4E to sites of 
mRNA decay. The function of eIF4E in the nucleus is under investigation; a proposed 
nuclear function of eIF4E is to export a subset of mRNAs from the nucleus (Lai and 
Borden, 2000; Rousseau et al., 1996). The dual role of 4E-T also might serve to 
sequester the limiting factor in translation initiation, eIF4E, as a means of maintaining 
translational homeostasis. It will be important to examine how 4E-T is regulated. It is 
reported that 4E-T is a phosphoprotein (Pyronnet et al., 2001); therefore it would be 
interesting to know what pathways regulate its phosphorylation and activity. 
While this paper was under review, two reports were published which demonstrated that 
eIF4E is found in P-bodies (Andrei et al., 2005; Kedersha et al., 2005) and that 4E-T is 
aiso concentrated in P-bodies (Andrei et al., 2005) 
129 
3.5 Materials and Methods 
3.5.1 Plasmids and Cell culture 
HA-4E-T, HA-4E-T (Y30A), HA-eIF4E, HA-eIF4E (W73A) (Dostie et al., 2000a) and 
GFP-Dcplb (Cougot et al., 2004) were described previously. GFP-4E-T was generated 
by subc10ning the coding region of 4E-T from pcDNA3-4E-T (Dostie et al., 2000a) into 
pFRED143 (provided by G. Pavlakis, National Cancer Institute, Frederick, MD). Myc-
EYFP-Me31B plasmid was a gift from A Nakamura (University of Tsukuba, Tsukuba, 
Japan). 
Construction of tetracycline-regulated p-globin expression plasmids: The starting 
plasmid CMV-glo-SPA, which contains the human ~-globin gene with the 3'-UTR and 
polyadenylation site replaced with a multiple c10ning site and a strong synthetic 
polyadenylation element (SPA) was described previously (Das Gupta et al., 1998). The 
first generation tetracyc1ine regulated globin construct pTet-O-BAc-glo-SPA was 
prepared by digesting CMV -glo-SPA with HindIII, end-filling with Klenow fragment 
DNA polymerase, then digesting with NcoI. The globin-SP A fragment was gel purified 
and c10ned into pGTetO~AcLuc3 (provided by Jose Garcia-Sanz, Universidad 
Autânoma, Madrid, Spain) in which the LUC insert was removed by digesting with 
BamHI followed by end-filling with Klenow fragment DNA polymerase plus digestion 
with NcoI. The c-fos ARE was recovered from the plasmid pBBB+AREcfos (provided 
by A-B. Shyu, University of Texas Medical School, Houston, TX) by PCR amplification 
with primers BBBAREI (5'-CGCTCTAGACAGAAGGTGGTGGCTGGTGTG) and 
BBBARE2 (5'-GCGTCTAGACTCAAGGGGCTTCATGATGTC). The GMCSF ARE 
was similarly recovered by PCR from pBBB+AREGMCSF using primers BBBAREI and 
BBBARE3 (5'CCCTCTAGAGCTGGTTATTGTGCTGTCTCA). The PCR products 
were digested with XbaI and inserted into XbaI-digested Tet-O-BAc-glo-SPA to create 
plasmids pTet-O-BAc-glo-ARE[ cfos ]-SP A and pTet-O-BAc-glo-ARE[GMCSF]-SP A 
These were used to prepare the second generation plasmids used in this study. The 
region spanning the tetracycline operator and ~-actin promoter elements of each of these 
plasmids was removed by digestion with Nhel and Ncol, and replaced with the region 
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spanning the tetracycline operator elements and minimal CMV promoter regions of 
pTREmyc. The latter was prepared by PCR amplification of pTREmyc using primers 
BM127 (5'-ATGCCATGGTGTCTAGCACGCG) and BM128 (5'-
CCGCTAGCCACGAGGCCCTTTCGTCTCG). The final plasmids are designated pTet-
CMV min-glo-SPA, pTet-CMVmin-glo-ARE[cfos]-SPA and PTet-CMV . -glo-mm 
ARE[GMCSF]-SP A. 
HeLa S3 cells from M. Wilkinson (M.D. Anderson Cancer Center, Houston, TX) (Carter 
et al., 1995) and HeLa CCL2 (American Type Culture Collection) were cultured in 
DMEM supplemented with 10% FBS. HeLa S3 cells usually were used unless specified 
otherwise. 
3.5.2 Short Interfering RNA (siRNA) Transfections 
siRNA annealed duplexes were purchased from Dharmacon and sequences are listed 
below. HeLa cells were transfected at 30% confluency in 6-well plates with siRNA (300 
pmole final) using oligofectamine according to the manufacturer's instructions. siRNA 
complexes were left ovemight and cells were processed 48 to 72 hours later. 
4E-T siRNA 5' GAACAAGAUUAUCGACCUA dTdT 3' 
4AIII inverted 5' CGACCAGAGCTTAAGGTGA dTdT 3' 
4E-T inverted 5' CGUACCGUGGAAUAGUUCC dTdT 3' 
3.5.3 Transient Transfections and Immunojluorecence 
Transfections of DNA plasmids were performed by the calcium phosphate method as 
described previously (Dostie et al., 2000a). HeLa cells were transfected at 50% 
confluency with 5ug (or 8ug for GFP-4E-T) ofplasmid DNA, and were processed 36 h 
after transfection. For transfection of myc-EYFP-Me31B (Fig. 5D), siRNA transfections 
were performed in 6- well plates as described above; after 24 h, 2ug of myc-EYFP-
Me31B was transfected by the calcium phosphate method. 48 h after siRNA transfection, 
cells were trypsinized into chamber slides and processed for immunofluorescence 12 h 
later. Immunofluorescence was performed as described previously (Dostie et al., 2000a). 
In brief, cells were plated onto Lab-Tek chamber slides (Nunc) 16 h before fixation. 
Cells were fixed with formaldehyde, permeabilized, blocked and incubated with affinity-
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purified rabbit anti-4E-T (11100) (Dostie et al., 2000a), affinity-purified rabbit anti-
Dcpla (1/200) (a gift from J. Lykke-Andersen, University of Colorado, Boulder, CO), 
and anti-Dcp2 (1120) (Liu et al., 2004) antibodies, or monoclonal anti-eIF4A (11100) 
(Edery et al., 1983), anti-eIF4E (1/10) (Kimball et al., 2003), and anti-HA (1/1000; 
Covance) antibodies for 2 h at RT. Cells were washed extensively and incubated with 
either Texas red or Alexa Fluor 488 or 594 conjugated secondary antibody (1/200; 
Molecular Probes) for 30 min. Nuclei were stained with Hoechst dye 33258 (Sigma-
Aldrich). Images were taken from a 63X objective of a Zeiss LSM 510 confocal 
microscope. Immunofluorescence analysis for each experiment was performed three to 
five times, and the most representative results are displayed. 
3.5.4 Western Blotting 
Cells were washed twice with ice cold PBS and pelleted at maximum speed for 10 
minutes in a microcentrifuge. Cell pellets were frozen on dry ice and thawed in RIPA 
buffer (150mM NaCI, 50mM Tris-HCl pH 7.5, 1% Nonidet P-40, 0.5% SDS and a 
mixture of protease inhibitors (Roche Diagnostics)). Extracts were incubated on ice for 
10 minutes and centrifuged for 5 min at maximum speed to recover the supematant. 
Proteins were resolved by SDSIP AGE, transferred to nitrocellulose membrane, blocked, 
and incubated with rabbit anti-4E-T (111000) (Dostie et al., 2000a), anti-Dcpla (1/1000), 
anti-Xp54 (1/2000) (Smillie and Sommerville, 2002), anti-eIF4E 5851 (1/1000) 
(Frederickson et al., 1991) polyclonal antibodies or monoclonal anti-eIF4A (111000) 
(Edery et al., 1983), anti-eIF4E (11100) (Kimball et al., 2003) anti-HA (1/2000) 
(Covance) and anti-~-actin (1/5000) (Sigma-Aldrich) antibodies. 
3.5.5 Vaccinia Virus Infection, Far Western, and Translation Assay 
HeLa cells (80% confluency) were infected with recombinant vaccinia virus for 1 hour at 
37°C (Fuerst et al., 1986). Cells were rinsed once with serum-free media and transfected 
with 5ug each of the reporter plasmid (pGEM-LUC-POLIRES-CAT) and pcDNA3-4E-T 
wt or mutant constructs using lipofectin (15ug; Invitrogen) as previously reported (Pause 
et al., 1994). After 16 h, cell extracts were collected and analyzed for LUC activity using 
a LUC assay system (Promega), and activity was measuredwith a luminometer; CAT 
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expreSSIOn was analyzed usmg ELISA (Boehringer). Far Western analysis was 
performed on transfected cell extracts as described previously (Dostie et al., 2000a) 
3.5.6 Northern blotting 
Total RNA was isolated using Qiagen RNAesy kit according to the manufacturer's 
instructions. Sug of total RNA was separated on a 1.3% agarose/formaldehyde gel, 
transferred to a Hybond-N membrane (GE Healthcare), and probed with 32P-Iabeled, 
random-primed DNA probe to detect p21 (LaI et al., 2004) or 32P-end labeled 
oligonucleotide, using terminal deoxynucleotidyl transferase (Invitrogen), to detect 18S 
rRNA (LaI et al., 2004). For ~-globin reporter assays, 4E-T or control siRNA was 
transfected into HeLa cells as described above. 36 h later, pTet-~-globin reporter 
plasmids and pTet Off (encoding for tTA, transactivator) were cotransfected. 12 h later, 
cells were split 1:6 and treated 16 to 20 h later with doxycycline (1 Jlg/ml). RNA was 
resolved on a formaldehyde gel as above and probed with 32P-Iabeled, random primed 
DNA probe for detecting ~-globin (Stoecklin et al., 2004) or GAPDH. 
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4.1 P-bodies: A Synopsis 
4.1.1 Components of P-bodies 
P-bodies were initially considered as mRNA decay centers but recent data supports the 
idea that P-bodies are more than just "junkyards", they are also recycling factories. P-
bodies contain transiationally repressed mRNPs that are bound by proteins which can 
either reinitiate translation (eIF4E) (Andrei et al., 2005; Ferraiuolo et al., 2005; Kedersha 
et al., 2005), mediate 5'-3'general decay (Dcpl/2, Lsml-7, Xml, Hedls, Edc3, 4E-T) 
(Cougot et al., 2004; Fenger-Gron et al., 2005; Ferraiuolo et al., 2005; Ingelfinger et al., 
2002; Liu et al., 2004; Sheth and Parker, 2003; van Dijk et al., 2002), officiate 
specialized pathways of decay (SMG5, SMG7, Upfl) (Unterholzner and Izaurralde, 
2004), or mediate RNA silencing (Agol, Ago2, GW182, p54) (Chu and Rana, 2006; 
Jakymiw et al., 2005; Liu et al., 2005a; Liu et al., 2005b; Sen and Blau, 2005). In 
addition to proteins, mRNA targets have been localized to P-bodies. mRNAs targeted by 
miRISC were identified in P-bodies in mammalian cells (Liu et al., 2005b). Silenced 
mRNAs were shown to return to the translating pool and away from P-bodies in both 
yeast and mammals (Bhattacharyya et al., 2006; Brengues et al., 2005; Teixeira et al., 
2005). Furthermore, mRNAs targeted by the NMD pathway as weIl as mRNA targets of 
the 5'-3'pathway of normal mRNA decay were localized in yeast P-bodies (Brengues et 
al., 2005; Sheth and Parker, 2003; Sheth and Parker, 2006; Teixeira et al., 2005). 
Moreover, mRNAs targeted for decay by siRNAlRISC were also reported to be in P-
bodies in human cells (Jakymiw et al., 2005). Therefore, it appears that components of 
141 
the three major eukaryotic mRNA decay pathways (deadenylation-dependent decay, 
specialized decay, and RNAi) converge to these focal points called P-bodies. 
The appearance of an mRNA will dictate its fate. Depending on the composition 
of proteinslRNA that it is swathed by, it can either be engaged in translation and 
unravelled into protein, or stored for later activation and translation; alternatively, it can 
be degraded by decay enzymes. Translation and rnRNA decay for the most part are 
antagonistic processes. The mRNA is in a balancing act between the translation apparatus 
and proteinslRNA which "tip" it into decay (Coller and Parker, 2005). The rate of 
mRNA turnover is influenced by translation. In the case ofNMD, the message is read by 
a scanning ribosome and when a termination codon is detected out of context, decay 
enzymes are recruited which carry out the destruction of the rnRNA. Translation rates in 
turn are influenced by miRNAs. Essentially, P-bodies represent another level of 
translational control because through repression and decay mRNAs are sequestered from 
the translating pool in P-bodies (Bruno and Wilkinson, 2006). 
4.1.2 Conservation of P-bodies 
Districts of Translational Control and mRNA Turnover A cross Species 
P-bodies are conserved from yeast to marnmals (Cougot et al., 2004; Sheth and Parker, 
2003). NMD targets are degraded within yeast P-bodies (Sheth and Parker, 2006) and 
since NMD components are found in marnmalian P-bodies, it is likely that this process is 
conserved in marnmals. NMD exists across organisms; however, whether the mechanism 
and regulation of decay occurs in similar bodies throughout phyla, has yet to be 
determined. P-bodies, or the equivalent of P-bodies which consist of districts within the 
142 
cell which regulate translation/decay, exist in Xenopus and Drosophila and control 
translation rates of maternaI mRNAs (Coller and Parker, 2004). It remains to be 
determined whether the mechanisms involved in the translational repression/derepression 
in localized "districts" across different organisms is conserved, as this will help to shed 
light on sorne characteristics of translational silencing and release in human cells. 
Me31B is involved in maskinglsilencing of maternaI mRNAs until fertilization in 
Drosophila (Nakamura et al., 2001). Me31 B is the Drosophila homolog of yeast Dhhl p 
and human p54 which are repressors of translation and are required for P-body assembly 
in yeast and mammals (Chu and Rana, 2006; Coller and Parker, 2005; Sheth and Parker, 
2003). Furthermore, the Xenopus homolog of p54 (Xp54) is also a key component of 
stored mRNA in oocytes and embryos (Smillie and Sommerville, 2002). In Drosophila, 
characterization of the translational regulation of oskar mRNA has revealed that Bruno, a 
protein which binds the Bruno Responsive Element in the 3'UTR of oskar mRNA, 
represses the translation of oskar prior to its localization at the posterior pole by two 
methods: (i) it concomitantly interacts with the eIF4E binding prote in Cup to directly 
inhibit recruitment of the 43S preinitiation complex. Interestingly, Cup is the putative 
Drosophila homolog of 4E-T (see section 1.2.4.3.); (ii) alternatively, Bruno mediates 
oligomerization of oskar mRNA into large (50-80S) RNP "silencing particles," which are 
unattainable to the translation apparatus (Chekulaeva et al., 2006). Incidentally, eIF4E 
and Cup are components of these silencing particles and so is the DEAD box RNA 
helicase, Me31B (Chekulaeva et al., 2006). It would appear then that the Bruno-
mediated silencing particles are similar in function to P-bodies; however, it is still unclear 
if they are related to the masking oskar particles which are derepressed after fertilization 
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or if they are separate entities (Tekotte and Davis, 2006). P-body-like structures exist in 
C. elegans as well. Recently, AIN-l, the C. elegans homo log ofGW182 was reported to 
localize in foci which resemble processing bodies (Ding et al., 2005). Furthermore, it 
was shown to interact with RlSC components and to target the Argonaute protein ALG-1 
to P-bodies when overexpressed (Ding et al., 2005). Therefore, mi RNA mediated 
translational silencinglmRNA degradation in P-bodies seems to be conserved in other 
organisms. Finally, in zebrafish, mi430 induces maternaI mRNA cleavage reminiscent of 
miRNA-mediated cleavage of ARE-mRNA in somatic cells (Wei gel and Izaurralde, 
2006). Whether this occurs in discrete foci is still unknown. Further analysis in other 
organisms may illuminate the mechanism of miRNA function and may unravel the means 
behind mRNA decay, as well as translational silencing and activation with regards to P-
bodies. This will ultimately cast sorne light on P-bodies as translational control centers 
and elucidate their influence on mRNA decay pathways such as NMD. 
4.1.3 Other Granules 
In summary, sorne mRNAs are immediately engaged by the translation apparatus and 
assembled into polysomes. Once translation is completed, the mRNAs are deadenylated, 
polysomes are lost, and the mRNA may be degraded or stored. In sorne cases, translation 
is prematurely interrupted and the mRNA is prompted for rapid decay. In other cases, 
mRNAs are not immediately translated, but are transported or stored until their later 
activation by developmental signaIs or environmental stimuli. Cytoplasmic granules 
refer to all nonorganellar mRNP aggregates which play important roles in the regulation 
of gene expression. RNA granules are visible cytoplasmic entities which regulate 
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translation/mRNA stability (reviewed in (Anderson and Kedersha, 2006)). They exist in 
germ cells (germ cell granules), in somatic cells (P-bodies and stress granules), and in 
neurons (neuronal granules) (Anderson and Kedersha, 2006). The previous section 
focused on the similarities between P-body components and function across phyla. Here, 
the differences between P-bodies and other granules are discussed briefly. The release 
and activation by developmental cues of maternaI mRNAs in Drosophila, Xenopus and 
worm granules are examples of germ cell granules (Anderson and Kedersha, 2006). 
Other granules include stress induced mRNP aggregates analogous to P-body structures, 
called stress granules (Anderson and Kedersha, 2006). Stress granules consist of stalled 
inactive mRNP translation complexes which can either be released and reinitiate 
translation when stress is alleviated, or can be shuttled into a P-body for degradation. 
Stress granules differ from P-bodies in several respects: stress granules are formed as a 
result of eIF2a phosphorylation and contain small ribosomal subunits, as well as 
initiation factors, unlike P-bodies (with the exception of eIF4E). Furthermore, mRNAs 
are not degraded in stress granules. Lastly, stress granules and P-bodies are 
morphologically distinct (Anderson and Kedersha, 2006). Neuronal granules also harbor 
ribosomal subunits, in this case the small and large subunits. These granules are said to 
contain "pretranslational" silenced mRNAs that are transported and released at synapses 
where they are translated after a stimulus is provided (Anderson and Kedersha, 2006). 
Neuronal granules differ from stress granules and P-bodies in that they contain highly 
specific rnRNAs (as do germ cell granules), whereas P-bodies and stress granules contain 
a variety ofmRNA cargo. P-bodies contain nonsense-containing rnRNAs, ARE-mRNAs, 
deadenylated mRNAs and mRNAs targeted by miRNA/siRNA. In essence, all RNA 
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granules contain nontranslating (silenced) mRNA (for reVlew see (Anderson and 
Kedersha, 2006). The mechanisms contributing to their formation and disintegration as 
well as the signalling pathways which impact upon them requires further investigation. 
Notably, not aH mRNAs are degraded in P-bodies. Components of the exosome are not 
present in yeast P-bodies which suggests that mRNA decay can occur away from P-
bodies (Coller and Parker, 2005). 
This work has contributed to a better understanding of the NMD pathway, 
upstream of degradation in P-bodies, and has identified a novel component of the EJC, 
eIF4AIII, which is critical for the detection of a nonsense codon by the translation 
apparatus. Furthermore, this work has identified 4E-T as a novel component ofP-bodies 
which is required for repression of translation (in an eIF4E-dependent manner), mRNA 
decay and P-body formation in human cells, and has also revealed the presence of 
initiation factor eIF4E in P-bodies. 
4.2 eIF4AIII: Analysis of eIF4AIII function and future 
directions 
Given the clinical importance of NMD, efforts have been made to uncover the 
mechanism of PTC recognition in mammalian cells, the factors involved and the 
regulation and localization of PTC-containing mRNA decay within cells. We and others 
have identified eIF4AIII as a novel component of the EJC (Chan et al., 2004; Ferraiuolo 
et al., 2004; Palacios et al., 2004; Shibuya et al., 2004) essential for NMD (Ferraiuolo et 
al., 2004; Palacios et al., 2004; Shibuya et al., 2004). Since eIF4AIII is related to eIF4AI 
(~67% identity), it can interact with eIF4Gl, and also possesses helicase activity 
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stimulated by eIF4B, we proposed that eIF4AIII substitutes for eIF4AI in the pioneer 
round of translation, during NMD (Chapter 2) (Ferraiuolo et al., 2004). However, our 
studies localized eIF4AIII at the exon-exon junction and it was reported by others to 
interact with EJC components (BaHut et al., 2005; Chan et al., 2004; Gehring et al., 2005; 
Palacios et al., 2004; Shibuya et al., 2004; Tange et al., 2005) (Fig. 4.1). Shibuya et al, 
on the other hand, proposed that the function of eIF4AIII in mammalian NMD is to bind 
mRNA directly and act as a scaffold for other EJC factors (Shibuya et al., 2004). This 
was based on the observations that eIF4AIII binds spliced RNA directly at the position of 
the EJC (-24) and that antibodies against eIF4AIII inhibit EJC assembly on the rnRNA, 
generating mRNA specific cleavage fragments normally protected from RNase H 
digestion by the EJC (Shibuya et al., 2004). It was therefore suggested that eIF4AIII acts 
as a "placeholder" upon whom other EJC factors assemble (Shibuya et al., 2004). Since 
then, the minimal stable core complex of the EJC was isolated from HeLa ceHs and found 
to consist of eIF4AIII, Y14, Magoh, and MLN51 (Tange et al., 2005). The EJC core 
complex also was recapitulated in vitro using purified proteins produced in E. coli (Ballut 
et al., 2005). The in vitro core complex is able to assemble onto ssRNA when ATP is 
bound to eIF4AIII, and encompasses a 8 nucleotide (nt) footprint on the RNA similar to 
that observed from EJC deposition on pre-mRNA during splicing (BaHut et al., 2005; Le 
Hir et al., 2000a). Furthermore, it was demonstrated that the core complex remains stably 
associated with RNA as a result of inhibition of eIF4AIII ATPase activity by Y14/Magoh 
(Ballut et al., 2005). eIF4AIII contains aIl the characteristic motifs conserved amongst 
DEAD-box proteins, as weIl as eight motifs which are specific to eIF4AIII. Subsequent 
to the studies mentioned above, mutational analysis of these motifs revealed that DEAD-
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box conserved motifs contribute significantly to EJC assembly and NMD (Motifs la, VI), 
as do eIF4AIII specific motifs (region H) (Shibuya et al., 2006). Therefore, there is 
substantial evidence which supports the initial proposition put forth by Shibuya et al, that 
eIF4AIII functions at the EJC as a stable clamp upon which other EJC factors assemble 
during splicing (Shibuya et al., 2004). The newly reported crystal structure of the core 
complex (eIF4AIII, Barentsz, Y14, Magoh with ATP analog and RNA) validates the idea 
that eIF4AIII represents a new class of DEAD-box proteins which function as 
"placeholders" (Andersen et al., 2006; Bono et al., 2006). These studies demonstrate that 
eIF4AIII enfolds an ATP molecule and binds a 6nt stretch of the RNA. Furthermore, it is 
affirmed from these studies that the ATPase activity of eIF4AIII is inhibited as a result of 
the interaction of core proteins (YI4, Magoh and Barentsz) at the interface between the 
two domains of eIF4AIII, essentially securing the interaction of eIF4AIII with RNA 
(Andersen et al., 2006; Bono et al., 2006). In effect, mutations within eIF4AIII which 
disrupt binding with other proteins in the complex (C-terminal region containing region 
H), ATP-binding (motif VI) or RNA binding (motif la) all have an effect on EJC 
formation and NMD function (Andersen et al., 2006; Bono et al., 2006; Shibuya et al., 
2006). 
Two recent studies raise interesting, yet contradictory, findings. It was reported 
that nonsense-mediated degradation of immunoglobin-Jl can occur independent of the 
EJC, and that degradation of nonsense-containing mRNA depends on the distance of the 
PTC from the 3 'UTR, reminiscent of PTC recognition in yeast. In this case, siRNA 
against eIF4AIII had no effect on degradation of the PTC-containing mRNA (Buhler et 
al., 2006). This result dispels the idea that eIF4AIII functions as an initiation factor in the 
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pioneer round of translation during NMD and that it plays an essential role in PTC 
recognition at the EJC. However, whether EJC-independent degradation is a global 
process in mammalian cells or if it specific to certain mRNAs, such as immunoglobin-J..l, 
is not known. 
Gehring et al demonstrated that two alternative NMD pathways exist in human 
cells (Gehring et al., 2005) (see section 1.3.4.6.). Two distinct mRNP minimal 
complexes were deduced, which have differential requirements for Upf2; tethering assays 
were employed to examine the distinct requirements for EJC components to elicit NMD. 
One pathway is dependent on eIF4AIIIIY14/MagohlBarentszlUpf3b to induce NMD but 
is unaffected by Upf2 depletion. The other NMD pathway is activated by 
RNPS 1/Upf3b/Upf2 but is unaffected by the depletion of eIF4AIII or Barentsz (Gehring 
et al., 2005). However, it is not yet clear if the RNPS 1-dependent mRNP is associated 
with eIF4AIII and other EJC factors at the exon-exon junction but these remain inactive 
or whether they are absent. It was suggested that RNPS1 acts as an alternative eIF4AIII-
independent clamp for EJC factors in this pathway (Gehring et al., 2005). However, 
RNPS1 may have bypassed the need for eIF4AIII in a tethering assay. If eIF4AIII 
functioned as an initiation factor in the first round of translation, one would imagine that 
RNAi against eIF4AIII would affect degradation mediated by tethered RNPS1. Since 
tethering assays are employed at the 3' end of a normal (not containing a PTC) transcript, 
deductions can be made of the nature of these factors with regards to PTC recognition 
and not to their functions in translation. At the very least, the fact that alternative NMD 
pathways exist which are independent of eIF4AIII (Buhler et al., 2006; Gehring et al., 
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2005), raises the possibility that eIF4AIII has additional functions, other than its role in 
NMD, in the cell (see below). 
Notably, mutation ofWalker A and Walker B motifs which are required for RNA-
dependent ATPase activity of eIF4AIII, had no effect on EJC formation or NMD 
(Shibuya et al., 2006). Inhibition of ATP hydrolysis is required to maintain EJC 
composure (Andersen et al., 2006; Ballut et al., 2005; Bono et al., 2006). In accordance 
with this, incubation of HeLa cells stably expressing a TeR-fi gene containing a mutation 
which results in a PTC, with the small molecule translational inhibitor pateamine, 
inhibited NMD (M.A. Ferraiuolo, unpublished data). Pateamine was shown to stimulate 
eIF4AI RNA binding and ATPase activity (Bordeleau et al., 2005). In addition to 
eIF4AI, a column coupled to pateamine was able to pull down eIF4AIII (Bordeleau et al., 
2005). Therefore, presumably the activation of eIF4AIII ATPase activity is targeted by 
pateamine, resulting in EJC disassembly and therefore abrogation ofNMD (see below). 
What then might be the function of eIF4AIII ATPase activity? The unwinding 
activity of eIF4AIII, like eIF4AI, is stimulated by eIF4B in vitro (Li et al., 1999). 
Furthermore, eIF4AIII interacts with the middle fragment of eIF4G1 (Li et al., 1999) 
(Fig. 4.1). Unlike eIF4AI, however, eIF4AIII does not form a 48S preinitiation complex 
in a ribosome binding assay from extracts reconstituted with general translation factors 
and (intronless) mRNA (Li et al., 1999). In addition, RNAi against eIF4AIII did not 
affect general translation rates measured by 35S-Methionine incorporation, nor did it 
affect poliovirus protein production, a system which is more eIF4AI sensitive (see 
Appendix, Figs. Al and A2). InXenopus, eIF4AIII overexpression does not stimulate 
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Fig. 4.1 Model for the function of eIF4AIII 
(A) Translation initiation of bulk mRNA in the cytoplasm. eIF4AIIII interacts with 
eIF4GI/II, which also binds eIF4E, the ribosome associated factor eIF3, and PABP, 
leading to the circularization of the mRNA, to initiate bulk cytoplasmic translation round. 
(B) Translation initiation of the pioneer round. CBP20/80 substitutes for eIF4E and 
PABP2 may substitute for PABPI during the pioneer round of translation when NMD 
occurs. eIF4AIII associates with the EJC, but eIF4AIII has the ability to interact with the 
middle portion of eIF4G and with eIF4G-like. The nature of this interaction may be to 
promote translation initiation during NMD or may be a separate role from its function at 
the EJC; altematively, the interaction with eIF4G-like may be to cause disruption of the 
closed loop and elicit mRNA decay enzymes. 
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overall protein synthesis; it does, however, regulate the translation of selective mRNA 
involved in epidermis formation (Weinstein et al., 1997). Notably, the closest homolog 
of human eIF4AIII is from Xenopus (Li et al., 1999); incidentally, NMD does not occur 
in Xenopus oocytes (Conti and Izaurralde, 2005; Lejeune et al., 2002). Taken together, it 
cannot be ruled out that eIF4AIII functions as a translational regulator. Accordingly, it 
has been reported that splicing enhances translation in mammalian cells (Kunz et al., 
2006; Nott et al., 2004; Wiegand et al., 2003; Wilkinson, 2005). The observed increase 
in translation of spliced rnRNAs is specifically attributed to the EJC (Kunz et al., 2006; 
Nott et al., 2004; Wiegand et al., 2003; Wilkinson, 2005). EJC components tethered 
within the ORF of a reporter luciferase gene, or tethered 6nt away from the translation 
termination codon of a reporter, stimulated its translation (Nott et al., 2004; Wiegand et 
al., 2003). The increased translational yield of spliced mRNA is correlated with enhanced 
polysome association. Interestingly, Upf3 proteins enhance translation when tethered 
within the ORF of Renilla luciferase, independent of its ability to interact with EJC 
factors, demonstrating that NMD and translation are separable activities of EJC factors, 
which may involve different protein complexes and the recruitment of different factors 
(Kunz et al., 2006). The fact that eIF4AIII can bind to eIF4G suggests a role in 
translation which may or may not be autonomous from its role in NMD. To dismiss the 
idea that eIF4AIII functions as translation factor during NMD, one experiment using a 
PTC-containing reporter which has a hairpin structure in the 5 'UTR could be undertaken. 
It was demonstrated that a hairpin structure in the 5'UTR of TCR-~ containing a PTC, 
inhibited its degradation (Wang et al., 2002a). Using this reporter, overexpression of 
eIF4AIII should alleviate inhibition and restore NMD. A mutant of eIF4AIII which 
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abrogates helicase activity or overexpression of eIF4AI wild type should have no effect, 
if eIF4AIII indeed substitutes for eIF4AI in the pioneer round. Altematively, to 
determine whether eIF4AI is excluded from the pioneer round, pateamine could prove 
useful. Patemaine inhibits NMD (M.A. Ferraiuolo, unpublished data); if this is an effect 
of its action on eIF4AI, then RNAi against eIF4AI and incubation with pateamine should 
reduce the inhibitory effect of the drug on NMD. 
Altematively, the interaction of eIF4AIII with eIF4GI observed in mammalian 
cells may be explained by the presence of MIF4G domains in Upf2 (see section 1.2.3.2) 
(Mendell et al., 2000). Perhaps Upf2 recruitment to the EJC occurs through interaction 
with eIF4AIII which disrupts its interaction with eIF4G at the S'end, disrupting the 
closed loop, exposing the S'end and eliciting decay enzymes. However, whether 
eIF4AIII at the EJC interacts with eIF4GI at the S'end and whether eIF4AIII interacts 
with Upf2 in a mutually exclusive manner with eIF4GI has not been verified. 
Furthermore, one must reconcile the fact that tethered eIF4AIII bypasses the need for 
Upf2 to degrade the mRNA (Gehring et al., 2005). Identification of an eIF4G-like 
prote in from mass spectrometry analysis of purified splicesomes raises the possibility that 
eIF4G-like, rather than Upf2, competes for interaction with eIF4G for eIF4AIII (Jurica et 
al., 2002; Rappsilber et al., 2002; Zhou et al., 2002). Indeed eIF4G-like contains MIF4G 
and MA-3 domains and interacts with eIF4AIII, but not eIF4AI, in HeLa cells; this 
interaction persists in micrococcal nuclease treated extracts (L. Huck, unpublished data). 
Proteomics has identified that OIP2, a prote in with 3'-5' exoribonuclease activity, 
interacts with eIF4G-like (L. Huck, personal communication). Therefore, an eIF4G-like 
interaction with eIF4AIII may induce a transition in the mRNP which allows for the 
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recruitment of decay enzymes. Altematively, eIF4G-like may substitute for eIF4G in the 
pioneer round of translation. 
In Drosophila, where exon-exon junctions do not determine PTCs, eIF4AIII is 
required for proper oskar localization to the posterior pole (Palacios et al., 2004). 
eIF4AIII is a component of oskar mRNP complexes where it may play a role in 
transporting and silencing translation of oskar until it is localized to its proper end. 
Drosophila Mago, Y14 and Barentsz are aIl necessary for proper oskar mRNA 
localization (Hachet and Ephrussi, 2001; Mohr et al., 2001; Palacios et al., 2004; van 
Eeden et al., 2001). Moreover, Barentsz is a component of mRNPs in the dendrites of 
hippocampal neurons (Macchi et al., 2003). Collectively, this suggests that EJC 
components could also function in mRNA localization or regulate the expression of 
specific mRNAs in humans (Bono et al., 2006). 
Clearly the ATPase function of eIF4AIII and its ability to bind to eIF4G/eIF4G-
like requires further characterization. From one perspective, the role of eIF4AIII in 
NMD may be considered as a translational inhibitor since its presence at the EJC inhibits 
the production of truncated protein. From another perspective, eIF4AIII may indirectly 
stimulate translation by enhancing the local concentration of eIF4G and perhaps 
eIF4AIIII onto spliced mRNPs (Chan et al., 2004). Since siRNA against eIF4AIII did not 
affect 35S-Methionine incorporation, it may regulate the translation of selective mRNAs, 
like its Xenopus counterpart. Furthermore, it remains to be determined whether the role 
of human eIF4AIII in translation, if any, is distinct from its function in NMD. The 
studies performed by Shibuya et al and the newly reported crystal structure of eIF4AIII 
have solidified the concept that eIF4AIII represents a novel class of DEAD-box proteins 
154 
which act as "placeholders" on the RNA (Andersen et al., 2006; Bono et al., 2006; 
Shibuya et al., 2006). Since the binding to RNA occurs in a sequence independent 
manner, it will be interesting to see if eIF4AIII acts as a general "placeholder" upon 
which other mRNP complexes are assembled. One intriguing possibility is that it may 
perform a function in RISC loading onto the mRNA. Interestingly, a 6nt stretch on the 
mRNA is essential for miRNA-mRNA complexes to form (Sarnow et al., 2006). 
Incidentally, eIF4AIII binds a 6nt stretch of the RNA template used in the crystal 
structure studies, and the EJC encompasses a 8nt stretch during pre-mRNA splicing 
(Andersen et al., 2006; Ballut et al., 2005; Bono et al., 2006; Le Rir et al., 2000a). 
4.3 4E-T Future Directions 
4E-T is an eIF4E-binding protein which is unique amongst its members. It regulates 
eIF4E function in cap-dependent translation by affecting its localization and sequestering 
it from the translating pool, either by carrying it into the nucleus or by sequestering it to 
P-bodies (Dostie et al., 2000a; Ferraiuolo et al., 2005). The role of eIF4E in the nucleus 
is not quite clear. It has been proposed to mediate the transport of growth-promoting 
mRNAs which contain extensive secondary structure in their 5'UTR (Rousseau et al., 
1996). Rowever, the molecular mechanisms underlying eIF4E release from 4E-T in the 
nucleus, eIF4E storage with splicing factors in speckles, and the signalling pathways and 
interactions regulating its release from these nuclear factories to engage in selective 
transport is not known. The nuclear receptor and auxiliary factors involved in the 
transport pathway have yet to be characterized as weIl. To date, PML is the only reported 
protein shown to regulate the nuclear function of eIF4E (Cohen et al., 2001; Lai and 
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Borden, 2000). It is suggested that it inhibits elF4E-mediated transport by reducing its 
affinity for the cap (Cohen et al., 2001; Lai and Borden, 2000). 4E-T may play a defining 
role in the nuclear function of eIF4E. elF4E is released from splicing factories by cap 
analogs as well as in cells overexpressing the SR protein kinase, Clk/Sty (Dostie et al., 
2000b). eIF4E, however, does not contain SR repeats and is likely not a direct substrate 
of the kinase. 4E-T, on the other hand, contains SR repeats which are conserved in 
mammalians (Fig. 1.7). Consequently, it is conceivable that 4E-T may regulate elF4E 
function through this motif. An in vitro kinase assay to test whether 4 E-T is a direct 
target of the Clk/Sty kinase, and the effect of mutations within this motif on elF4E 
localization and function should be investigated. 
4E-T is a phosphoprotein (Pyronnet et al., 2001). 4E-T phosphorylation 
correlates with decreased binding to eIF4E, at least in mitosis-arrested cells (Pyronnet et 
al., 2001). Accordingly, hypophosphorylation of 4E-T correlates with decreased 
translation rates under prolonged hypoxia, presumably due to its increased interaction 
with elF4E (Koritzinsky et al., 2006). Under steady state conditions, 4E-T is 
phosphorylated ((Pyronnet et al., 2001) and M. Jaramillo, unpublished data). The 
signalling pathway/s and kinase/s influencing its phosphorylation, the residues 
phosphorylated, and the effect of phosphorylation on 4E-T functions (i.e. the nuclear 
import of elF4E and 4E-T/eIF4E localization in P-bodies) at steady state, and under 
various stresses, is currently under investigation. 4E-T may be subject to 
phosphorylationldephosphorylation in both cellular compartments (nucleus and 
cytoplasm), and by different enzymes. To date, the phosphorylation of 4E-T appears to 
be sensitive to stimulation by serum and its phosphorylation is inhibited by the MEK 
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inhibitor U0126 (M. Jaramillo, unpublished data). Therefore, 4E-T is influenced by the 
ERK. pathway. Identification of the sites phosphorylated by these kinases will aid to 
decipher the role ofthis signalling cascade on the reported functions of 4E-T. A putative 
phosphorylation site by ERK. is serine 587. This residue was identified by proteomic 
analysis of phosphporylated sites in the developing mouse brain (Ballif et al., 2004) and 
is conserved in other species (Fig. 1.7). 
The murine homolog of 4E-T, Clast4, is also post-translationally modified by 
phosphorylation (Villaescusa et al., 2006). The function of 4E-T phosphorylation in this 
study was not documented; however, several interesting observations were reported, 
including the identification of an altematively spliced isoform of 4E-T, which is missing 
the arginine stretch and the NLS present in the longer isoform. EST database search 
revealed a human EST sequence corresponding to this shorter isoform. It would be 
interesting to know if it is expressed differentially from the long form amongst various 
tissues, whether the short form of 4E-T is produced as a result of an autoregulatory 
response, and whether it exclusively functions in rnRNA decay (since 4E-T localization 
in P-bodies is insensitive to LMB treatment). AIso, the importance of the arginine rich 
region in the isoforml (4E-T), which is missing in isoform2, may allude to a role in the 
nuclear function of isoforml. Secondly, a two hybrid screen identified a subunit of eIF3 
as an interactor ofmurine Clast4 (unpublished observations by (Villaescusa et al., 2006)). 
Similarly, two subunits of eIF3 coimmunoprecipitated with 4E-T from HeLa cells and 
were identified by mass spectrometry analysis (J. Dostie, unpublished data). This raises 
the interesting possibility that 4E-T binds to eIF4E and eIF3 instead of eIF4G and 
represses translation of certain mRNAs for later activation by eIF4G. A role of 4E-T in 
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silencing mRNAs is in accordance with its localization in P-bodies (see below). 
Furthennore, the Drosophila 4E-T homolog, Cup, plays a role in translational repression 
of nanos and oskar mRNA and is present in silencing particles (see below; (Chekulaeva 
et al., 2006; Wilhelm and Smibert, 2005)). 
Clearly, 4E-T plays a role in deadenylation-dependent mRNA decay (Chapter 3). 
What might be the molecular mechanism behind the role of 4E-T in decay? Because 4E-
T interacts directly with eIF4E and this interaction is necessary for the reduced 
expression of a luciferase reporter (Fig. 3.2), it presumably directly interferes with 
recruitment of the 43S pre-initiation complex and inhibits translation. This interaction 
may precede deadenylation of the mRNA and could possibly play an indirect role in 
recruiting the deadenylase complex once P ABP and eIF4G no longer interact. 
Altematively, it may play a more direct role by interacting with proteinls bound at the 
3'UTR, such as TTP and/or BRF-1, which can trigger recruitment of the deadenylase 
complex (Lai et al., 2003; Lykke-Andersen and Wagner, 2005). Interestingly, the RNA-
binding protein Smaug, which interacts with Cup, recruits the Ccr4 deadenylase complex 
in Drosophila embryos (Semotok et al., 2005). The recruitment of the Ccr4 complex by 
Smaug is either the result of Smaug/Cup/eIF4E mediated translational repression of 
nanos or occurs simultaneously with repression (Semotok et al., 2005). In mammalian 
cells, disruption of the translation initiation complex by 4E-T/eIF4E may trigger the 
recruitment of deadenylase activity by 4E-T interaction with ARE-BPs. On the other 
hand, 4E-T may bind eIF4E after deadenylation. A stimulus may trigger recruitment of a 
3 'UTR binding protein which favors recruitment of the deadenylase complex and 
removal of the poly(A) tail, disrupting the closed loop and resulting in 4E-T tethering to 
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the cap-bound eIF4E. 4E-T may then elicit mRNP rearrangements which favor 
aggregation of mRNAs into P-bodies and consequently a decrease in translation. It 
would therefore be a point of interest to determine if 4E-T associates with polyadenylated 
mRNA and/or deadenylated mRNA as weIl as to identify 4E-T interacting proteins (i.e. 
deadenylases, ARE-BPS etc; see below). 
The formation of P-bodies is a process which is clearly dependent on 4E-T since 
its depletion from HeLa cells resulted in disruption of P-bodies (Fig. 3.5). What are the 
signaIs which prompt 4E-T to assemble P-bodies? The effect of 4E-T phosphorylation 
on P-body assembly is currently being studied (see above). Interestingly, rapamycin 
negatively affected P-body formation. HeLa cells treated overnight with rapamycin 
exhibited a decrease in P-bodies (M.A. Ferraiuolo, unpublished data). The effect of 
rapamycin on the phosphorylation of 4E-T, and on its interaction with eIF4E, remains to 
be established. Furthermore, the effect of such a treatment on the phosphorylation of 
eIF4E as weIl as other P-body components must also be assessed. Stressing HeLa cells 
with arsenite or heat shock caused the expected formation of stress granules but 4E-T did 
not colocalize with stress granule markers, rather it was present in close proximity to 
stress granules, as was reported for other P-body components (M.A. Ferraiuolo and R. 
Mazroui, unpublished data). This may denote that 4E-T plays primarily a role in rnRNA 
decay and not in translational repression. To gain insight into the relationship between 
cellular translation and P-body formation, infections with several viruses are being tested 
for their effect on P-bodies. In yeast, P-bodies are sites of viral assembly (Beliakova-
Bethell et al., 2006). In marnmalian ceIls, P-bodies have not only been implicated in viral 
assembly, but also in host-cell defense mechanisms against viruses (Wichroski et al., 
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2006). Analysis of the viral effect on P-bodies could reveal which host factors play a role 
in P-body assembly/disassembly and could indicate the factors involved in viral assembly 
and host-cell defense. Furthermore, since viruses are also subject to regulation by 
miRNAs, studying viruses could illuminate the role of 4E-T and other host factors in the 
regulation of gene expression by miRNAs (Sarnow et al., 2006; Schutz and Sarnow, 
2006). Interestingly, several have alluded to the possibility of a link between P-bodies 
and disease (Marx, 2005). Hypoxia is a marker for poor prognosis in human tumors. 
Under prolonged hypoxic conditions, 4E-T is hypophosphorylated and translation is 
inhibited (Koritzinsky et al., 2006). The effect of hypoxia on 4E-T/eIF4E interaction, 
localization in P-bodies and mRNA stability is currently under investigation. 
The possibility of 4E-T mediated translational silencing in P-bodies has emerged 
from this study (Chapter 3). 4E-T may incite repression in several manners. Firstly,4E-
T may induce repression mediated by miRISC. RISC components and mRNA targets of 
miRNA are localized in P-bodies (see sections 4.1 and 1.3.5). 4E-T is imperative to the 
formation of P-bodies (Fig. 3.5). Consequently, 4E-T should play a decisive role in 
miRNA translational repression. However, knockdown of 4E-T resulted in a slight 
derepression of translation «2-fold) of a luciferase reporter fused to the natural 3 'UTR of 
K-Ras (which has severallet-7 miRNA binding sites) when compared to a control siRNA 
(M.A. Ferraiuolo, unpublished data), and had no effect on a reporter fused to the 
synthetic let-7 miRNA binding sites (L. Huck, unpublished data). The observed effect on 
the K-Ras reporter fusion was not significant to conclude that 4E-T plays a crucial role in 
miRNA silencing, similar to the results obtained from depleting the Cup-like protein in 
Drosophila S2 cells (Rehwinkel et al., 2005). Recently, it was demonstrated that 
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knockdown of Lsml in HeLa cells disrupts P-bodies but like 4E-T has no affect on 
miRNA-mediated repression (Chu and Rana, 2006). Based on these results (and ours), 
this would suggest that miRNA-mediated translational repression does not require P-body 
structures and the localization of mRNA targets and RlSC components in P-bodies is the 
effect of translational repression and not the cause of translational repression (Chu and 
Rana, 2006). The role of Lsml and 4E-T in the miRNA response cannot entirely be ruled 
out. It is possible that they exert functions in miRlSC mediated repression other than let-
7 miRlSCs. In this regard, other reporters should be tested. Furthermore, to entirely rule 
out the causal effect ofP-bodies on miRlSC repression, the localization ofGW182 in 4E-
T depleted cells should be tested. A function of GW182 in RNA silencing has been 
established (Behm-Ansmant et al., 2006; Ding et al., 2005; Jakymiw et al., 2005; Liu et 
al., 2005a; Rehwinkel et al., 2005) Furthermore, miRNA processing is required for 
formation of GW-bodies (Pauley et al., 2006). Therefore, RNAi may specifically take 
place in GWl82-containing bodies or may move from P-bodies to GW bodies for the last 
step in RNAi biogenesis (Pauley et al., 2006). In contrast to 4E-T and Lsml, depletion of 
p54 disrupts P-bodies and alleviates repression induced by miRNA (Chu and Rana, 
2006). Depletion of p54 caused an increase in general translation rates, in addition to 
release of miRNA-mediated repression (Chu and Rana, 2006; Coller and Parker, 2005). 
ln addition, p54 was isolated from active RlSC complexes and interacts directly with 
Agol and Ag02 (Chu and Rana, 2006). Depletion of Lsml had no effect on p54 
interaction with Agos (Chu and Rana, 2006). However, p54 depletion did not affect 
siRNA mediated silencing by RlSC (Chu and Rana, 2006). Therefore, p54 is specific to 
the miRNA response. Intriguingly, 4E-T may play a specific role in the siRNA response 
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as opposed to the miRNA response. Preliminary results have suggested a role of 4E-T in 
siRNA-mediated decay. siRNA against 4E-T, but not a control siRNA, inhibited gene 
silencing by siRNA against eIF4E or lamin AlC (M.A. Ferraiuolo, unpublished data). 
Furthermore, depletion of 4E-T inhibited Ag02 ("slicer") localization in P-bodies (M.A. 
Ferraiuolo, unpublished data). Whether 4E-T knockdown inhibits degradation of a 
siRNA reporter has yet to be tested. Moreover, it would be interesting to see the effect of 
4E-T knockdown on p54 interaction with Ago1 and Ag02 and other RISC components. 
Secondly, since 4E-T inhibited cap-dependent translation, it is possible that it 
mediates selective mRNA repression by interaction with proteins bound to the 3 'UTR, 
other than RISC, such as is reported for its Drosophila homolog. 4E-T may act as an 
adaptor molecule between eIF4E at the 5'end and a protein bound at the 3'end, similar to 
the way Cup is sandwiched between eIF4E and Bruno. Alternatively, 4E-T may interact 
with eIF4E at the 5' end and interact directly with an RNA element in the 3'UTR much 
like the 4E-HP/BicoidiBRE (Bicoid Responsive Element) interaction (Cho et al., 2005; 
Wilhelm and Smibert, 2005). Sorne candidate pro teins at the 3' end that may interact with 
4E-Tare: ARE-BPS, which have known functions in the regulation of translation 
(Barreau et al., 2005), Bruno human homologs (Good et al., 2000) and CPEB 
(cytoplasmic polyadenylation element (CPE) binding factor), the latter of which is 
complexed with 4E-T in Xenopus oocytes (N. Standart, persona! communication) and 
which is localized in mammalian P-bodies (Wilczynska et al., 2005). Interestingly, 
Xenopus p54 (Xp54) and CPEB interact in oocytes in large complexes which also contain 
eIF4E; furthermore, tethered Xp54 represses translation in Xenopus oocytes (Minshall 
and Standart, 2004). An interaction of 4E-T with p54 was also detected in Xenopus 
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oocytes, which is independent of RNA, therefore, 4E-T may be in a complex with Xp54 
and CPEB and repress translation by preventing the binding of eIF4E with eIF4G in 
Xenopus oocytes (N. Standart, personal communication). It would be of interest to 
determine if 4E-T interacts with p54 in vivo in mammalian cells, and whether general 
translation is affected by this interaction. The idea that 4E-T interacts with specific RNA 
elements in the 3 'UTR is suggested by the presence of an arginine rich stretch within 4E-
T and a serine rich stretch which may function as RNA binding domains (Fig. 1.7). The 
ability of 4E-T to interact with RNA directly should be examined. 
The latter point raises a third possibility in which 4E-T may mediate repression. 
This is inspired by studies performed in Drosophila, in which oskar rnRNA silencing 
occurs by Bruno-mediated RNA oligomerization (Chekulaeva et al., 2006). Although 
RNA oligomerization is independent of a Cup/eIF4E interaction, Cup is present in these 
large RNP partic1es (Chekulaeva et al., 2006). Surprisingly, it was also observed in this 
study that Cup recruits eIF4E to the mRNA independent of the cap (Chekulaeva et al., 
2006). Therefore, examining the role ofthese putative RNA-binding elements, discussed 
above, within 4E-T may prove informative. Furthermore, the high proline content of this 
protein implies a role in multiprotein associations, which may be needed for mRNP 
aggregation. Lastly, it should be reiterated that the speculated modes of translational 
repression mediated by 4E-T here, derives from the fact that 4E-T is present in P-bodies 
(which are "silencing centers") and that its overexpression inhibits cap-dependent 
translation in HeLa cells. 4E-T can hypothetically regulate gene expression in two 
manners: translation repression and mRNA degradation. Whether the two are separable 
roles of 4E-T requires further analysis; although we have demonstrated a role of 4E-T in 
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mRNA decay, translation repression and mRNA decay are not necessarily mutually 
exclusive properties of 4E-T, as was demonstrated for GW182 (Behm-Ansmant et al., 
2006). It is conceivable that the biological context or stimuli and the nature of the 
resultant mRNA-bound proteins will dictate the pathway by which 4E-T incites a 
decrease in gene expression, i.e. mRNA decay versus translational repression or both. 
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